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ABSTRACT
THE RELATIONSHIP BETWEEN CANCER-RELATED FATIGUE AND UPPER
EXTREMITY FUNCTION IN BREAST CANCER SURVIVORS
Meryl Marger Picard
Seton Hall University
2012
Chair: Dr. Genevieve Pinto-Zipp

Background: Cancer-related fatigue (CRF) and arm morbidity constitute the two most
common symptom complexes impacting breast cancer survivors (BCS) following
surgery and adjuvant treatment, but these multifaceted entities have traditionally been
researched as if they were separately occurring events in the survivor's recovery.

Objective: This study examined the relationship between breast cancer survivors'
perceptions of CRF and upper extremity function one to six years post-diagnosis. The
study further investigated the impact of multiple adjuvant therapies, node dissection
procedures, caring for dependent children, and physical aspects of employment on CRF
and upper extremity function.

Methods: One hundred fifty-eight BCS responded to an exploratory internet-based
cross-sectional demographic survey, the FACIT-F and the DASH. Descriptive statistics,
correlation and simple linear regression were used for data analysis.

Results: An analysis revealed a moderate statistically significant relationship between
CRF and upper extremity function, r = -.661, P < .001, such that BCS with higher levels
of fatigue also exhibited higher levels of arm morbidity. In addition, 22.3% reported
persistent fatigue symptoms, consistent with the criteria for a diagnosis of CRF, with

14

45.5% of the fatigued subset also reporting significant limitations in upper body function.
BCS demonstrated significantly higher levels of fatigue when compared to prior
research on a nationally representative sample of adults (p = .037). Women who were
caregivers of at least one dependent child demonstrated higher levels of fatigue than
women without dependent children (p

=0.38). The BCS reported high levels of function

overall indicating that many survivors are functioning well in the years that follow
treatment, however a subset of women reported persistent problems that interfere with
daily function and participation, and the overall sample was more fatigued than the
general population.

Conclusions: The results from this exploratory study document preliminary evidence
that a relationship exists between CRF and upper extremity morbidity. It also adds
support for persistent fatigue in a subset of BCS long after surgery and adjuvant
therapies conclude. Further research is indicated in order to meet the long term
survivorship needs of this growing population.
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CHAPTER I
Introduction
Survivorship
Increased longevity for many individuals diagnosed with cancer has served to
refocus the research community and government agencies on the phase of the cancer
trajectory that begins after acute medical interventions conclude. Survivorship, even
when measured well beyond the calculated five-year survival rates, may be
accompanied by a myriad of physical, psychosocial and economic consequences of
living with the late effects of the disease process and treatment modalities (NCI, 2006;
Hausman, Ganz, Sellers, & Rosenquist, 2011). A national panel, convened to study
issues of survivorship, concluded that survivorship research and intervention is a priority
for all cancer patients in order to enhance quality of life for this growing population
(Centers for Disease Control [CDC], 2005). The results of this CDC study signify a
paradigm shift in cancer care that envisions and defines the long-term post-intervention
needs of cancer survivors as a chronic disease state that must be monitored
longitudinally, rather than viewed as an acute medical condition (2005). Survivorship
can thus be conceptualized as a distinct stage in the continuum of the life experience of
the person living with cancer, one that requires an equivalent amount of attention as
afforded the acute management experience (NCCN, 2006). Defining the breadth and
scope of the problem, understanding key symptomatology, better identification and
follow-up of at-risk individuals, and the development of targeted interventions are
therefore indicated for this population.
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Zebrack (2000) defined cancer survivorship as "the state or process of living after
a diagnosis of cancer, regardless of how long the person lives" (p. 239). Family and
friends of diagnosed individuals are also included within the definition of survivorship
due to the impact of cancer on roles and socialization (National Cancer Institute [NCll,
2006). The term survivor is accepted by most national cancer organizations and
governmental agencies, although some individuals with a cancer diagnosis object to the
use of this label (Twombly, 2004; Jennings, 2010). A unified concept of survivorship has
yet to be established rendering attempts to develop survivorship theories to support
clinical practice and research agendas more difficult (Doyle, 2008). The term BCS
(Breast Cancer Survivor) will be used throughout this document for consistency and
readership ease to refer to women living with breast cancer, unless individuals living
with other forms of cancer are discussed.
Definitions of Survivor and Survivorship
National Cancer Institute (n.d., para. 1)
"In cancer, survivorship covers the physical, psychosocial, and economic issues
of cancer, from diagnosis until the end of life. It focuses on the health and life of a
person with cancer beyond the diagnosis and treatment phases. Survivorship
includes issues related to the ability to get health care and follow-up treatment,
late effects of treatment, second cancers, and quality of life. Family members,
friends, and caregivers are also part of the survivorship experience."
National Coalition for Cancer Survivorship (n.d., para. 2 - 3)
"The term survivorship, as defined by the founders of NCCS, is the experience of
living with, through and beyond a diagnosis of cancer. The founders of NCCS
also extended the term survivor to apply to an individual's friends and
caregivers. "
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American Cancer Society (2012)
"The American Cancer Society believes that each individual has the right to
define his or her own experience with cancer and considers a cancer survivor to
be anyone who defines himself or herself this way, from the time of diagnosis
throughout the balance of his or her life."

In the United States, 2010 prevalence statistics for persons living with a history of
cancer or a cancer diagnosis with treatment are estimated at 13.8 million persons
(Centers for Disease Control, 2011; Mariotto, Yabroff, Shao, Feuer, & Brown, 2011). If
current trends prevail, the estimated population of cancer survivors will rise to 18.1
million by 2020 (Mariotto et aI., 2011). Female breast cancer survivors comprise the
largest segment of this growing population, estimated at 22% of all cancer diagnoses
(NCI, 2011). According to the National Cancer Institute (2010) one in eight American
women will be diagnosed with breast cancer during her lifetime. The prevalence
estimate for breast cancer survivors in the United States is 2.6 million women with over
200,000 women diagnosed annually (NCI, 2010; Howlader et aI., 2010). Further
expansion of this population is anticipated as 5 and 10 year survival rates continue to
improve (NCI, 2010). Earlier detection has resulted in more positive five-year survival
outcomes for Caucasian BCS (91 %); African-American BCS still have a disturbingly
lower percentage of survival for the same time period than other ethnic or racial groups
(79%) (NCI SEER Statfact, 2011).
Background of the Problem
A robust body of literature suggests that select cancer-related sequelae may not
resolve after surgical and adjuvant therapy interventions conclude, subtly or overtly
impeding functional capacity in everyday activities as well as negatively impacting
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quality of life (Sadler et aI., 2002; Portenoy & Itri, 1999; Vogelzang et aI., 1997). A
recent qualitative study exploring BCS survivorship needs found that there was not a
clearly defined path or consistent quality of care to help women address post-treatment
transitional needs, including residual symptoms (Roundtree, Giordano, Price, & Suarez
Almazor, 2010).
As the information that follows will clarify, the most common and noteworthy of
these potentially prolonged symptom complexes for breast cancer survivors are cancer
related fatigue (CRF) and upper extremity morbidity.

Cancer-Related Fatigue
Cancer-related fatigue (CRF) has been long-recognized as a side effect during
adjuvant cancer therapies or potentially due to the cancer disease process itself (Piper
& Cella, 2010; Portenoy & Itri, 1999). There is evidence to indicate that fatigue
symptoms resolve following intervention for many survivors, but studies repeatedly
identify a subset of BCS for whom CRF will become a chronic fatigue condition creating
difficulties completing daily tasks, employment responsibilities and socialization (Stone,
Richardson, Ream, Smith, Kerr, & Kearney, 2000; Servaes, Verhagen, S., &
Bleijenberg, 2002). CRF has also been identified as one of the most likely causes of
decreases in perceived quality of life (CDC, 2005; National Institutes of Health State-of
the-Science Panel, 2003; Curt, Breitbart, Cella, Groopman, Horning, Itri et aI., 2000;
Andrykowski, Curan, & Lightner, 1998; Broeckel, Jacobson, Horton, Balducci, & Lyman,
1998). This fatigue complex can persist for years or decades after treatment concludes,
despite achievement of remission or disease-free status (Bower et aI., 2006; Servaes,
Verhagen, S., & Bleijenberg, 2002; Andrykowski, Curan, & Lightner, 1998).
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Estimates from NCI (2011) and the National Institutes of Health [NIH] State-of
the-Science Panel (2003) place the prevalence rate of fatigue in individuals with all
forms of cancer at 14 - 96% of the total cancer population. Other research findings
report prevalence rates from diagnosis through the varying phases of intervention as
high as 100% (Ream & Richardson, 1999). Inconsistencies may be due to differences in
study deSigns, fatigue measurement tool selection, defining cancer fatigue terminology,
and the heterogeneous nature of the fatigue experience for each survivor. Despite
these disparities in consensus, it is widely agreed that CRF is the most commonly
experienced symptom of patients across the cancer trajectory which negatively impacts
the lives of survivors.
CRF is a complex multi-dimensional symptom construct that comprises a distinct
entity from acute complaints of fatigue or exhaustion experienced by busy adults due to
high daily task demands, over-exertion, or stress-related daily events (Stasi, Abriani,
Beccaglia, Terzoli, & Amadori, 2003; Wu & McSweeney, 2001). CRF is not resolvable
by a temporary reduction in daily activities or rest and is more closely aligned with the
quality of fatigue experienced by individuals with chronic fatigue syndrome (Young &
White, 2006). The National Comprehensive Cancer Network [NCCN] defines CRF as a
"distressing, persistent, subjective sense of physical, emotional and/or cognitive
tiredness or exhaustion related to cancer or cancer treatment that is not proportional to
recent activity and interferes with usual functioning" (2012, p. FT-1).
Although the exact etiology is as yet unknown, contributing factors to CRF
include experiences of pain, side effects of chemotherapy and radiation, anemia,
metabolic disorders, immune function disturbances, sleep dysfunction, inactivity,
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medication use, psychological distress and additional disease comorbidities (Mortimer,
Barsevick, Bennett, Berger, Cleeland, DeVader, & Escalante et aI., 2010; Portenoy &
Itri, 1999; Yellen, Cella, Webster, Blendowski, & Kaplan, 1997). One recent study
examining the role of several biomarkers suggested that elevated C-Reactive Protein
levels, as one measurement of underlying inflammatory cell activity, may have a
potential contributory role in CRF (Alexander, Minton, Andrews, & Stone, 2009).
Depression, frequently correlated with fatigue symptoms in mental health diagnosis, has
been implicated as a co-morbid factor in CRF, but there are conflicting research study
results as to whether depression exists as a pre-existing psychiatric comorbidity or
results from living with a chronic fatigue-based condition (Bower et aI., 2006; Sadler et
aI., 2002; Broeckel et aI., 1998). The sheer scope ofthese factors presents difficulties
when designing and interpreting fatigue study outcomes. Mortimer et al. (2010)
identified the conundrum faced by researchers since a clearly articulated conceptual
framework and definition of CRF must currently be defined by each study's parameters,
further limiting comparisons and generalizability.
Instrumentation design and choice to measure the variability and extent of the
fatigue experience remains elusive owing to the multidimensional nature of this
construct. CRF, as it is experienced during different stages of cancer treatment and its
aftermath, cannot necessarily be measured by a single assessment tool or assumed to
be a static state. Similar to accepted beliefs regarding the assessment of pain, the
assessment of fatigue is acknowledged to be a subjective experience with the National
Institutes of Health State of the Science Panel (2003) stating that reporting of fatigue
symptoms are "best assessed by the patient" (p. 1111), identified as a self-perceived
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state (NCI, 2011). Patient self-perception is increasingly recognized in research and
medical outcomes studies as a viable indicator of quality of life. In one longitudinal
study, self-ratings of fatigue by breast cancer patients were found to be predictive of risk
of cancer recurrence (Groenvald, Peterson, Idlen, Bjoourner, Fayers et al., 2007).
Numerous fatigue questionnaires have been developed and researched to
establish psychometric properties with multiple instruments receiving support from
researchers and clinicians. However, there has been no consensus as to which of the
fatigue assessment tools currently available constitutes the gold standard for fatigue
assessment (National Institutes of Health State of the Science Panel, 2003). Brief,
single-item CRF assessment tools have been found to be advantageous for use in
clinical settings where time is often at a premium, but these tools are often limited to
unidimensional aspects of fatigue, such as daily fatigue level or disturbance in daily
routines (Butt, Wagner, Beaumond, Paice, Peterman, & Shevrin et aI., 2008; Schwartz,
Meek, Nail, Linquist, & Donofrio et aI., 2002). Lengthier, more cumbersome multi
dimensional tools provide the breadth of knowledge of the extent of the fatigue
experience, but can be time consuming for the respondent and therefore are often
relegated to research studies and not in general use in clinical settings (Schwartz &
Meek et aI., 2002). More than 25 CRF tools were identified by an expert panel with no
single tool emerging as the standard for this construct, although the NCCN committee
recently charged with this task developed a consensus-based screening tool for clinical
use (Mortimer et aI., 2010). The new tool, focused on contributory influences, activity
levels and exercise, does not include questions about the impact of fatigue on daily
functional performance in the spheres of self-care, home and community activities or
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employment, outcomes of significant importance to cancer survivors. It is derived from
expert opinion and not from quantitative outcomes from randomized controlled trials.
Attempts to define the CRF construct in recent years resulted in a compilation of
clinical findings by fatigue experts for a proposed diagnostic category for CRF in the
International Classification of Disease, 10th edition, Clinical Modification (ICD-10 CM)
(Sadler et aI., 2002; Portenoy & Itri, 1999). The goal of the criteria was to provide
clinicians with a defined symptom list to assist in identification of patients experiencing
CRF. The proposed criteria have been used in research studies to validate the symptom
list and determine prevalence rates (young & White, 2006). Post-intervention cancer
fatigue prevalence estimates are reduced to 17-25% of the survivor population when the
proposed ICD-10 criteria for CRF are applied (Gerber et aI., 2010; Young & White,
2006; Sadler et aI., 2002; Cella, Davis, Breitbart & Curt, 2001). Conservative estimates,
using the proposed ICD-10 CM criteria for inclusion, therefore approximates the
severely fatigued BCS population at 391,000 - 483,000 women living in the United
States. However, recent actions by the NCCN committee charged with developing
national recommendations identified CRF as a "subjective changing experience not a
diagnosis" (Mortimer, 2010, p.1132). Formal implementation ofthe ICD-10-CM is not
expected until October 2013; however a code description, R530, Neoplastic (Malignant)
Related Fatigue, has been identified (CDC, 2011).
Early studies on fatigue assessment and management primarily targeted
individuals undergoing cancer treatment (Passik, Kirsh, Donaghy, Holtsclaw, &
Theobald, et aI., 2002; Curt et aI., 2000). Late onset fatigue was less likely to be
identified and addressed by health care professionals after cancer treatment concludes
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(Curt et aI., 2000; Carlson et aI., 2004, Stone et aI., 2003). Failure to identify and
address CRF is a complex problem for patients who may be reluctant to request
assistance with a symptom that appears to be an expected consequence of the cancer
experience (Passik et aI., 2002), one that patients believe has no solution (Vogelzang et
aI., 1997), or one that is identified as a commonly experienced symptom in the general
adult population (Cella, Lai, Chang, Peterman, & Slavin, 2002). Physicians may fail to
assess or document fatigue, underestimate the impact of it on daily function, provide
limited advice on fatigue management, prescribe rest as a solution or offer no
intervention advice at all (Gerber, Stout, McGarvey, Soballe, Shieh, & Diao et aI., 2010;
Vogelzang et aI., 1997). While physical sequelae such as hematopoiesis during or
following treatment is more easily identified and treated by oncology teams, prolonged
variable fatigue symptoms with an unclear etiology may not be as clearly targeted. The
result is that individuals living with CRF may not be referred for supportive care to other
health professionals, such as occupational and physical therapists, who might be able
to address residual symptoms and ameliorate the impact on function and role
performance (Watson & Mock, 2004; Taylor & Currow, 2003; Galantino, Capito, Kane,
Ottey, & Switzer et aI., 2003).
Barriers to effective management of fatigue in patients with cancer "include a lack
of awareness that fatigue is the most prevalent symptom, a lack of knowledge about the
causes of fatigue among physicians and patients, and a lack of proven methods to treat
fatigue" (National Institutes of Health State-of-the-Science Panel, 2003, p.1113). Other
impediments to fatigue management include a dearth of evidence-informed
interventions offered to patients experiencing CRF by health professionals, as well as
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patients lacking the knowledge that possible solutions exist (Passik et aI., 2002; Wu &
McSweeney, 2001).
One population with a demonstrated need for ongoing CRF evaluation and
intervention is women with breast cancer, BCS in remission or those who have
achieved disease-free states, who still experience fatigue on a daily or weekly basis.
The Agency for Healthcare Research and Quality (Carr et aI., 2002) documented
prevalence rates in post-treatment breast cancer survivors that ranged from 35 - 56%.
Fatigue has a documented significant effect on reported quality of life and functional
ability in women with breast cancer (Servaes, Verhagen, C., & Bleijenberg, 2002b; Curt
et ai, 2000; Stone, Richardson, Ream, Smith, Kerr, & Kearney, 2000). A subset of BCS
experience ongoing fatigue that persists much later in the treatment process (Yates et
aI., 2005) and can continue for years or decades after treatment concludes
(Andrykowski et aI., 1998). BCS who are considered free from disease may also
experience CRF symptoms that interfere with daily life tasks and employment (Stone et
aI., 2003; Curt et al., 2000; Andrykowski et aI., 1998).
In one study, BCS reported fatigue frequency at one year post-diagnosis
equivalent to that of newly diagnosed women (Vogelzang et aI., 1997). A study of
disease-free BCS found that women classified by fatigue measures as severely fatigued
or non-severely fatigued experienced greater impairment in the ability to manage and
complete daily activities than a control group without breast cancer (Servaes, Verhagen,
C., & Bleijenberg, 2002b). Research on this topic has addressed population
identification, prevalence, and assessment of CRF, but concerted efforts to develop and
research interventions for prolonged fatigue in cancer survivors remain limited. This is a
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critical area for continued study that acknowledges the persistent nature of the fatigue
experience and the impact on BCS and their families.
Those stud ies with documented interventions for the management of treatment
related or prolonged post-treatment fatigue (Yates et aI., 2005; Stanton et aI., 2005;
Barsevick, Dudley, Beck, Sweeney, Whitmer, & Nail, 2004; Holley & Borger, 2001;
Grant, Golant, Rivera, Dean, & Benjamin, 2000; Mustian et aI., 2004; Galantino, Capito,
Kane, Ottey, Switzer, & Packel, 2003) have generally not incorporated an approach to
assess the impact of fatigue on functional performance of daily life tasks, although many
address quality of life. Only one study was identified that used an established measure
of occupational performance for activities of daily living (ADLs) (Mallinson, Cella, Cashy,

& Holzner, 2006). Less frequent follow-up visits for BCS once they enter the extended
survivorship phase create barriers for women with prolonged CRF unless clinicians
mount a concerted effort directed toward identification and monitoring of this symptom.

Upper Extremity Function
A separate body of research suggests that upper extremity deficits and altered
sensory experiences following cancer surgery and treatment produce additional side
effects that may also persist following the conclusion of surgical and adjuvant therapies
for breast cancer. Differences in treatment options for type and stage of breast cancer,
location of tumors, individual preferences regarding treatment and clinical expertise
figure strongly into the physician-patient decision making process. Those decisions and
the underlying disease processes and other patient factors can potentiate or alleviate
development of upper extremity sequelae.
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The literature offers insights into the impact of breast cancer surgery and adjuvant
therapies on upper extremity physical function (Hayes, Battistutta, & Newman, 2005;
Collins, Nash, Round, & Newman, 2004; Reitman, Dijkstra, Debreczeni, Geertzen, &
Robinson, 2004). Upper extremities are the 'tools' that permit dynamic interaction with
the environment, performing the majority of functions that promote participation and
fulfillment of life roles. The consequences of reduced arm function can impair the ability
of survivors to independently perform and complete desired activities including self-care
tasks requiring reaching, household tasks necessitating increased demands for upper
body strength, employment tasks and community activities (Reitman et aI., 2003; Collins
et aI., 2004).
The unique contributions of factors instrumental to the development of extremity
symptoms following breast cancer surgery or intervention are multifaceted. The majority
of the research conducted has focused primarily on lymphedema prevalence,
assessment and intervention rather than the functional implications of those physical
factors. Lymphedema is defined as the "swelling that occurs when protein-rich lymph
fluid accumulates in the interstitial tissue" (NCI, 2011). In BCS, lymphedema, identified
as a potentially distressing side effect may limit arm function, diminish participation in
life spheres and alter body image (Reinertsen et aI., 2010; Hack et aI., 2010; Hayes,
Rye, Battistutta, DiSipio, & Newman, 2010). It is one of the most dreaded side effects
of breast cancer, negatively impacting the ability of the survivor to fulfill life roles and
maintain occupational performance (Collins et aI., 2004), potentially altering or
disfiguring physical appearance, and limiting full use of the affected extremity.
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Generally accepted incidence figures for lymphedema indicate that 15 - 30% of BCS
will develop lymphedema at some point following surgery and treatment (Hayes et aI.,
2008; Petrek & Heelan, 1998), with an estimated 120,000 - 600,000 BCS experiencing
this complication (Soran et aI., 2006). A recent cross-sectional national study in
Denmark was conducted surveyed the entire BCS population (N = 3253, 85%), 13 - 41
months post surgery, in a country with standardized health care and defined adjuvant
and surgical protocols (Gartner, Jensen, Kronborg, Ewertz, Kehlet, & Kroman, 2010).
Depending upon surgical and treatment modality, the authors reported a self-perceived
lymphedema prevalence rate of 13 - 65% with 11 - 44% of BCS also reporting
decreased occupational performance after treatment, particularly for employment
(Gartner et aI., 2010, p. 511).
In a longitudinal multi-center study with complete data on 296 subjects, persistent
edema was noted in 32% of BCS within 3 years following surgery with three times the
risk for developing arm edema noted with every additional lymph node that was
dissected (Paskett, Naughton, McCoy, Case & Abbot, 2007). Fifty percent of women
reporting upper extremity edema identified diminished abilities to complete household
chores (Reitman et aI., 2003) with 69% of BCS reporting decreases in the ability to
complete activities of daily living due to edema (Oliveri et aI., 2008). Hayes, Battistutta,
Parker, Hirst, & Newman (2005) reported the highest task burden was noted when
"carrying a moderate weight, washing the upper part of the back, opening a tight jar,
and doing up a bra" (p. 257). A subsequent study by Hayes et al. (2008) indicated that
some women confuse typical short-term upper extremity and breast side effects of
radiation with lymphedema, noting that self-perceived symptoms may overestimate the
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population. It is also possible that women may perceive slight increases in limb swelling
before mechanical measurements can detect this changes. Several validated
measurement options are available to measure limb edema including circumferential
tape measurements, volumetric water displacement, bioelectrical impedance analysis
and self-report (Johannson & Branje, 2010; Norman, et aL, 2009; Hayes, Janda,
Cornish, Battistutta, & Newman, 2008).
The advent of sentinel node biopsy has overtaken axillary node biopsy as the
prevailing standard of care and is the most commonly performed procedure for initial
surgical node removal and staging (McGuire et ai, 2009), altering the landscape for
BCS and researchers. This trend developed following more than a decade of literature
suggesting that a significant relationship exists between the number of lymph nodes
removed during axillary node dissection and the development of subsequent arm
morbidity and sequelae such as lymphedema (Hack et aL, 2010). Breast conserving
surgery with follow-up radiotherapy, chemotherapy, and hormonal therapy or
combination therapies has accelerated the acceptance of this method of node removal
(McGuire et aI., 2009). However, women with positive sentinel nodes on biopsy may
require additional axillary node removal to obtain an accurate diagnosis and differentiate
treatment choices. Therefore node removal remains a great source of concern for
women with breast cancer and for those involved in survivorship care.
Extensive axillary node dissection and radiation to the axilla and chest wall have
been strongly implicated as causal agents resulting in the development of post-surgical
extremity symptoms such as lymphedema (Rietman et aI., 2006; Tsai et aL, 2009). One
study contradicted those findings implicating chemotherapy as causative (Paskett et aI.,
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2007). Mastectomies can produce more arm limitations and potential lymphedema than
breast-conserving therapy, such as lumpectomies. A meta-analysis of 98 lymphedema
studies found that women followed for three years or less who underwent mastectomy
demonstrated the most significant correlations for lymphedema and women who
underwent radiation therapy and axillary dissection were at the highest risk of the
development of lymphedema (Tsai et aI., 2009). Recent evidence suggests that
mastectomy rates have risen at major cancer centers after several years of diminishing
percentages of women who underwent this more extensive surgery (McGuire et aI.,
2009; Katipamula et aI., 2009). Factors accounting for this unexpected rise include an
increase in contralateral prophylactic mastectomies as genetic testing provides women
with significant breast cancer risk factors options to prevent the development of breast
cancer, decisions by some women to request more extensive surgery to avoid or
decrease the use of radiation or chemotherapy, and younger women hoping to avoid
recurrence (McGuire et aI., 2009; Katipamula et aI., 2009). The impact on the
prevalence of lymphedema as a result of this trend is unknown.
While arguably the most serious and visually distressing problem, swelling from
lymphedema is not the only extremity side effect that may result from breast cancer
surgery or treatment (Fu & Rosedale, 2009). Surgical procedures, type of node biopsy
and notably radiation therapy may also be accompanied by other upper extremity
sequelae including muscle weakness, numbness, pain, paresthesias, loss of shoulder
range of motion, strength, tightening of scar tissue, and decreased hand strength and
function (Fu & Rosedale, 2009; Karki, Simonen, Malkia, & Selfe, 2005; Stariano &
Ragland, 1996). Pain in the upper extremity has been reported to negatively impact arm
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function, decrease task performance, participation and quality of life (Oliveri et aI., 2008;
Dawes, Meterissian, Goldberg & Mayo, 2008). Pain has also been linked to higher
levels of disability (Dawes et aI., 2008).
As the magnitude of the survivor population increases in the United States, the
imperative to clarify and address upper extremity functional deficits expands as well.
Interest in assessing and promoting long-term quality of life for individuals across the
cancer care continuum must include special attention to education and management of
the prolonged or delayed onset of arm symptoms in survivors that interfere with daily
life.

Purpose of the Study
This descriptive, exploratory cross-sectional study was designed to examine perceived
upper extremity functional status and cancer-related fatigue in breast cancer survivors
who have achieved remission or disease-free status one

(~

12 months) to six years (:::;

72 months) after the conclusion of surgical and adjuvant therapies. Perceived upper
extremity functional status and cancer-related fatigue were further explored by
examining participant differences in node dissection status, adjuvant therapies received
and dependent caregiver responsibilities.

Research Questions
Four questions were guided by the literature for this study.
1. Is there a relations~lip between self-reported cancer-related fatigue and
perceived upper extremity functional deficits in breast cancer survivors?
2. Is there a difference in perceived upper extremity function and fatigue between
survivors who underwent sentinel node dissection and those who underwent
axillary node dissection?
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3. Is there is a difference in perceived upper extremity function and fatigue between
survivors who underwent differing types of adjuvant cancer therapies, including
chemotherapy, radiation, or combination therapies?
4. Is there a difference in perceived upper extremity function and fatigue between
survivors who have dependent caregiver responsibilities and those without
dependent caregiver responsibilities?
Pilot Study
A pilot study (n

=42) was conducted in early 2011 to determine the feasibility of

the snowball recruitment methodology and to assess the ease of completion of the
researcher designed demographic survey and standardized questionnaires.
Conceptual and Theoretical Framework
The capacity to fulfi" life roles and participate in the everyday activities that
create meaning and identity in our lives is part of the experience of adulthood. Adults
can be described as "occupational beings ... a person who is fully engaged in the world
of activity - work, play, leisure - who is productive and feels a sense of self-worth"
(Clark, Ennevor, & Richardson, 1996, p.374). This ability to engage in desired
occupations has been shown to have a positive impact on health and well-being (World
Health Organization, 2001, Clark, Ennevor, & Richardson, 1996). Occupations are
meaningful activities that individuals choose to engage in. The term 'occupation' is not
restricted to activities tied to employment but is defined as "daily activities that reflect
cultural values, provide structure to living, and meaning to individuals; these activities
meet human needs for self-care, enjoyment, and participation in society" (Crepeau et
aI., 2003, p. 1031).
Adults form perceptions of their identities through participation in these
meaningful activities, acquiring skills and achieving completion of desired and required
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tasks that are woven throughout the life narrative. Furthermore, the ability to complete
daily occupations and routines creates opportunities for goal attainment and add
meaning to our daily existence. Christiansen (1999) described successful goal
achievement as resulting in feelings of efficacy and influence over the environment. Any
illness or disability that disrupts the continuity of performance of these common
activities can threaten beliefs about competence and therefore impact identity
(Christiansen, 1999).
Frank (1995) refers to this disruption as a loss of the "destination and map" that
previously helped the person navigate through difficult periods in life. People who
believe that they can successfully manage disruptive life challenges are better able to
cope with

the

stressors that accompany life-threatening

illness.

Yet,

Frank

acknowledges that current health care practices do not sufficiently prepare the person
to live in the world after biomedical intervention for the disease process has concluded
(1995). Even occupational therapists, skilled in addressing compensatory and adaptive
strategies for specific impairments in life skills, have not sufficiently "focused on
assisting survivors of disability to handle the social environment with which they
inevitably collide after hospitalization" (Clark, 1999, p. 388).
Theoretical models. Theories of cancer survivorship are not well established

since basic conceptual models and definitions for shared terminology are still evolving
(Doyle, 2008). Recent efforts have centered on clinical applications, such as the
development of survivorship care plans to manage the period of time post-treatment
when survivors lose consistent contact with the oncology team (Hausman, Ganz,
Sellers, & Rosenquist, 2011). Planning in advance for the acute to post-treatment
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progression may facilitate the survivor's transition to community-based resources
(Hausman, et aI., 2011).

To adequately address survivorship needs posed by this

burgeoning population requires a multipronged approach that includes attention and
accessibility to medical, psychosocial, financial, employment and health care system
resources.
The biopsychosocial model (BPS) and International Classification of Function
(ICF) were chosen as the framework for this project since the implementation of best
practice using this holistic model and international taxonomy includes person and
environmental factors leading to enhanced participation in daily life. Conjointly, it is not
possible to discuss the post-treatment experience without reference to the staged
survivorship model, "Seasons of Survivorship", developed by Dr. Fitzhugh Mullan
(1985), framing his own cancer experience as a physician and cancer patient.
Mullan (1985) aptly described the inadequacies of available services:
"It is as if we have invented sophisticated techniques to save people from
drowning, but once they have been pulled from the water, we leave them on the
dock to cough and sputter on their own in the belief that we have done all that we
can (p. 273)."
His model was later reframed by Miller, Merry, and Miller (2008) to better reflect
a quarter of a century of survivorship research, including awareness of the
heterogeneity and increasing diversity of the lives of cancer survivors, many of whom
are living well beyond the five year longevity benchmark defined in governmental
surveillance databases. It is increasingly clear that these stages or phases of the cancer
experience can extend for decades beyond acute medical management, further
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supporting the paradigm shift from a biomedical, reductionistic model to one in which
quality of life and resumption and continuation of life activities move to the forefront.
These underlying frameworks will be discussed more fully in this section.

Biopsychosocial Model (BPS) and the International Classification of
Function (ICF). The biopsychosocial model (BPS) was conceptualized by George
Engel in a seminal 1977 article arguing for the need to create a holistic framework that
would account for the patients' perceptions of their illness experience, and
psychological, social and biological factors encountered within the dynamics of the
healthcare system. He hoped that an integrated model would provide guidance to
practitioners and researchers and shift the paradigm away from the inherent mind-body
dualism of the biomedical model (Engel, 1977). BPS was also conceptualized as an
alternative holistic model to drive occupational therapy practice, focusing on the
complex factors required to enhance participation in the community (Mosey, 1974).
"Occupational therapy practitioners recognize that health is supported and maintained
when clients are able to engage in occupations and activities that allow desired or
needed participation in home, school, workplace, and community life (American
Occupational Therapy Association [AOTA], 2008, p.629). A review of BPS model
twenty-five years after Engel's publication reaffirmed the need to honor the subjective
illness experience in clinical practice and research (Borrel-CarriG, Such man, & Epstein,
2004).
The World Health Organization (WHO) used the BPS model as the foundational
theory during construction of the ICF, stating that "In order to capture the integration of
the various perspective of functioning, a 'biopsychosocial approach is used" (WHO,
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2001, p.20). The use of this theory fostered an integrated perspective on the biological,
psychological, social, environmental and individual perceptions of health-related quality
of life (HRQOL) (WHO, 2001). These alterations represented a sUbstantial shift from the
early disablement model of the International Classification of Impairments, Disabilities
and Handicaps (ICIDH) (WHO, 1980-1993) to one that identified health, personal and
contextual factors as integral to function and participation.
The ICF (WHO, 2001) is in actuality a taxonomy as opposed to a theory or
practice model, providing an international language and systematic classification to
facilitate communication about global health, participation and environment. The ICF
domains describe body functions (e.g., underlying physiologic systems), structures
(e.g., anatomical, cellular, neurochemical), activities (all daily tasks and occupations
across the lifespan) and participation (e.g., engagement in occupation with attention to
physical, social, and environmental factors, and economic barriers) (WHO, 2001). The
structure identifies participation as involvement in a variety of life spheres, including
learning and applying knowledge, general tasks and demands (handling responsibilities,
stress and other psychological demands), communication, mobility, self-care, domestic
life (acquisition of needed daily resources, household management. caring for personal
and other household

objects,

and

caregiving),

interpersonal

interactions and

relationships, major life areas (work and school). and community, social, and civic life
(recreation and leisure activities, spirituality and religious participation, and politics)
(WHO, 2002). Research studies have documented "the positive influence on health and
well-being" (Law, 2002, p.641) that participation in these desired and meaningful
occupations provide.
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Documenting the positive impact of the development of the ICF model on
interventions, Oston, Chatterji, Kostansjek, & Bickenbach (2003) opined that the
biological view was only one facet of the ICF, demonstrating a more comprehensive
view of the individual and environmental factors influencing health and disability.
Recently Huber, Sillick and Skarakis-Doyle (2010) suggested that while the ICF clearly
references the internalized subjective experience articulated in the BPS model, these
concerns are subsumed under contextual factors and may not be easily identified when
viewing the actual design. Seaburn (2005) countered, proposing that it is not the design
or model that is problematic but the adoption and application of the biopsychosocial
approach within the current health care system. Nevertheless, researchers are
increasingly using the ICF framework and adding health-related quality of life (HRQOL)
measures to studies (Allan, Campbell, Buptill, Stephenson, & Campbell, 2006; Dixon,
Johnston, McQueen, & Court-Brown, 2008). There is enhanced recognition that the
gestalt of the person's life experience is central to understanding the trajectory though
the illness process. Assessment of life roles, psychoemotional responses and function
in self-care, instrumental activities of daily living, productivity, and social interactions
offer rich insights that enhance patient care (Ryff & Singer, 2000). Addressing these
areas, particularly psychoemotional functioning, is helpful for individuals with chronic
diseases where cure is not the clear objective (Ryff & Singer, 2000). van Dijk (2000)
described quality of life "as degree of goodness of daily living" (p. 104). envisioned as
the meaningfulness of the transaction between the person and life contexts in which
activities take place. Well-being incorporates role performance, productivity and daily
function (Ryff & Singer, 2000). Internalized perceptions of capacity and quality of
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performance compose the individual's understanding of their HRQOL (Huber et aI.,
2010). The focus on the subjective lived experience of cancer is an essential
component of HRQOL, and serves as the core of conceptual models of survivorship.
Stages of survivorship. Some survivors experience cure following completion

of all medical interventions, others live with partial or complete remission, encounter
recurrence, or will continue with ongoing treatment to address maintenance needs or
secondary complications from the cancer. Additionally, psychological, cognitive, or
physical sequelae may persist. Fears of recurrence may resurface across the survivor's
lifespan at critical junctures for medical tests or follow-up visits. The lived experience of
survivors, noted through personal identification of subjective well-being, focuses on
completion of daily activities that are meaningful or desirable.
Mullan (1985), additionally cited in a CDC document on cancer survivorship
(2005), described a three-stage model of acute, extended and permanent events that
support the identification of changes in daily occupations based on patient experiences
of cancer. The acute stage encompasses the initial diagnostic process (Mullan, 1985;
CDC, 2005, p.3). During the extended stage, described as a hypervigilant state which
begins when treatment is completed or remission occurs; the individual begins to
consider the potential for recurrence, and realizes that there are still residual daily
symptoms that must be addressed (Mullan, 1985; CDC, 2005, p.3 - 4). The permanent
stage occurs when the medical status of the cancer is deemed to be very stable, but the
survivor is still facing sequelae of cancer treatment including persistent symptoms and
socioeconomic concerns (Mullan, 1985; CDC, 2005, p.4).
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This oft cited model was later reframed by Miller et al. (2008) to better reflect the
increasing diversity of cancer survivors, many of whom are living well beyond the five
year benchmark. The definition of the acute survivorship stage remained unchanged
from Mullan's original conceptualization. Transitional survivorship was added to
correspond to the time when either "watchful waiting" or maintenance therapies may be
present, but the survivor and family are readjusting to the consequences of the cancer
experience (Miller et aI., 2008, p.372). Extended survivorship, described by Mullan
(1985) and augmented by Miller et al. (2008), highlights the ambivalent
psychoemotional responses and heterogeneity of the post-treatment experience,
whereby some individuals may be in remission while others continue ongoing
maintenance treatment with potential side effects. Life for those individuals vacillates
between "'regular life' and 'the ups and downs' of living with cancer and its treatment"
(Miller et a!., 2008, p.372). Expansion of the permanent survivorship stage, also viewed
as a heterogeneous experience, was divided into "individuals who are cancer free and
free of cancer"; those who are "cancer free, but not free of cancer" (Miller et aI., 2008, p.
372); those with "secondary cancers" resulting from adjuvant therapies; and those with
new "second cancers" whose lives revert to the acute survivorship phase (p. 373). The
expanded stages offer further direction to researchers seeking to explore the diverse
and variable lived experiences of cancer survivors.
For the purpose of this study, individuals participating in the study were
conceptualized as falling into the permanent survival stage - specifically "cancer-free
and free of cancer" or "cancer free but not free of cancer" (Miller et aI., 2008, p. 372),
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focusing on women who had concluded all adjuvant therapies and surgery a minimum
of one year prior to completing the survey.

Survivorship and Breast Cancer
Prolonged symptoms, such as cancer-related fatigue and upper extremity
morbidity, resulting from the cancer experience are noteworthy due to the disruption
they cause to typically predictable daily routines and occupations. These symptom
complexes profoundly impact the ability of BCS to continue desired occupations,
especially targeting instrumental activities of daily living (IADLs), work, leisure, and
socialization. It is noteworthy that basic self-care or activities of daily living (ADLs) are
not typically identified in the literature as problematic for BCS, except for those with
significant lymphedema (Fu & Rosedale, 2009). IADLs are defined as "essential self
maintenance activities which are necessary for independent living that are not
considered basic ADL, or self-care tasks" (Christiansen & Baum, 2004, p.598). These
include activities such as home maintenance, shopping, meal preparation, caregiving,
communication device use, financial management, health management and
maintenance, and community mobility (Christiansen & Matuska, 2004). Difficulties in
these more complex daily activities have been reported in cancer survivors with physical
comorbidities, such as fatigue and pain, resulting from the cancer and subsequent
interventions (Miller et aI., 2008).
For the majority of BCS, symptoms resolve after treatment and adjuvant
therapies such as surgery, cytotoxic chemotherapy, radiation, or a combination of
modalities concludes. However, a proportion of this population will be impacted by
prolonged, persistent symptoms that may continue for years or even decades after the
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cessation of treatment, impairing participation in life-performance arenas for those
individuals. Previously learned coping strategies may be ineffective when confronting a
variable condition such as CRF or arm morbidity and may leave the survivor unable to
resolve encountered occupational dilemmas.
The changeable nature of fatigue alters the ability to be an active participant in all
of the life spheres described by the ICF, disrupting daily routines and life roles that
functioning adults take for granted. A systematic review documenting qualitative
comments gleaned from 26 cancer fatigue studies concluded that the severity of the
impact of fatigue on daily task performance was far more damaging to survivors than
the actual physical feelings of fatigue (Scott, Lasch, Barsevick, & Piault-Louis, 2011).
Therefore, CRF that interferes with daily performance constitutes a disability that
negatively impacts participation in occupations. Law (2002) stated that the presence of
such a disability potentially increases social isolation resulting in less diversified
participation in activities in society.

Past strategies that were developed for acute

fatigue resulting from overexertion or stress are not responsive to the prolonged and
daily variability of cancer-related fatigue.

New strategies must be conceived and

implemented to address management of this symptom. A WHO report (2002) on
Innovative Care for Chronic Conditions (ICCC), designed to improve management and
prevention of chronic conditions, cites the need to develop innovations in relaxation
techniques, coping skills training, and problem solving to decrease cancer-related
symptoms such as fatigue (p.95).
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Summary
A national panel convened by the Centers for Disease Control (CDC) to study
issues of survivorship concluded that survivorship research and intervention is a priority
for all cancer patients, confirming the paradigm shift that envisions the long-term post
intervention needs of cancer survivors as a chronic disease state (Centers for Disease
Control [CDC], 2009). Studies that explore the perceived functional impact of persistent
symptoms resulting from cancer, surgery, or adjuvant therapies are needed. Framed
within the ICF and BPS theory, this project examines body structures (upper extremity
use), body functions (fatigue), and self-perceptions of activity execution, limitations and
participation restrictions. The increasing emphasis on survivorship by federal agencies
and healthcare organizations addressing the needs of this population affords us the
opportunity to better understand the impact of perceived persistent symptoms on the
lives of BCS.
The potentiality of a relationship between CRF and upper extremity morbidity,
two entities that may continue to challenge breast cancer survivors after treatment
concludes, is not well described in the literature. It is not known whether these two
underreported and under-diagnosed symptom complexes (Paskett et aI., 2007; Stone et
aI., 2003; Stone, Richardson, Ream, Smith, Kerr, & Kearney, N., 2000) indeed
represent separate concerns, or if a subset of the larger BCS population experiences
both sets of symptoms. Understanding these relationships may enable healthcare
practitioners to determine which women require further screening, monitoring or referral
for interventions to address CRF or upper extremity dysfunction.
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No studies were located exploring whether there is a relationship between
cancer-related fatigue and upper extremity morbidity, despite prevalence statistics that
conservatively suggest that approximately 30% or more of breast cancer survivors may
experience either syndrome (Lash & Silliman, 2002; Hayes et aI., 2008). Current
research remains compartmentalized, focused on upper extremity morbidity and
lymphedema, or cancer-related fatigue. The profound negative impact on occupational
performance of desired activities and tasks is well documented for both concerns.
Additionally, these two symptom complexes may appear long after adjuvant therapies
conclude or continue permanently, thus altering quality of life. The International
Classification of Function (lCF) Core Sets for Breast Cancer categorize the activities
and tasks deemed critical to this population, based on the ICF from the World Health
Organization, and include specific reference to addressing hand and arm use, activities
of daily living, instrumental activities of daily living, employment, leisure and
socialization (Brach et aI., 2004).
Statements from the National Comprehensive Cancer Network [NCCN] Practice
Guidelines in Oncology, additionally confirm the "necessity to develop interventions that
focus on fatigue as a primary endpoint for research" (NCCN, 2009, p. MS-10), further
supporting the need for research on CRF. Without knowledge of how these two
fundamental constructs may be linked, it will be difficult to fully address the needs of
breast cancer survivors or develop targeted interventions. The extended lifespan
estimates for this population support further examination and explication of prolonged
symptoms that interfere with daily life. There is a preSSing need to explore the potential
relationship between CRF and upper extremity functional deficits in order to begin to
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ascertain how best to monitor and address survivors' desires to remain full and active
participants in desired and required life tasks. This exploratory study may offer an
alternative vantage point from which to begin to view prolonged symptoms, assisting
clinicians to design screening tools and educational models to address BCS concerns,
as well as laying the groundwork for future studies to help determine which women are
at highest risk for prolonged effects from breast cancer interventions.
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CHAPTER II
REVIEW OF LITERATURE

This chapter provides a review of the relevant literature on cancer-related fatigue
(CRF) and upper extremity function in breast cancer survivors (BCS), including the
impact of symptoms on activities of daily living (ADLs), instrumental activities of daily
living (IADLs), employment, and caregiver status. Biological and physical contributors
to fatigue and upper extremity deficits resulting from surgical interventions to the breast
or adjuvant cancer therapies that impact daily function will also be explored.
Furthermore, identification of current research trends, knowledge gaps and study
limitations in the literature that provided the basis for this study and formulation of the
study hypotheses will be reported.
Cancer-Related Fatigue (CRF)

Fatigue has long been recognized as one of the most common and significant
cancer symptoms resulting from the cancer disease process, surgical intervention,
chemotherapy, radiation, combined treatment interventions, immunotherapy, or marrow
transplantation (Portenoy & Itri, 1999; Cella, Davis, Breitbart, & Curt, 2001; Sadler et aI.,
2002). It is also one of the most frequently researched symptoms across the cancer
trajectory. Fatigue can produce undesirable consequences that diminish concentration
and attention to tasks, result in sleep dysfunction, psychological distress, depression or
anxiety (Sadler et aI., 2002) or bring about physical weakness and diminished energy
(Portenoy & Itri, 1999; Cella et aI., 2001). The subjective experience of CRF can be
characterized by a multiplicity of attributes including fatigue severity, duration, intensity,
and variability, and exacerbating and remitting factors that potentially contribute to a
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negative impact on occupational performance, socialization, and participation in the
community (Bower, Ganz, Desmond, Rowland, Meyerowitz, & Belin, 2000; Curt et aI.,
2000; Portenoy & Itri, 1999).
The following section describes and defines CRF, known etiologies, prevalence
rates, and patient and practitioner awareness of the frequency of CRF and potential
interventions. The section further explicates the physical and emotional symptoms
associated with CRF.
Definitions, Etiology and Prevalence

Cancer-related fatigue [CRF] is a distinct phenomenon with differential
presenting symptoms that distinguish it from the acute fatigue experience typified by
activity overexertion, a single poor night's sleep or the presence of stressful events.
Acute fatigue symptoms are characterized by a connection to particular activities or
events, responding to rest or cessation of activities and resolving within a reasonable
time period to permit resumption of typical functional capacity. Conversely, the
individual with CRF experiences a more persistent chronic form of fatigue that does not
resolve with periods of rest, and may interfere with the performance of life tasks
including employment (Spelten et aI., 2003). The National Comprehensive Cancer
Network (NCCN) defines CRF as a "distressing, persistent, subjective sense of
physical, emotional and/or cognitive tiredness or exhaustion related to cancer or cancer
treatment that is not proportional to recent activity and interferes with usual functioning"
(2012, p.

FT-1). Fatigue has been shown to negatively impact occupational

performance in instrumental activities of daily living (Curt et aI., 2000), and negatively
impact the ability to return to work (Spelten et aI., 2003).
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Portenoy and Itri (1999) speculated that CRF may "represent a final common
pathway to which many predisposing factors or etiological factors contribute" (p.2).
Potential contributors to the etiology include anemia, decreased cytokine or antibody
responses, underlying metastatic disease, abnormalities of energy metabolism,
neurophysiologic changes of skeletal muscle, chronic stress response. hormonal
changes, adjuvant therapies. comorbid systemic diseases, sleep disorders, immobility
and lack of exercise, use of pain medications. and psychosocial variables such as
depression and anxiety (Stasi et aI., 2003; Portenoy & Itri, 1999). Identifiable disorder
based symptoms such as anemia, metabolic or hormonal dysfunction may be
adequately addressed or alleviated through medical intervention. thus allowing those
individuals to experience reduction or resolution of their CRF symptoms. For other
patients, the frequency of the fatigue experience combined with an elusive defined
etiology is commonplace, particularly in survivors who have already completed the
acute phase of cancer treatment.
In a study by Stone et al. (2000). patients identified fatigue as the most poorly
controlled symptom in their cancer experience (p < .0001). They suggested that the
population of individuals with cancer-related fatigue might be under-represented in
current prevalence statistics due to the failure of patients to report their CRF symptoms,
and the failure of health professionals to request detailed information about fatigue
experiences during patient visits (Stone et aI., 2000). A cross-sectional. questionnaire
based survey was used to investigate perceptions of cancer-related fatigue and the
impact on quality of life on 576 patients and 576 caregivers (Stone et aI., 2000). Fatigue
was identified as the most significant symptom (P < .0001) resulting from patient cancer
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experiences with 82% experiencing it at least a few days over a month-long period, 56%
experienced it on most days or every day, with only 7% not reporting any fatigue (Stone
et aI., 2000, p.972).

CRF and Adjuvant Therapies
Research on CRF over the past decade predominantly detailed the impact of
fatigue on recently diagnosed oncology patients undergoing treatment with adjuvant
therapies. Cancer treatment, particularly chemotherapy and radiation therapy, has been
implicated as a potential cause for CRF. Reported results have been contradictory with
CRF correlated with chemotherapy in some studies (Broeckel et aL, 1998; Bower et aL,
2000), with radiation therapy in others (Lee et aL, 2007), and with combined adjuvant
therapies in still others (Jacobsen, Donovan, Small, Jim, Munster, & Andrykowski, 2007;
Bower et aL, 2006). Patients who receive cyclic chemotherapy usually experience
fatigue within a few days of treatment, which then declines until the next treatment cycle
is initiated (Portenoy & Itri, 1999). For patients undergoing radiation therapy, fatigue
appears to be cumulative, potentially increasing with time in treatment (Portenoy & Itri,
1999).
Prevalence rates vary dramatically in the research literature providing confusing
estimates of the scope of this problematic symptom. In a 2002 review of 54 articles on
cancer fatigue prevalence, Servaes, Verhagen, C., & Bleijenberg (2002a) identified a
prevalence range of 25 - 99% in the literature. Some discrepancies appear to be
population dependent, with expanded sampling along the continuum of the cancer
experience trajectory accounting for some of the variation, and the operational definition
of fatigue used in a particular study accounting for additional variance (Servaes et aI.,
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2002a). If patients were asked if they were fatigued and responded affirmatively without
further delineation for a fatigue diagnosis, then the prevalence rates appeared to be
higher and may be artificially inflated (Cella et aI., 2001; Servaes et al., 2002a). Patients
who are in the process of undergoing adjuvant therapies almost universally report
fatigue at some point in time during treatment. These prevalence numbers are
substantially reduced when only post-treatment survivors are examined. Overall
prevalence rates in disease-free survivors are estimated at between 17 - 30% of the
total cancer survivor population (Servaes et aI., 2002a). These numbers are further
reduced when the more stringent proposed ICD-10 neoplastic related fatigue diagnostic
criteria are applied.
Broeckel et aL (1998) authored one of the original studies supporting the
persistence of CRF after adjuvant therapies concluded. The investigators completed a
cross-sectional questionnaire-based survey combined with a researcher-conducted
phone survey in 61 BCS who were 3 - 36 months post chemotherapy treatment and
compared them to peer-matched controls (8roeckel et al.). Univariate analysis revealed
that patients treated with chemotherapy agents reported more severe fatigue (P < .05)
at 1.5 times the level of the controls, and higher levels of current fatigue (P < .05)
(8roeckel et al.). Other studies have not SUbstantiated the impact of cancer treatment
modality on the development of CRF in off-treatment populations (Reinertsen, 2010).
In a later study, Bower et aL (2000) surveyed two large independent samples of
breast cancer survivors to examine fatigue in survivors of breast cancer. Two centers,
one in Los Angles and one in Washington, D.C. (N

=1957) recruited women to examine

health-related quality of life, depression, sleep and vasomotor symptoms. All survivors
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were between 1 - 5 years post diagnosis and had completed all medical treatment for
breast cancer. Data results were compared with two national sets of norms; one for
general population scores on the Medical Outcomes Short-Form 36 (SF-36) as well as
against baseline data from a large (N = 9,749) prevention trial for women at high risk for
breast cancer (Bower et aL, 2000).
Women with increased fatigue rated health-related quality of life as lower than
women who had higher scores on the energy/fatigue scale (Bower et aL, 2000).
Fatigued women were younger, less likely to be married, less affluent (p < 0.05), and
more likely to have received combination treatment (Bower et aL, 2000). The results
documented improvements in energy levels until the second year post-adjuvant
therapies when gains stabilized; however, one-third of the women surveyed
experienced persistent moderate to severe fatigue beyond the expected two years post
diagnosis (Bower et aL, 2000).
Bower et aL (2006) continued the aforementioned research study, conducting a
longitudinal assessment of 817 disease-free BCS to evaluate the persistence of CRF
five to ten years post-diagnosis, finding persistent fatigue in sixty-three percent of the
women who were classified as fatigued in the original study (p.754). Fatigue prevalence
rates for in both studies was 21 % with income as the only significant fatigue correlate in
the second study (P = 0.05) (Bower et aL, 2006).
Another longitudinal study examined predictors, prevalence and correlates of
CRF in 317 long-term BCS at two time points: 2.5 - 7 years post-treatment, and 2.5 - 3
years following initial data collection (Reinertsen et aL, 2010). Twenty-three percent of
the sample documented CRF at both data collection points, a small sample
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demonstrated resolution of initial fatigue (10%), and 16% exhibited new CRF at the
second data collection point (Reinertsen et aL, 2010). This study was of interest not only
for the length of time the participants were followed, but because the authors provided
support for the development of new cases of CRF long after diagnosis and treatment
conclude.
The ICD-10 diagnostic criteria was applied to a nationally representative sample
of 379 cancer patients living in the United States, the majority of whom were between 1
- 5 years post-diagnosis (Cella et aL, 2001). Seventy-nine percent reported significant
fatigue as the most common symptom, versus 21 % who reported no fatigue during the
continuum of pre- to post-treatment (Cella et aL, 2001). When the CRF criteria were
applied, only 17% ofthe sample satisfied the diagnostic criteria (Cella et aL, 2001). This
is particularly significant because the ICD-10 criteria, as opposed to some other
measures of cancer fatigue, specifically requests confirmation that the patient
experiences dysfunction in areas of occupational performance for daily tasks as a result
of CRF. The authors note that the prevalence rate obtained would appear to be more
accurate for off-treatment survivors, but cautioned that these figures may still
underestimate the population (Cella et aL, 2001). Persistence of the prevalence figures
was demonstrated when 1 year off-treatment survivors were compared to 5-year off
treatment survivors (Cella et aL, 2001) indicating that fatigue symptoms in the subset of
individuals meeting the ICD-10 criteria do not easily resolve over time and may leave
the survivor with persistent functional deficits.
Prevalence rates in off-treatment survivors are sufficiently high to warrant
continued research into the potential factors that underlie this common symptom. The
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need for practitioners and survivors to attend to the potential serious ramifications of
fatigue symptoms was underscored in a study by Groenvald et al. (2007). The authors
conducted a longitudinal study (median follow-up 12.9 years) of 1,588 patients with
breast-cancer in Denmark examining how self-perceived fatigue and other quality of life
health measures might impact long-term survival and recurrence rates (Groenvald et aI.,
2007). The reported results indicated that fatigue was the only significant predictor of
breast cancer recurrence (risk ratio 1.45, confidence interval 1.04 - 2.04, P

=0.030),

whereas emotional function emerged as the only predictor of overall survival (Groenvald
et ai., 2007). Using psychoneuroimmunologic theory linking emotional distress and
immune function, they concluded that mind-body interventions should be designed to
decrease fatigue in order to exert an influence on recurrence, but could not conclude
that potential interventions would ultimately alter survival rates (Groenvald et aI., 2007).
Patient and Practitioner Awareness of CRF
Awareness of cancer-related fatigue has increased as published research
studies with an emphasis on quality of life in cancer patients become known, but
practitioner and patient awareness of the pervasiveness of CRF remains a significant
problem in clinical practice. As recently as 2010, Escalante, Kallen, Valdres, Morrow,
and Manzullo noted that CRF remains an enigma to patients and providers alike,
acknowledging that persistent CRF that develops into a chronic condition for a subset of
survivors requires the focused attention of a dedicated multidisciplinary team of
providers.
An early study by Stone et al. (2000) demonstrated that patients experiencing
fatigue attempted to discuss fatigue with their physician during most appointments
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(25%) or at least once (43%) in a cross-sectional randomized survey. A startling 52% of
the overall sample in the study had never discussed CRF with their physician (Stone et
aI., 2000). The authors posited a potential explanation for this lack of identification as
stemming from patient values and beliefs about their cancer experience. Forty-three
percent of respondents surveyed felt that fatigue was an inevitable side effect of cancer
treatment or the actual disease process, 34% thought it was unimportant, and 27%
thought it was untreatable (Stone et aI., 2000). Only 22% believed that the fatigue
symptoms could be controlled by some kind of intervention (Stone et aI., 2000). The
authors concluded that patients did not discuss what they felt could not be ameliorated.
Prevalence rates may therefore not be reflective of the total population of individuals
with CRF, since patients who fail to report symptoms might not be included in data
surveys that rely on health providers for identification of this population.
In a nationally randomized study that assessed perceptions about CRF and
prevalence rates in 419 patients, 200 patient-nominated caregivers, and 205
oncologists, Vogelzang et al. (1997) reported that 78% of patients reported the
experience of fatigue during the cancer treatment experience. The mean prevalence of
daily fatigue for all groups was 32%, with younger adult patients experiencing more
fatigue (45%), women experiencing more daily fatigue (36%) and one-year post
diagnosis rates similar to those recently diagnosed (Vogelzang et aI., 1997, p.6). One
third of patients reported that fatigue significantly impacted daily activities and routines,
limited their ability to work, engage in social activities (57%). and participate in
community mobility (48%) (Vogelzang et aI., 1997). Fatigue resulted in slowed task
completion (69%), reduced task completion (49%). or rendered them unable to care for
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their families (Vogelzang et aI., 1997). Sixty-one percent reported that fatigue was the
primary symptom affecting daily life with younger patients and working patients
reporting that fatigue impacted life functions more than pain (Vogelzang et aI., 1997,
p.6). Patients did not view fatigue as manageable with only 50% of patients in this study
reported ever bringing this concern to the attention of their treating physician
(Vogelzang et aI., 1997). Seventy-three percent of respondents who vocalized about
the fatigue symptoms to their oncologist reported that they were told this was "a
symptom to be endured" (Vogelzang et aI., 1997, p.8). Primary recommendations from
the surveyed oncologists identified rest as the potential solution to these symptoms
(Vogelzang et aI., 1997). Patients and oncologists reported few prescriptions or ideas
for treating fatigue, with oncologist most often advising rest (68%), medication (42%),
diet or nutrition (30%) and infrequently, exercise (7%) (Vogelzang et aI., p.9). Dimeo,
Stieglitz, Novelli-Fischer, Fetscher, & Keul (1999) suggested that during adjuvant
therapies, patients altered activity choices in an attempt to self-modulate fatigue and
"down-regulate their level of activity" secondary to deconditioning, thus furthering a self
perpetuating cycle that led to the need for increased rest (p.2274). Vogelzang et al.
concluded that patients who received specific treatment for CRF felt that it was a
controllable symptom and provided some relief (66%); however surveyed oncologists
only believed that attempted treatment successfully impacted 17% of patients with CRF
(1997, p.9).
Mortimer et al. (2010) documented an exploratory study to examine patient
descriptions of the functional impact of fatigue on function utilizing 26 articles from a
literature search of previously published research. The patients documented functional
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limitations in activities of daily living, instrumental activities of daily living and
socialization and indicated that survivors begin to self-limit daily tasks and decrease
expectations of task accomplishment (p. E197 -199).

Fatigue and Other Symptomatology
Additional cancer-related or treatment-related symptoms have been correlated
with CRF in numerous research studies. Of specific concern is the ongoing controversy
in the literature surrounding the meaning or presence of depressive symptoms in
individuals experiencing CRF. Twenty-five percent of patients with a cancer diagnosis
are also diagnosed with a major depressive episode at some time during the course of
their illness, with highest risk for depression in those with advanced disease,
uncontrolled cancer-related symptoms such as pain, or a prior history of a mood
disorder (Bower et aI., 2000; Portenoy & Itri, 1999). The importance of understanding
the presence of depression is highlighted when reviewing the anticipated ICD-10 CRF
diagnostic criteria which denote the need to rule out major affective disorders or other
comorbid psychiatric disorders in order to assign a diagnosis of CRF (CDC, 2007; Cella
et aI., 2001).
In a previously referenced study by Broeckel et al. (1998), the presence of a prior
psychiatric disorder was not statistically significant in determining CRF; only a current
disorder accompanying the breast cancer emerged as significant lending credence to
the idea that CRF contributes to depression and not vice versa. Spelten et al. (2003)
found statistically significant results demonstrating decreases in fatigue, physical
complaints and psychological distress from the first to last data collection in a
prospective inception cohort study with 12 months follow-up of 195 previously employed
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patients with a primary recent (4-6 months) cancer diagnosis (Spelten et aI., 2003).
Upon baseline assessment, fatigue and depression were correlated (r
fatigue and physical complaints (r
distress (r

=0.61), sleep problems (r =0.33), and emotional

=0.32) (Spelten et aI., 2003).

depression and sleep (r

=0.54), as were

Physical complaints were related to

=0.50) and depression was related to psychological distress (r

> 0.50) (Spelten et aI., 2003).

Fatigued women also reported greater frequency and number of menopausal
symptoms than non-fatigued women, and identified more depressive symptoms (Bower
et aI., 2000). The predictive model described by the latter was significant (P
with depression (p = 0.001) and pain (p

=0.0001)

=0.001) emerging as the strongest predictors of

CRF (Bower et aI., 2000). Bower et al. (2000) concluded that even though their results
demonstrated that depression was the strongest predictor of fatigue, there was no
causal relationship citing the reciprocal nature of fatigue symptoms such as diminished
occupational functioning preceding depressive mood or depressive mood causing
fatigue. In a 2006 study, Bower, Ganz, & Desmond et al. affirmed their previous
findings. Fatigued women were more depressed, had increased comorbid pain, higher
fear of cancer recurrence, and were more likely to have undergone both chemotherapy
and radiation than non-fatigued women (Bower et aI., 2006).
Sadler et al. (2002) found that increased reporting of depressive symptoms were
higher in individuals meeting the ICO-10 criteria (P = 0.02). Since decreased energy is a
significant symptom in individuals meeting the DSV-IV-TR criteria for a depressive
mood disorder, this might argue in favor of CRF as a manifestation of an underlying
mood disorder. However, Sadler et al. concluded that the ICD-10 CRF criteria are
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designed to specifically eliminate those individuals with an underlying mood disorder
before the criteria can be accurately applied (2002).
Researchers have also explored the potential for CRF existing as part of a
defined symptom cluster. Dodd, Miaskowski, & Paul (2001) investigated linkages
between fatigue, pain, and sleep dysfunction in a longitudinal study with 93 participants
who had recently completed chemotherapy. The Karnofsky Performance Scale (KPS), a
clinical assessment tool used to classify patients based on the extent of medical
intervention needed, patient disease prognosis, and a measure of functional
performance, revealed the emergence of fatigue as the highest rated predictor for
changes in KPS scoring, with pain emerging as a secondary predictor (Dodd et aL,
2001). The study's findings refuted their hypothesis that fatigue, pain, and sleep
constituted a cluster, and lends credence to the view of cancer-related fatigue as a
multi-faceted single entity (Dodd et aL, 2001).

Cancer-Related Fatigue Instrumentation
A gOld-standard measurement tool for CRF has yet to be identified. Over 25 self
perception tools assessing CRF, ranging from single item to complex multifaceted
scales, are available for use with varying psychometric reliability and validity (Mortimer
et aL, 2010). Previous research studies have validated instruments capable of defining
aspects of CRF, but none have emerged in either research or clinical settings as the
outcome measure of choice. Difficulties in measurement are directly attributable to the
problem of defining the parameters of this multidimensional construct. For example,
instruments that are capable of measuring the physical attributes of fatigue, may not
record the undesirable consequences that interfere with daily life. Attempts to refine the
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CRF construct and discriminate it from other forms of fatigue have resulted in the
development of ICD-1 0 diagnostic criteria.
The development of the proposed diagnostic category for CRF for the next
publication of the International Classification of Disease, 10th edition, Clinical
Modification (ICD-10 CM) (Sadler et aL, 2002; Portenoy, & Itri, 1999), should assist
clinicians in the identification of patients experiencing CRF. The proposed criteria have
been studied to validate the symptom list and determine prevalence rates (Young &
White, 2006). For researchers, a formal diagnosis of neoplastic related fatigue offers the
potential to identify and target interventions meeting the needs of severely fatigued
patients living with cancer; however the criteria poses the risk of excluding individuals
with fairly significant fatigue who may fall short of the required six symptoms for
diagnosis.
Young and White (2006) utilized the ICD-10 criteria to estimate prevalence rates
of CRF in 69 disease-free BCS in Scotland and to further validate the draft criteria due
to concerns regarding discrepancies in the literature between higher reported
prevalence rates when self-perceived fatigue questionnaires were used with cancer
survivors versus prevalence when the new criteria was applied. Twenty-three percent of
participants met symptoms criteria, while 18.8% met the determination of interference
with daily function (Young & White, 2006, p.33). Those meeting the criteria reported
daily fatigue patterns that worsened as the day progressed, had received more types of
adjuvant therapy, and experienced higher psychological distress (Young & White,
2006). They also reported a broader fatigue experience that impacted daily life tasks,
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experiencing fatigue an average of 2.7 more days per week and reported increased
anxiety, depression, and psychological distress (Young & White, 2006, p.35)
Sadler et al. (2002) evaluated off-treatment fatigue in 51 individuals who had
previously undergone autologous or allogenic blood or marrow transplantation to
establish validity for a structured CRF interview based on the P-ICD-10 CM. Results
indicated that the interview discriminated between fatigued and non-fatigued
populations, identifying 43% of the sample (n = 22) experiencing fatigue daily or nearly
every day during at least two weeks within the past month (p. 409),77% of those who
were fatigued perceived the need to struggle to overcome activity, and 36% reporting
that they had difficulty completing daily tasks due to fatigue (Sadler et aI., 2002, p.410).
Twenty-one percent of the sample (n = 11) met at least 6 of the 11 symptoms in the
criteria, defined as the cut-off for a diagnosis of CRF (Sadler et aI., 2002, p. 410).
A Belgian study of 834 cancer patients established cut-off scores for the ICD-10
for the purposes of diagnosis (Van Belle et aI., 2005). Descriptive statistics revealed that
79% of fatigue-positive patients documented "difficulty completing daily tasks attributed
to feeling fatigued" versus 24% of non-fatigued patients, and 65% of fatigue-positive
patients reported "decreased motivation or interest in engaging in usual activities"
versus 24% of non-fatigued patients (Van Belle et aI., 2005, p.249).
In a randomized representative sample of U.S. households with individuals with
cancer (Cella et aI., 2001) the prevalence of CRF was found in 17% of 379 individuals
evaluated using the guidelines for symptoms and functional impact of the ICD-10
criteria. Committees of researchers working to refine the definition of CRF have
suggested that the ICD-10 diagnosis for CRF include four criteria: "the presence of CRF
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for 2 or more weeks, significant distress or impairment, consequence of cancer or its
treatment, and absence of comorbid psychiatric disturbance (Mortimer et aI., 2010, p.
1332)."
The FACIT -fatigue scale was used to assess a population of cancer patients with
and without anemia compared to a general U.S. sample population (Cella, Lai, et aI.,
2002). The general population, as expected, reported lower levels of fatigue than cancer
survivors regardless of anemia status (p < .0001). Using a cut-off score of 43, the
FACIT-fatigue was capable of distinguishing between the general population and cancer
survivor with and without anemia (sensitivity 0.92; specificity 0.68).
Functional Assessment of Cancer Therapy - Fatigue Subscale (FACT-F).
Based on prior studies and psychometric stability, the Functional Assessment of Cancer
Therapies (FACT) was chosen as the fatigue scale for this study. FACT is a system of
well-researched self-report questionnaires designed to evaluate various QOL impact of
cancer therapies on individuals living with cancer (Yellen et aI., 1997). The FACT is a
subset of the larger Functional Assessment of Chronic Illness Therapy (FACIT) system,
a vast test bank of questions designed for a variety of health-based conditions and
translated into 43 languages (Stasi et aI., 2003). Subsumed, as part of the FACT
system, is a tool that was designed to assess anemia (FACT-An) in individuals
undergoing treatment for cancer. Contained within the FACT-An is a 13-item subscale
designed to assess cancer-related fatigue since fatigue is foremost among symptoms of
anemia. Subsequent research validated the FACT -F as a separate assessment
instrument from the FACT-An questionnaire that can be used across the cancer

60
spectrum to assess fatigue-based symptoms (Van Belle et aI., 2005; Hwang, Chang,
Rue, & Kasimis, 2003; Passik et aI., 2002; Yellen et aI., 1997).
The FACT-F is composed of the same 13-item fatigue subscale described in the
FACT-An, as well as questions from the FACT-G on information related to the impact of
fatigue on quality of life concerns such as physical, social, emotional, and functional
status (Cella, Eton, Jin-Shei, Peterman, & Merkel, 2002; Yellen et aL, 1997). Each item
retrospectively assesses the experience of fatigue over the past seven days and is
rated on a 5-point Likert scale, from 0 "not at all" to 4 "very much so" (Cella, Lai et aL,
2002; Van Belle et aI., 2005). Higher scores are indicative of better functioning (Yellen
et aI., 1997). Estimated completion time for the complete FACT-F is 10 minutes; the 13
item subscale would therefore take less than 10 minutes to complete. The FACT system
has a reading level of 6.0, making it suitable for a range of populations and can be
administered via verbal interview or questionnaire (Yellen et aI., 1997). The FACT-F has
been documented as a suitable measure of self-perceived fatigue in populations with
cancer (Mustian et aI., 2004; Bennett, Goldstein, Lloyd, Davenport, & Hickie, 2004;
Stasi et aL, 2003; Yellen et aI., 1997). Van Belle et at confirmed the validity in the
FACT-F subscale and unidimensional measure of fatigue for systematized assessment
of fatigue in individuals with cancer (2005).
Another study delineated a cut-off score of 37 out of the 52 possible points on the
FACT-F subscale as constituting moderate to significant fatigue in a population of
women with breast cancer undergoing and following radiation therapy (Wratten et aI.,
2004), but the sample size of 52 was small. In this study, baseline fatigue subscale
scores, along with neutrophil and red blood count, were found to be predictive of
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membership in fatigued versus non-fatigued groups at 6-week post-treatment (Wratten
et aI., 2004). The cut-off score was chosen based on an earlier study which
extrapolated this test score from high correlation scores between the FACT-F and Brief
Fatigue Inventory (BFI). The relationship between the FACT-F and BFI was supported
by the work of Hwang et al. (2003) who found that a factor analysis yielded 91% of the
variance through loading on one factor between the FACT-F and BFt. Van Belle et al.
(2005) established that a cut-off score of 34 allowed for prediction of ICO-1 0 status in
93% of 470 patients (sensitivity 0.91, specificity 0.75) (p.251). For this proposed study,
the Van Belle cut-off score of 34 will be considered to define significant fatigue on the
FACT-F.

CRF Summary
The exigent circumstances that surround the imperative to develop interventions
for CRF are noted as the BCS population grows in response to early detection with
increasing survival statistics. These women remain at risk for the development of
secondary morbidities such as fatigue and upper extremity deficits after adjuvant
therapies conclude directly impacting occupational performance in all spheres of life.
The majority of the research literature has focused on defining the parameters of the
construct and determining prevalence rates. There is still a paucity of intervention
research addressing CRF and functional status. The potential for long-standing health
deficits and functional limitations that spiral from the persistent experience of CRF,
including the potential for cancer recurrence, supports concerted efforts directed toward
furthering our understanding of CRF and its impact on daily life.
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Upper Extremity Function
The range of deficits and impairments found in the upper extremity secondary to
breast cancer diagnosis, surgery, or adjuvant therapies is broad, thus defining the
impact of these symptoms depends upon the research variables of interest, definitions
of function, instrumentation choices and when data is obtained. There is a sizable body
of literature describing the impact of breast cancer surgery and adjuvant therapies on
upper extremity physical function (Hayes et aI., 2005; Collins et aI., 2004; Rietman et
aI., 2004), but less is known about the impact of residual symptoms on function in BCS.
Incidence rates for all problems vary from 7 - 80%, with pain and sensory deficit
estimates ranging from 9 - 68%, lymphedema from 2 - 17%, and decreases in range of
motion from 3 - 73% (Hack et aI., 2010). Lymphedema of the ipsilateral extremity is a
potential complication of breast cancer surgery and treatment, with differing incidence
and prevalence numbers reported due to variations in research study parameters,
impacting 15 - 20% of BCS (Petrek & Heelan, 1998). Hack and colleagues documented
that multiple treatment and demographic factors, often in combination, influence
persistent symptoms including pain, lymphedema, and ROM on the results of a
Canadian multi-center assessment of persistent arm dysfunction in 316 BCS (2010).
A focal point for recent literature has compared the significance on upper
extremity function resulting from axillary lymph node dissection [ALNO] or sentinel
lymph node biopsy [SLNB] during the diagnostic process (Rietman et aI., 2006). Node
biopsy and particularly radiation therapy may be accompanied by upper extremity
sequelae including muscle weakness, numbness. pain, paresthesias, loss of shoulder
range of motion, tightening of scar tissue, and risk for or exacerbation of lymphedema
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(Karki et aI., 2005). These resulting deficits can further complicate hand function in the
affected extremity (Karki et aI., 2005). The consequences of reduced physical function
in the upper extremity and hand directly impact occupational performance in all areas of
occupation (Collins et aI., 2004). The upper extremities typically provide the means
through which performance of most activities of daily living and instrumental activities of
daily living take place. Therefore, marked impairment in upper extremity function will
likely also impact life role fulfillment and quality of life.
Surprisingly, research on CRF has not explored the interrelationships between
upper extremity deficits resulting from surgery or adjuvant therapies on energy usage
and the experience of fatigue. Linkages within the CRF body of literature clearly identify
occupational performance deficits resulting from the fatigue experience (Ashbury,
Findlay, Reynolds, & McKerracher, 1998). It is also acknowledged that both CRF and
upper extremity limitations are commonly experienced by many BCS and diminish
quality of life. These two distinctive impediments place an undue burden on survivors'
abilities to perform IADLs, work-related tasks, leisure and socialization, and in turn
impact family relationships (Hayes et aI., 2005; Taylor & Currow, 2003).
In light of the emphasis on engagement and partiCipation in all life spheres
emphasized by the World Health Organization (2001), this section stresses the
importance of the impact of upper extremity function on occupational performance in life
tasks and roles. Definitions for terminology related to functional performance and study
variables are located in Appendix A. It concludes with a description of the research
literature supporting the use of the Disability of the Shoulder, Arm, and Hand (DASH) as
an outcome measurement tool for this proposed study.
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Impact of Breast Cancer on Upper Extremity Physical Parameters
Hladiuk, Huchcroft, Temple, & Schnurr (1992) reported results from a pilot study
to examine objective measures of upper extremity function when compared with the
contralateral extremity in a sample of 57 BCS who underwent ALND alone or in
combination with surgical tumor resection, describing follow-up from 6 - 15 months
post-surgery. The most improvement in range of motion occurred by month 6 and
roughly stabilized thereafter, with external rotation demonstrating the highest level of
residual limitations in 12% of the participants (Hladiuk et aI., 1992). Of particular interest
in this study was the finding that 42% of the women experienced ongoing, measurable,
diminished function after one year post-surgery (Hladiuk et al., 1992). Diminished grip
strength was documented in 16% of the participants, with a reduction of 12 -18% when
compared to grip strength of the non-surgical arm, although arm dominance was not
related to recovery of physical function (Hladiuk et aI., 1992, p.49). Women who
continued to follow the typical health professional BCS guidelines for post-surgical
upper extremity exercise a year following surgery documented a trend toward less
impaired grip strength, but the small population size and the decision of the authors to
alter the alpha level to 0.25 brings the results into question (Hladiuk et aI., 1992).
The impact of dominance and treatment side is a critical issue when examining
functional performance resulting from upper extremity deficits after adjuvant treatment
concludes and is another area of breast cancer morbidity that has been underreported.
Hayes et al. (2005) examined the relationships between objective upper body function
and subjective questionnaires on quality of life measures in Australian BCS under the
age of 75 using the Disability of Arm, Shoulder, and Hand (DASH) questionnaire, the
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Functional Assessment of Cancer Therapy, Breast (FACT-B), and upper body strength,
range of motion, and grip strength as objective measures. Radiation therapy emerged
as the only adjuvant treatment associated with decreased flexibility, but only when the
non-dominant side was treated (Hayes et aI., 2005). When the dominant side was
treated, participants consistently demonstrated greater objective upper body function for
strength, endurance, and grip strength (p < .001), but simultaneously reported lower
quality of life (Hayes et aI., 2005). Similar findings were observed for the IADL task of
childcare which was positively correlated with hand grip strength, but negatively
associated to self-perceived function (Hayes et aI., 2005, p.3-4). Income. extensive
axillary node dissection, and lymphedema were all associated with factor with
decreased upper body function (Hayes et aI., 2005, p.4). This unexpected finding that
the dominant treatment side demonstrated increased function was first identified in an
earlier study by Swedborg and Wallgren (1981). The authors reported higher grip
strength scores and more degrees of external rotation on the dominant affected side,
with 34 - 44% of BCS demonstrating better grip strength and 40 - 48% with improved
range of motion (Swedborg & Wallgren, 1981). The authors conjectured that women
whose dominant side was affected still needed to use the arm functionally resulting in
increased objective measures, but greater recognition of subtle losses in function
resulted in less satisfaction in performance (Hayes et aI., 2005).
Node Dissection and Adjuvant Therapy Impact to the Upper Extremity
It was previously mentioned that the methodology used for the staging of breast
cancer frequently involves dissection of the lymphatic nodes in the axilla. Historically,
ALND was the standard of care for decades with multiple nodes removed for biopsy
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often at the same time as surgical resection of solid breast tumors. This procedure is
identified as "the most prognostic variable in patients with breast cancer "(Rietman et
aI., 2003, p.229). However, ALND has been associated with the development of upper
limb dysfunction in BCS (Rietman et al., 2006; Rietman et aI., 2003). Nodal staging
during the last decade has been supplanted by SLNB (McGuire et aI., 2009, p. 2682).
Breast conserving surgery with follow-up radiotherapy, chemotherapy, hormonal or
combination therapies further accelerated the acceptance of this method of node
removal. However, many women with positive sentinel nodes on biopsy will require
further axillary node removal to obtain an accurate diagnosis and differentiate treatment
choices. Therefore node removal remains a great source of concern for women with
breast cancer.
The advent of SLNB, as opposed to ALND, as the prevailing standard of care for
initial surgical node removal and diagnosis has altered the landscape for BCS and
researchers. The National Cancer Institute describes sentinel node biopsy as the
process of locating and systematically examining the most likely lymph nodes to be
affected by cancer cells from the primary tumor (2005). Radioactive dye is used via
Iymphoscintigraphy, followed by the use of a gamma probe to identify the sentinel
nodes for surgical biopsy (Rietman et aI., 2006). Typical ALND regional clearance of
many or most nodes may not be necessary if the sentinel nodes, once examined by
pathologists, are clear of metastasized cancer cells (NCI, 2005). SLNB is usually
performed as a separate procedure from breast tumor resection; therefore women may
need to undergo more than one invasive procedure. Removing fewer lymph nodes for
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staging and diagnostic purposes has the potential to cause less arm morbidity; however
current research has not fully established this link (NCI, 2005).
A decade of literature suggests that a significant relationship exists between the
number of lymph nodes removed and the development of subsequent arm morbidity
and sequelae such as lymphedema (Hack et aI., 2010). While SLNB has become an
alternative diagnostic procedure resulting in lower numbers of removed nodes, research
has not yet established this techniques' accuracy in enhancing survival rates or
identifying cancer recurrence (NCI, 2005).
There is also recent evidence that mastectomy rates are increasing again after
years of diminishing percentages of women undergoing this more extensive surgery
(McGuire et aI., 2009; Katipamula et aI., 2009). Identified factors accounting for this
unexpected rise include an increase in contralateral prophylactic mastectomies followed
by reconstruction as genetic testing provides women with increased information that
may alter collaborative decision-making with the oncology team, as well as decisions of
women to request more extensive surgery in order to try to avoid or decrease radiation
or chemotherapy (McGuire et aI., 2009).
The impact of SLNB on upper extremity function and self-perceived occupational
performance and quality of life was the focus of a study of 181 BCS in the Netherlands
in a pretest-posttest design examining upper limb, function-based, and quality of life
assessments from the day before surgery to a second time period two years post
surgery (Rietman et aI., 2006). ALND was predictive of negative adverse effects two
years after treatment concluded in objective physical measures including decreased
grip strength, decreased shoulder abduction and some diminished aspects of ADL
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status and quality of life (Rietman et aI., 2006). Individuals who had undergone radiation
therapy further demonstrated diminished range of motion and increased arm swelling
(Rietman et aI., 2006). Women who underwent SLNB experienced less adverse effects
in all areas measured (Rietman et aI., 2006).
Radiation therapy was also implicated as a contributing factor in upper extremity
morbidity in a much earlier study of 475 BCS who underwent modified radical
mastectomies in Stockholm, and were randomized to pre-surgical radiation therapy,
post-surgical radiation, or no radiation therapy (Swedborg & Wallgren, 1981). One
hundred sixty of the original cohort underwent further physical evaluation for volumetric
lymphedema measurement, shoulder range of motion, and grip strength (Swedborg &
Wallgren, 1981). Following surgery and/or radiation, it was noted that BCS who did not
undergo radiation therapy experienced less edema, had increased mobility, and a trend
toward increased grip strength in the affected upper extremity, but with no significant
differences for the two radiation therapy groups (Swedborg & Wallgren, 1981).
Conflicting results on the role of chemotherapy in the development of
lymphedema and functional impairments have been reported. Rietman et al. (2004)
found that radiotherapy was the most significant predictor of loss of range of motion,
with chemotherapy contributing only minor predictive interest. Paskett et al. (2007)
focused on the prevalence of lymphedema and resulting impact to quality of life in a
sample of 627 women recruited from four nationally recognized cancer centers. Lymph
node removal was the most significant factor in the development of lymphedema (P

=

0.003) with hazard equations demonstrating an increasing risk of 2.2% for every
additional node removed (Paskett et aI., 2007, p.779). The unexpected finding was the
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high risk of lymphedema in those receiving chemotherapy (76%), as well as increased
risk in married women. Paskett et al. conjectured that increased lymphedema risk for
married women might be related to more frequent engagement in IADL tasks (2007).

ADL and Upper Extremity Instrumentation
The predicament of how to measure fatigue outcomes is echoed by the same
difficulties when comparing studies that measure occupational performance or upper
extremity function. Rietman et al. (2003) conducted a literature search yielding 15
studies that met their criteria to explore the effects of late morbidity on function and
quality of life. They documented the lack of uniformity, documented criteria, and
psychometrically sound assessment tools to measure ADL and IADL function, as well
as in tools those chosen to measure upper extremity dysfunction. For the proposed
study, one measure has been chosen to assess self-perceived ADUIADL function and
upper body symptoms. The Disabilities of the Arm, Shoulder, and Hand (DASH) was
chosen due to its reliable and validated psychometric properties with a variety of
patients with upper extremity dysfunction (Jester, Harth, Wind, Germann, & Sauerbeir,
2005; Beaton, Katz, Fossell, Wright, & Tarasuk, 2001; SooHoo, McDonald, Seiler, &
McGillivary, 2002; Hudak, Amadio, Bombardier, & Upper Extremity Collaborative Group
[UECG], 1996).

Disabilities of the Arm, Shoulder, and Hand (DASH). Developed by the
Institute for Work and Health in Toronto, Canada, and the American Academy of
Orthopedic Surgeons in 1996, the Disabilities of the Arm, Shoulder, and Hand
questionnaire (www.dash.iwh.on.ca/index.htm) is a standardized quality of life outcomes
measure designed to assess patient perceptions of upper extremity musculoskeletal
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disability causing limitations in ADL and IADL tasks, as well as perceived extremity
related symptoms such as pain or weakness (Hudak et aI., 1996; Kennedy, Beaton,
Solway, McConnell, & Bombardier, 2011). It consists of a 30-item questionnaire asking
patients to assess their ability to perform common ADL and IADL tasks within the prior
week using a 5-point Likert scale with answers ranging from "not at all" to "extremely."
The instrument has been translated into 17 different languages resulting in an
increasing body of international literature on upper extremity musculoskeletal disorders
to support the use of this instrument in assessing perceived disability, as well as health
burden (Gummesson, Atroshi, & Ekdahl, 2003).
Normative data in the DASH from a United States random population sample
using the National Family Opinion's household panel database matched to the U.S.
census has been documented (Hunsaker, Cioffi, Amadio, Wright, & Caughlin, 2002). In
this nationally representative sample, the DASH exhibited Cronbach's alpha ranging
from 0.94 to 0.98, Pearson correlations of 0.49 to 0.87, and item internal consistency of
100 (Hunsaker et aI., 2002, p.213). Mean scale scores for global function on the DASH

=1706) was 10.10 (SO 14.68); Sports optional scale (n =1113) 9.75 (SO 22.72); and
Work optional scale (n =1610) 8.81 (SO 18.37) (Hunsaker et aI., p.211, 2002).
(n

Reliability of the DASH was demonstrated in this population with a Cronbach's alpha
coefficient above 0.9 (Gummesson, 2003, p.4).
Construct validity of the DASH as an extremity specific quality of life outcome
measure was supported by data from SooHoo, McDonald, Seiler, and McGillivary
(2002) in a study examining correlations of the DASH to the Medical Outcomes Study
Short-Form 36 (SF-36), a well established quality of life outcome measure with available
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standardized normative scores for the U.S. population. The hypotheses were confirmed
with moderate correlations observed ranging from 0.36 for the general health subscale
to .62 for the role emotional subscale (SooHoo et al., 2002).
Beaton et at (2001) also assessed the psychometric properties of the DASH,
examining within-subject responsiveness, reliability and validity in a study sample of 172
patients from major hospital centers in Toronto (n = 109) and Boston (n = 91) engaged
in treatment for a variety of upper extremity disorders. Working patients demonstrated
lower DASH disability scores than those who were unable to work due to upper
extremity dysfunction, demonstrating statistically significant discriminative validity (26.8
vs. 50.7, t

=-7.51, P < .0001) between these groups, as well as between those

diagnosed with shoulder vs. hand conditions (Beaton, 2001, p.135). Reliability of the
DASH as measured by Cronbach's alpha was reported as 0.97 (Beaton et aI., p.140)
during baseline data collection and is further supported by data from Gummesson et al.
(2003), documenting Cronbach's alpha levels above 0.90.
Convergent construct validity was also found in Pearson correlations exceeding
0.70 between the DASH and joint-specific measures, the Shoulder Pain and Disability
Index (SPADI) and the Brigham questionnaire for hand and wrist dysfunction (Beaton,
2001, p.135). Pearson correlation using data over the course of 3 - 5 days from 56
subjects, indicating that they had no change in deficits during that time period, was 0.96
and Spearman ranked correlation was 0.96 at the 95% CI (Beaton et aI., 2001)
indicating high test-retest reliability. The ICC was 0.96 (95% CI) and the SEM of 4.6
points provided a minimally detectable change (MIDC) of 12.75 on the 100-point scale
or 10.7 of 100-points using a 90% MIDC (Beaton, 2001, p.135). This is also consistent
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with the 10 point MIDC described by Gummesson et aL (2003) and Hunsaker et aL
(2002). Results indicate that the DASH is a valid, reliable, and responsive tool for single
or multiple disorders in the upper extremities.
One dissenting study from Australia questioned the discriminative validity of the
instrument. Dowrick, Gabbe, Williamson and Cameron (2006) evaluated the use of the
Short Musculoskeletal Functional Assessment (SMFA) and the DASH comparing three
groups of individuals with upper extremity injuries, lower extremity injuries, and a control
group. Reported data supported previous DASH validation studies to identify upper
extremity dysfunction, but noted that the lower extremity group demonstrated higher
scores on the DASH than the control group (z

=-7.1, P < .001) (Dowrick et aL, 2006,

p.526). While this finding was not supported by other research, identification of some
lower limb disability using the DASH provides support for the complexities inherent in
ADl and IADl tasks. If certain ADl and IADl tasks delineated on the DASH were
subjected to an activity analysis, they might not solely be comprised of upper quadrant
requirements as these tasks are typically performed by adults in daily life. The authors
cautioned that investigators should attempt to insure that only upper extremity disorders
exist when choosing the DASH as an upper quadrant outcome measure (Dowrick et aI.,
2006). In that study, the Dowrick et al. altered the instructions to request information
about lower extremity function. The standardized instructions developed by the DASH
developers will be used since all subjects in this study have experienced some type of
medical intervention in one breast that has the potential to impact upper quadrant
function.
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One study was located describing the use of the DASH as a measure of
perceived upper extremity function for research on recovery advice given to women with
breast cancer (Round et aI., 2006). All of the research studies previously described
(Beaton et aI., 2001; SooHoo et aI., 2002; Gummesson et aI., 2003) support the use of
the DASH as an outcomes measurement with established psychometric properties that
can be used to assess upper quadrant dysfunction, including upper extremity function in
women with breast cancer.

Impact of Fatigue and Upper Extremity Dysfunction on Occupational Performance
The consequences of cancer-related fatigue are disturbing, but the negative
impact of fatigue on occupational performance highlights the need to further define the
functional implications. Occupational performance of IADLs suffered most from the
impact of CRF in the daily lives of survivors, however ADLs that involve lifting, pushing,
carrying, or tasks that demand increased shoulder range of motion can be affected as
well (Hayes et aI., 2005; Stariano & Ragland, 1996). Patients with advanced stage
cancer reported more significant ADL deficits that increased as the disease process
progressed (Taylor & Currow, 2003). In 1998, Ashbury et al. surveyed 913 Canadian
cancer survivors to assess the perceived relationship between fatigue and function.
Seventy-eight percent of the respondents reported moderate to severe interference with
occupational performance (P < .0001) with work, socialization, family relationships, and
personal finances highlighted as the most affected activities. In the 2000 study by
Stone et aI., the authors also documented specific areas of occupational performance
that were most frequently impacted. These included work-related functions, the ability to
enjoy life, and sexual relations (Stone et aI., 2000). Broeckel et al. (1998) documented
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the negative impact on employment by fatigue symptoms (P < .05). Aside from the
emotional factors that accompany the ability to work, the economic impact of loss of
work is large with 75% of survivors and 40% of caregivers noting changes in the status
of their employment attributable to fatigue (Spelten et aI., 2003).
Servaes, Verhagen, S., & Bleijenberg (2002) compared a sample of 150 younger
disease-free pre-menopausal BCS in the Netherlands (6 - 70 months post-adjuvant
therapies) with 78 peer-nominated controls to assess various dimensions of the fatigue
construct. Results indicated that 38% of the BCS met the criteria for severe fatigue on
self-perceived fatigue measurement tools and 16% met the criteria for non-severely
fatigued status, whereas only 11 % of the control group met the same criteria. Severely
fatigued BCS reported more functional impairments than controls, although the authors
found no difference in task demands or hours spent in daily tasks between the groups
using a prospective recording form for ADL and IADL activity that was completed four
times daily over 12 days; their findings indicated that BCS performed the same tasks as
disease-free counterparts, but performance was more difficult due to fatigue (Servaes,
Verghagen, S., & Bleijenberg, 2002). BCS were also employed for fewer hours per day
than the control counterparts and fatigued BCS also reported less physical activity and
less social functioning than controls or less-severely fatigued BCS (Servaes,
Verghagen, S., & Bleijenberg et aI., 2002).
Not all studies have examined CRF as a correlate to occupational performance
deficits, yet many have clearly identified the loss of functional status in BCS from
specific upper extremity deficits. Hayes et al. (2005) identified specific ADL and IADL
tasks that caused difficulty for BCS, stratifying difficult tasks into those that were usually
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performed more frequently to calculate which daily tasks created the greatest overall
burden. The tasks most frequently cited were "carrying a moderate weight, washing the
upper part of the back, opening a tight jar, and doing up a bra" (p.257). BCS also
identified other difficulties in IADLs that included carrying, pushing or pulling tasks such
as laundry and grocery shopping; repetitive tasks such as vacuuming, raking, or
sweeping; and tasks that involved reaching overhead (Hayes et aI., 2005). The
presence of lymphedema increased task burden by 15 - 21 % (Hayes et aI., 2005).
Taylor and Currow (2003) conducted a cross-sectional prevalence survey in 104
outpatients and 13 inpatients to identify unmet ADL and IADL needs in a mixed cancer
population in Australia. Thirty-percent of patients identified unmet ADL and IADL needs
that might benefit from assistance to develop alternative techniques or the use of
adaptive equipment, with women identifying more unmet needs than men. Work,
leisure, and driving were the most frequently cited concerns (Taylor & Currow, 2003).
A qualitative study of twenty-four BCS in Australia confirmed previous literature
results documented the impact of upper extremity impairments on occupational
performance and continued complaints of upper extremity dysfunction in 50% of the
participants six months post-surgery (Collins et aI., 2004). IADL task performance was
impacted most once BCS had completed all surgery and adjuvant therapies, but were
further complicated by perceived fatigue and emotional distress (Collins et aI., 2004).
Task deficits reported in this study included "sleeping on the affected side, putting
washing on the line, putting curtains up, washing the windows, gardening, writing,
cutting vegetables, ironing, computer work, carrying a handbag, doing up a bra, wearing
a bra and buying a comfortable one, and driving in a car (seatbelt wearing, putting
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hands on the wheel and driving over bumps) (Collins et aI., 2004, p.109). Women
expressed uncertainty, confusion, or denial about the need to include exercise as a
component of breast cancer recovery, but women who attended a gentle exercise group
described the benefits of the exercises and increased realization of the extent of their
upper quadrant deficits (Collins et aI., 2004). This study was important in providing a
detailed description of specific activities that resulted in deficits in occupational
performance, despite the small sample size and participants who once again composed
an educated cohort within a higher socioeconomic class.
The heterogeneity of breast cancer survivors has been described throughout the
literature. Individual variability in fatigue throughout the day was explored by Dhruva et
al. (2010), in a repeated-measures study of 73 BC patients examining patterns of
fatigue throughout and following radiation therapy. This study confirmed the variability of
idiosyncratic fatigue experiences and identified differences in predictive factors for
morning and evening fatigue. Two occupational performance variables, specifically
caregiving for children and employment, emerged as predictive for evening fatigue
(Dhruva et al., 2010).
Fatigue and Arm Function Symptoms

No studies have specifically examined the relationship between cancer-related
fatigue and physical symptoms in the ipsilateral extremity, but a few have documented
findings that suggest that factors related to limb function and CRF may interact In a
large study (n =1,933) conducted in Korea that examined prevalence rates and
relationships between CRF! depression and QOL in BCS, Kim et al. (2008) documented
five risk factors for developing CRF and depression: dyspnea, sleep disturbance,
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appetite loss, constipation, arm symptoms, and lower monthly income. Further details
about arm symptoms, which were assessed as part of a larger quality of life measure,
were not explored. A recent study by Gerber et al. (2010) reported significant correlates
of biological and behavioral factors to persistent fatigue in 44 BCS nine months post
diagnosis, identifying higher levels of fatigue in women with increased body mass index
(BMI), WBC counts > 8,000, increased ipsilateral limb size, and decreased levels of
physical activity. Their findings indicated the presence of a predictive relationship
between defined symptoms of upper body morbidity, lifestyle factors, and cancer fatigue
in breast cancer survivors (Gerber et aI., 2010). Significant fatigue was found in 25% of
the study sample using a single item 0 - 10 point numeric rating scale (Gerber et aI.,
2010). Several studies have also identified pain, although not always specified as
related to upper limb function, as a contributing factor in CRF. Reinertsen et al. (2010)
noted this relationship in a longitudinal study of off-treatment long-term BCS described
earlier in this section, reporting statistically significant pain and discomfort on the side of
the body treated for cancer (p < .001).
Impact of CRF and Arm Function on Employment

Women spend a great deal of their daily life at work when usual economic
conditions prevail, and additional time performing household maintenance tasks and
child care. The United States unemployment rate for 2011, the time period during which
data was collected for this study, was 7.9% for adult women (U.S. Bureau of Labor
Statistics, 2012). Time use studies on the U.S. population documented that employed
and non-working women between ages 20 - 64 spent a mean of 20.9 - 27.3 hours per
week in work related tasks, a mean of 10 - 18.3 hours on household tasks and a mean
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of 27.4 - 36.2 on leisure activities (U.S. Bureau of Labor Statistics, 2010). Women with
more education devoted more weekly hours to employment, whereas women with less
education spent more hours on household tasks (U.S. Bureau of Labor Statistics, 2010).
For BCS under retirement age, employment during or following treatment for
breast cancer is often a desirable outcome and some may view the return to work as a
hallmark of successful management of the disease process (Spelten et at, 2003).
Persistent symptoms resulting from the cancer or subsequent surgical or adjuvant
therapy interventions may alter the trajectory of employment for BCS, particularly since
nearly half of all cancer survivors are under retirement age (de Boer et aI., 2009).
However persistent symptom burden resulting from the disease process or treatment
may negatively impact employment status (Hansen, Feurerstein, Calvio, & Olsen,
2008). Employment was a secondary area of interest for this exploratory study; several
questions were formulated in the demographic survey to survey potential changes in
employment resulting from the breast cancer itself or current United States economic
conditions, as well as to understand the current employment profile for the study
sample. In addition, data from the Disability of the Arm Shoulder Hand (DASH) Optional
Work Module was collected to try to ascertain perceived interference from upper
extremity symptoms on physical work-related tasks.
A review of the cancer survivor literature revealed that the majority of studies on
employment were conducted on individuals who were still receiving cancer treatment
during data collection. de Boer et al. (2009) conducted a meta-analysis and meta
regression analysis of 26 articles compiling results from 26 stUdies to ascertain key
factors that may predispose survivors to employment risk. Breast cancer survivors were
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found to be 1.28 times more likely to be unemployed than comparable healthy controls
(35.6% vs. 31.7%) (de Boer, 2009, p. 757). Limitations in physical status or persistent
residual cancer symptomatology were identified as key factors contributing to
unemployment in all cancer survivors, although not inclusive to BGS (de Boer, 2009). A
longitudinal study examined physical and cognitive task requirements for job
performance in 447 BGS and 267 prostate cancer survivors at 12 and 18 months post
diagnosis demonstrated that there was a subset of survivors that continue to experience
work-related problems secondary to physical limitations even though many survivors do
well following the conclusion of treatment (Obserst, Bradley, Gardiner, Schenk, & Given,
2010). At one year post-diagnosis, they found that 71 % of the BGS reported the need to
perform physical job task demands and almost universal agreement on the requirement
for cognitive task demands at work (Obserst et aI., 2010). More women reported
physical disability at one year that limited work performance (60%) with improvement at
18 months (36%; p < .01), but employment decreased for women with disabling residual
physical limitations at both time points compared with BGS without these limitations
(Obserst et aI., 2010, p. 326).
Hansen et al. (2008) captured information regarding residual symptom burden in
a study of 100 working BGS who were an average of four years post-treatment and a
healthy comparison group responding to an online survey. The authors found that
fatigue was significantly higher in BGS than the comparison group (p < .001), as were
symptoms of depression, anxiety and cognitive limitations, with fatigue accounting for
71 % of the total symptom burden (p. 781). The study did not examine the impact of
residual arm symptoms in the BGS, although pain was noted to be a non-significant
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contributor as was tumor stage and cancer treatment. It is difficult to compare these
studies since Obserst et al. (2010) examined actual task demands and Hansen et al.
(2008) reported on a range of symptoms, but did not address the actual work tasks
performed by the respondents. The impact of going to work every day with persistent
symptoms should not be underestimated. Studies researching the economic burden of
survivorship indicate that when time post-treatment is included as a variable, working
survivors still experience more functional limitations and variability in employment status
than individuals without cancer (Yabroff, Lund, Kepka, & Mariotto, 2011).
Literature Summary

The imperative to address the needs of breast cancer survivors is repeatedly
affirmed in the literature and throughout government agencies focused on cancer
survivorship. Cancer-related fatigue [CRF] has been shown to contribute to decreased
quality of life and reductions in occupational performance in BCS and persists as a long
standing symptom in a subset of women after adjuvant therapies conclude. In addition,
upper extremity deficits resulting from the cancer disease process, surgical excision of
tumors and single or combination adjuvant therapies also negatively affect occupational
performance and quality of life. The loss of functional status in specific tasks related to
IADLs, work, and social participation are oft cited for the physical parameters
associated with upper extremity dysfunction, as well as those resulting from fatigue
sequelae.
CRF is regarded as a complex multi-dimensional construct measured most
accurately by self-report and by noticeable effects on occupational performance of life
tasks. Research is necessary to contribute to the growing body of evidence that
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supports acknowledgement and interventions for these disruptive symptoms and
prevention of secondary morbidities resulting from surgical intervention and adjuvant
therapies. A desirable goal must be to assist BCS to return to full participation in all daily
occupations, including the performance of ADLs, IADLs, work, leisure, and socialization
activities.
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CHAPTER III
METHODS

Introduction

This study describes the relationship between perceived cancer-related fatigue
and upper extremity functional status in breast cancer survivors a minimum of one year

(> 12 months) to a maximum of 6 years « 72 months) following the conclusion of
surgical and adjuvant therapies. Perceptions of cancer-related fatigue and upper
extremity functional abilities were additionally explored by examining participant
differences in node dissection status, adjuvant therapies received and caregiving
responsibilities. This chapter details the methodology for the study including design,
subject criteria and sampling methodology, an overview of the psychometrics related to
the outcome variables of interest, and administrative procedures.
Design
The study is an exploratory, cross-sectional descriptive design. A correlational

study was chosen since the relationship between the two main constructs of interest,
cancer-related fatigue and upper extremity function, have not been explored in the
literature. This type of study can be used to generate other research hypotheses and
further describe the variables of interest (Polit & Hungler, 1995; Portnoy & Watkins,
1993). A series of self-report instruments were provided to obtain demographic and
health data, and to assess perceived cancer-related fatigue and upper extremity
function. On-line convenience-sample survey methodology was employed to recruit the
sample and collect data.
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Research Questions and Hypotheses
There were four research questions for this study.
RQ1. Is there a relationship between self-reported cancer-related fatigue and
perceived upper extremity functional deficits in breast cancer survivors (BCS)?
Ha.1. There is a relationship between self-reported cancer-related fatigue
and perceived upper extremity functional deficits in BCS

RQ2. Is there a difference in perceived upper extremity function and fatigue between
breast cancer survivors (BCS) who underwent sentinel node dissection and those
who underwent axillary node dissection?
Ha.2.1: There is a difference in perceived upper extremity function
between BCS who underwent various node dissection procedures,
including axillary node dissection, sentinel node dissection and both
axillary and sentinel node dissection.
Ha.2.2: There is a difference in perceived cancer-related fatigue between
BCS who underwent various node dissection procedures, including
axillary node dissection, sentinel node dissection and both axillary and
sentinel node dissection.

RQ3. Is there is a difference in perceived upper extremity function and fatigue
between breast cancer survivors (BCS) who underwent differing types of adjuvant
cancer therapies, including chemotherapy, radiation, or combination therapies?
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Ha3.1: There is a difference in perceived upper extremity function
between BCS who underwent chemotherapy, radiation, immunotherapy,
hormone therapy or combination therapies.
Ha3.2: There is a difference in perceived cancer-related fatigue between
BCS who underwent chemotherapy, radiation, immunotherapy, hormone
therapy or combination therapies.

RQ4. Is there a difference in perceived upper extremity function and fatigue between
breast cancer survivors (BCS) who have dependent caregiver responsibilities and
those without dependent caregiver responsibilities?
Ha4.1: There is a difference in perceived upper extremity function
between BCS who have dependent caregiver responsibilities and those
without dependent caregiver responsibilities.
Ha4.2: There is a difference in perceived cancer-related fatigue between
BCS who have dependent caregiver responsibilities and those without
dependent caregiver responsibilities.

Description of Participants
Women were eligible to participate in the study if they (1) were between 21 - 65
years of age (2) could read English; (3) had a confirmed diagnosis of breast cancer,
Stage 0 to III (And rykowski , Curran, & Lightner, 1998); (4) had received and completed
required surgical intervention, adjuvant chemotherapy and/or radiotherapy treatment for
breast cancer a minimum of 1 year (>12 months) and a maximum of 6 years «72
months) prior to participation in the study (Curran, Beacham, & Andrykowski, 2004;
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Young & White, 2006), (5) were currently in remission or considered to be disease-free,
(6) had access to the internet; (7) were willing to complete on-line questionnaires and a
demographic survey and (8) resided in the United States. Women who were not in
rernission or considered to be disease-free, were in Stage IV (metastasis), were still
undergoing active cancer treatment or surgical intervention, did not have internet
access, resided outside the United States, or whose diagnostic and treatment
completion parameters did not fall within the designated time parameters, were
excluded. No compensation or incentives were offered to participants who volunteered
to complete the study.
Pilot data was obtained from February 2011 through April 2011. Active
recruitment for the final data sample occurred from October 2011 through January
2012.

Sample Size Estimate. An a priori sample size of 268 participants was
estimated using G*Power, version 3.1, based on a medium effect size of 0.30, an alpha
level of 0.05 (two-tailed) and 0.80 power (Faul, Erdfelder, Lang, & Buchner, 2007).

Sampling Method
An internet snowball sampling strategy was chosen due to the exploratory nature
of the study. Locating an adequate sampling frame for participants within the narrowly
defined inclusionary criteria was anticipated to be difficult without a broader recruitment
effort. Snowball recruitment has been found to be less expensive than mail recruitment
methods, time efficient for respondents and uses increasingly available informal and
social networking to bolster recruitment efforts (Ritter, Lorig, Laurent, & Matthews,
2004). This methodology has been used to recruit populations that are difficult to access
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by other means, including for studies that must request sensitive health or personal
information (Sadler, Lee, Lim, & Fullerton, 2010). This sampling schema originated in
'''contact tracing' in public health in which one individual names all other individuals who
were associated with a specific event" (Sadler et aI., 2010, p. 370), or as one researcher
euphemistically described, using the social equivalent of "six degrees of separation"
between contact groups (Gruppetta, 2005, p.8).
Research is limited on internet use patterns for women with breast cancer. Fogel,
Albert, Schnabel, Ditkoff, and Neugut (2002) conducted a cross-sectional study, using a
mailed questionnaire, to examine the use of the internet for breast cancer-related
concerns by 188 BCS in New York City who were under the age of 65 and within three
years of diagnosis. They found that 41.5% of the sample reported utilizing the web for
information, finding that users were more educated, had higher socioeconomic status,
were more likely to be Caucasian, and trended toward younger ages (Fogel et aI.,
2002). They further noted that minority participants demonstrated a trend toward less
use of the internet for health-related concerns (Fogel et aI., 2002). This is consistent
with other studies that continue to report the existence of a digital divide in computer
and internet access.
A 2011 survey by the Pew Research Center's Internet and American Life Project
documented the use of the internet by 78% of adults residing in the United States, with
59% of all adult users researching health-related information (Fox, 2011, p.5). The
largest percentage of health information seekers, 66%, searched for specific medical
conditions with women seeking health information (83%) more often than men (73%)
(Fox, 2011, p.9). White users (70%; N

=1267) comprised the largest group of
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individuals who sought information on health problems regardless of gender, followed
by Latino users (58%; N = 285) and Black users (54%; N = 356) (Fox, 2011, p.23),
although the Pew Foundation noted that increasing access to mobile devices, such as
cell pll0nes, may continue to positively alter user percentages in rninority populations
over time (Fox, 2011, p.3). Limitations in the sampling and recruitment method are
discussed in Chapter V.
Breast cancer survivors constitute the largest percentage of cancer survivors in
the United States, but are a heterogeneous group. Women may not participate in virtual
or in-person support group networks or return to clinical sites for follow-up on a time
table that permits cost-effective and timely recruitment efforts for research. The
parameters for this study were further limited to a narrow sector of the overall population
of breast cancer survivors living in the United States. Since community-dwelling BCS
who had completed all initial treatment were the target population, it was felt that a
general snowball recruitment effort would result in sufficient subject self-selection to
meet the a priori population estimate. Additionally, recruitment efforts for the final
sample were initiated at the beginning of October during Breast Cancer Awareness
Month, typically a time of focused attention on this population in popular media and
NGO educational and fundraising directives. Unlike snowball recruitment using mail
surveys, participant anonymity was maintained and researcher blinding was not
required since it was not necessary for the investigator to contact an identified potential
respondent in order to forward the survey. This type of recruitment is, however,
considered to be non-probability sampling and typically does not produce a random
sample or reduce all recruitment bias (Sadler et aI., 2010; Etter & Perneger, 2000).
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Study Sample Recruitment. Faculty, Staff, and Students in the School of Health
and Medical Sciences (SHMS) as well as professional and personal contacts received
the pilot e-mail snowball recruitment announcement requesting voluntary participation in
the study for eligible BCS, or asked the recipient to forward the e-mail to other
individuals who might be eligible. Distinct collectors, for example, 'Faculty and Staff
were identified by the investigator using the collector function in Survey Monkey prior to
deployment of the survey. Each collector was automatically assigned a unique URL
address by the software package that was individually pasted into the e-mail request for
participation in order to assess the responsiveness of selected groups to recruitment
efforts. Anonymity was maintained since collectors only covered broad categories of
potential respondent pools. Pilot sample snowball recruitment invitations were sent to 7
administrators, 8 staff, 41 faculty (N. Blaszka, personal communication, February 23,
2012), and 428 students in the School of Health and Medical Sciences at Seton Hall
University (D. Verderosa, personal communication, February 23,2012), along with 7
personal contacts, an oncology nurse specializing in breast cancer and two oncology
social workers.
Final sample recruitment included 506 administrators, 341 staff, and 455 faculty
on the South Orange Campus, and 43 administrators, 42 staff, and 81 faculty at the
Newark Law School Campus (M.J. Hudson, personal communication, February 23,
2012). Additionally, 5300 undergraduate students and 4400 graduate students on the
Seton Hall University South Orange Campus (SHU.edu, 2011) received the e-mail
invitation to participate or forward the study information. An additional 21,495 Seton Hall
University alumni also served as initial contact sources (D.P. Nugent, personal
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communication, February 16, 2012), along with 300 personal and professional contacts,
solicitation of cancer support organizations serving breast cancer survivors, and three
physician practices willing to forward the survey information or place IRB approved
recruitment fliers in their offices. In December 2011 , a second request for participation
was forwarded to the South Orange Campus only through the Seton Hall University
Campus Digest, a university news and event e-newsletter that replaced the Broadcast
e-mail system for non-administrative contact with faculty, staff and students. The e-mail
and paper recruitment letters included an e-mail address and phone number in the
event that contact with the investigator was desired, as well as IRB contact information.
Procedures
Institutional Review Board approval was obtained for the pilot study and for
clarification in the wording for selected items on the demographic survey questions prior
to final data collection to facilitate ease of completion by respondents. Moreover, a
sentence was added to the recruitment invitation asking BCS who completed the pilot
survey to refrain from responding to the survey a second time. Modifications in
demographic survey questions included the following alterations:
Question 1 was changed from "What is your date of birth?" to "What is your
age?" since the exact date of birth was not required for data analysis. An additional
response option, "Asian" was added to Question 3, "How do you identify yourself?", as
this variable was inadvertently omitted from the pilot study demographic questionnaire.
An open-ended response option permitted respondents to self-identify in whatever
manner they deemed appropriate and was available for pilot and final data collection
surveys; no individuals in the pilot survey self-identified as Asian. Question 13, "Have
you had more than one episode (recurrence) of breast cancer (yes, no)? Right or Left
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side?" was added to the final data collection after two respondents in the pilot study
indicated that they developed recurrence of breast cancer during the inclusionary time
period of 12 to 72 months post-treatment. The exclusionary criteria eliminated BCS
diagnosed with metastasis, but did not request incidence information about recurrence.
It was felt that recurrence data should be captured for accuracy in data analysis and
reporting of results.
Question 14 was amended from "What type of surgery did you have? (Choice of
none, lumpectomy, partial mastectomy, total mastectomy, reconstruction - can select
more than one response)" to "What type of surgery did you have? (Choice of none,
lumpectomy, mastectomy, reconstruction - can select more than one response). Pilot
data collection indicated that participants may have had difficulty understanding the
medical terminology used to describe mastectomy procedures. Definitions were not
provided during the pilot study, therefore simplifying the terminology to a single category
of 'Iumpectomy' for breast conserving surgery and 'mastectomy' was deemed to be less
confusing to respondents. The research hypotheses for this study did not require further
delineation of the specific type of lumpectomy. mastectomy or reconstructive surgery
procedure.
Two optional open-ended questions, "Are there any other daily activities that
have been impacted by having fatigue (list)?" and "Are there any other daily activities
that have been impacted by problems with arm function (list)?" were added to the
survey following pilot data collection. Functional activities identified in the FACIT-F or
DASH surveys might not capture the full range of performance deficits in tasks that BCS
encounter on a daily basis. Questions 33 and 34 permitted the respondent to describe
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other activities impacted by fatigue or problems with arm function, unimpeded by the
assumptions of the validated instruments or investigator-generated questions.
Broadcast e-mails through Seton Hall University, e-mails to cancer support
groups, selected community organizations, professional and personal contacts were
used to recruit participants. Snowball recruitment methodology was utilized. All
individuals who received the initial recruitment request were asked to forward,
"snowball", the e-mail to women they knew who might be interested in participating in
the study or individuals who might be willing to forward the request to others. Women
interested in participating were directed to click on a link to a unique URL address on
Survey Monkey, allowing them to view and complete the self-administered survey.
Seven unique URLs were assigned to the final survey during data collection to identify
collector sources, e.g., professional contacts, in order to assess the snowball
recruitment methodology during data analysis. A brief summary of the research study,
inclusionary and exclusionary criteria and informed consent information was posted on
the initial e-mail. In addition, a paper version of the recruitment e-mail solicitation was
approved by the Institutional Review Board for distribution, but survey completion was
only available through the Survey Monkey internet-based site.
The survey was conducted via Survey Monkey, an internet-based survey
company providing server and encryption security to ensure data protection. According
to company information, Survey Monkey is one of the most frequerltly used web survey
platform tools available on the internet (surveymonkey.com, 2009). Prospective
participants or individuals who might know potential respondents received an e-mail
invitation to participate and were then provided with a URL address specific to this
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survey if they are eligible and willing to participate. Confidentiality of participants was
maintained by the automatic assigning of unique numeric codes to each participant
during data downloads into SPSS from the survey site.
Survey Monkey parameters were set to cue participants, through highlighted text,
to complete any unanswered questions on the demographic surveyor assessment tools
prior to allowing respondents to submit that section of the surveyor questionnaire in an
attempt to obtain complete information and reduce missing data points. Data obtained
from participants was secured in a locked file cabinet in the School of Health and
Medical Education on the Seton Hall University South Orange campus.
Assessments were administered in the same order to all participants:
demographic information and health history, Functional Assessment of Cancer Therapy
Fatigue Scale (FACT-F), Disabilities of the Arm, Shoulder, and Hand (DASH), Optional
Work Module of the DASH, and two optional open-ended questions, Q32 and Q33,
inquiring about other daily activities that have been impacted by having fatigue or
problems with arm function respectively.

Instrumentation
Demographic Survey. Demographic information collected included ICF
Personal Factors (age, state of residence, race, marital status, number of dependent
children, and highest level of education achieved (WHO, 2001), ICF Work and
Employment Factors (current occupation collected as part of the Disability of the Arm
Shoulder Hand [DASH] Optional Work Module) and employment status) and ICF
Environmental Factors ascertaining whether employment status was impacted by the
breast cancer or the current state of the U.S. economy respectively (WHO, 2001).
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Participant-reported health history included ICF Body Functions and Structures (hand
dominance, side of tumor location, year and stage at diagnosis, type of surgery
including reconstruction, adjuvant therapies received, and lymphedema diagnosis,
treatment or management, including the preventative wearing of compression sleeves)
(WHO, 2001).
Respondents also answered an investigator developed set of questions for
cancer-related fatigue that corresponded to the major ICF Activities and Participation
categories of self-care [Self-care], care of others [Assisting Others], household tasks
[Domestic Life], shopping or errands [Domestic Life], work [Work and Employment],
leisure or relaxation [Community, Social and Civic Life], and socialization [Interpersonal
Interactions and Relationships] (World Health Organization [WHO], 2001). Perceptions
of the impact of fatigue on these functional activities were not addressed in items on the
Functional Assessment of Cancer Therapy Fatigue Scale (FACT-F). The questions also
corresponded to the Occupational Therapy Practice Framework, 2 nd edition, delineating
the domains of practice for the profession of occupational therapy (AOTA, 2008). They
were added to the survey to provide a better descriptive understanding of the impact of
fatigue on daily function.
Disabilities of the Arm, Shoulder, and Hand (DASH). Developed by the
Institute for Work and Health in Toronto, Canada, and the American Academy of
Orthopedic Surgeons in 1996, the Disabilities of the Arm, Shoulder, and Hand
questionnaire [DASH] (Kennedy et aI., 2011) is a standardized health-related quality of
life (HRQOL) outcomes measure designed to assess patient perceptions of upper
extremity function resulting in limitations in ADL and IADL tasks, as well as perceived
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extremity-related symptoms such as pain or weakness. It consists of a 30-item
questionnaire asking patients to assess their ability to perform common ADL and IADL
tasks, noting the level of disruption to function and musculoskeletal symptoms within the
prior week using a 5-point Likert scale with answers ranging from "not at all" to
"extremely" (Kennedy et aI., Beaton, Solway, McConnell, & Bombardier, 2011). The
questionnaire is designed to be self-administered. It requests responses to several
different facets of upper quadrant function. The composition of the questionnaire details
21 questions about the respondent's ability to complete specific activities of daily living
such as washing one's back or cutting food, and instrumental activities of daily living,
including items asking for ability to complete heavy housework, meal preparation or
changing a light bulb (Kennedy et aI., 2011). Five questions assess physical symptoms
such as pain, tingling and weakness, and four questions request information on
socialization, global ability to complete tasks, sleep, and feelings of overall confidence in
the ability to complete daily tasks (Kennedy et al., 2011).
The DASH was chosen due to its reliable and validated psychometric properties
with a variety of patients with upper extremity dysfunction, including employed and
disabled workers (Kennedy et aI., 2011; Jester et aI., 2005; Bot et aI., 2004; SooHoo,
McDonald, Seiler, & McGillivary, 2002; Beaton et al., 2001; Hudak et aI., 1996). The
instrument has also been used to research perceived upper body function in breast
cancer survivors, with and without lymphedema (Smoot et al., 2010; Koh & Morrison,
2009; Dawes et aI., 2008; Hayes et aI., 2005). It is also one of the few measurement
tools for the upper extremity that focuses on the functional activity outcomes resulting
from whole arm movement patterns, rather than attending to single joints. It has been
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also been studied relative to its fit with the ICF structure (Dixon et aL, 2008),
demonstrating the ability to measure ICF outcomes at the impairment, activity, and
participation level and is thus consistent with the theoretical framework that supports
this study.
In 2002, the scoring for the DASH was revised, now calculated by adding the
sums of the item responses divided by the number of completed items, subtracting 1,
and multiplying by 25 (Kennedy et aL, 2011). This produces a transformed value
ranging from "0" or no perceived disability, to "100", a greater level of perceived
disability. Greater than three missing item responses results in an inability to score the
questionnaire (Kennedy et aL, 2011). Up to three missing items can be addressed by
replacing those values with "the mean value of the responses to the other items before
summing" (Beaton et aL, 2001, p.129). The DASH takes an estimated 6 minutes to
complete and 3 minutes to score (Michener & Leggin, 2001).
There are also two optional DASH modules recording the self-perceived impact
of upper extremity dysfunction on work and on sports/performing arts. Either or both
modules may be used to obtain additional information. Each optional module consists of
4 questions rated on a 5-point Likert scale ranging from "no difficulty" to "unable"
(Kennedyet aL, 2011). Each module is scored separately by adding the values for each
response, dividing by 4, subtracting 1 and multiplying by 25 (Kennedy et aL, 2011). All
four questions on each module must be answered in order to obtain the summary score.
For the purpose of this study, only the optional work module was used since
employment is a key concern of cancer survivors and is often the benchmark by which
survivors measure their return to prior life activities (Maunsell et al., 2004). The DASH
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Work Module has only four items and is designed to assess the level of physical
difficulty the person has performing employment activities, including performing tasks in
a similar manner as before illness and performing at usual levels (Kennedy et aL, 2011).
It does not assess or question other aspects of work performance, but does have an
open response question asking the respondent to list their current job. Chronbach's
alpha for this optional module is 0.89 (Tang, Pitts, Solway, & Beaton, 2009). It has been
shown to discriminate differences in some diagnostic groups as well as by the number
of upper quadrant regions impacted, resulting in increased levels of disability (Fan,
2008). There was only one study located that specifically cited the use of the optional
work module with a sample of 18 individuals who had undergone latissimus dorsi "flap
reconstruction, including 4 BCS who underwent reconstruction following mastectomy
(Koh & Morrison, 2009).
In a nationally representative sample in the United States, the DASH exhibited
Cronbach's alpha ranging from 0.94 to 0.98, Pearson correlations of 0.49 to 0.87, and
item internal consistency of 100 (Hunsaker et aL, 2002, p.213). Mean scale scores for
global function on the DASH (n = 1706) was 10.10 (SD 14.68) and 8.81 (SD 18.37) on
the Work Optional Scale (n

=1610) (Hunsaker et aL, p.211).

The Institute for Work &

Health 3rd edition of the DASH user's guide enumerates normative values for women in
the general U.S. population (N

= 1008), with a mean of 11.96 for the DASH and 9.44 for

the DASH Optional Work Module (Kennedy et aI., 2011, p.143). These values, rather
than those delineated in the earlier publication by Hunsaker et aI., were chosen for
comparison with the study sample due to the ability to isolate gender-based scores.
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Construct validity of the DASH as an extremity specific quality of life outcome
measure was supported by data from SooHoo et aI., (2002) in a study examining
correlations of the DASH to the Medical Outcomes Study Short-Form 36 (SF-36), a well
established quality of life outcome measure with available standardized normative
scores for the U.S. population. The hypotheses were confirmed with moderate
correlations observed ranging from 0.36 for the general health subscale to .62 for the
role emotional subscale (SooHoo et aI., 2002). Beaton, et al. (2001) also assessed the
psychometric properties of the DASH, examining within-subject responsiveness,
reliability and validity in a study sample of 172 patients from major hospital centers in
Toronto (n = 109) and Boston (n = 91) engaged in treatment for a variety of upper
extremity disorders. Discriminative validity was established between employed patients
and those on disability, as well as between individuals diagnosed with shoulder versus
hand conditions (26.8 vs. 50.7, t = -7.51, P < .0001) (Beaton, 2001, p. 135). Reliability of
the DASH as measured by Cronbach's alpha was reported as 0.97 (Beaton, p.140)
during baseline data collection and is further supported by data from Gummesson et al.
(2003) documenting Cronbach's alpha levels above 0.90.
Convergent construct validity was also found in Pearson correlations exceeding
0.70 between the DASH and joint-specific measures, the Shoulder Pain and Disability
Index (SPADI) and the Brigham questionnaire for hand and wrist dysfunction (Beaton,
2001, p.135). Pearson correlation using data over the course of 3 - 5 days from 56
subjects reporting that they had no change in deficits during that time period was 0.96
and Spearman ranked correlation was 0.96 at the 95% CI (Beaton et aI., 2001)
indicating high test-retest reliability.
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Prior research supports the use of the DASH as a valid, reliable, and responsive
HRQOL tool for single or multiple musculoskeletal disorders in the upper extremities. A
review of the literature did not reveal any articles documenting computer-based self
administration of this instrument. Permission was granted from the Institute for Work
and Health in Toronto, Canada, to use the DASH and to place the instrument in an on
line environment in Survey Monkey for participants (G. Palloo, personal communication,
January 10, 2010).

Functional Assessment of Cancer Therapy Fatigue Scale (FACT-F): Fatigue
Subscale. The Functional Assessment of Cancer Therapy (FACT) is a system of self
report questionnaires designed to evaluate various QOL impact of cancer therapies on
individuals living with cancer (Yellen et aI., 1997). The FACT is a subset of the larger
Functional Assessment of Chronic Illness Therapy (FACIT) system, a vast test bank of
validated questionnaires designed for a variety of health-based conditions and
translated into 43 languages (Stasi et aI., 2003). Subsumed as part of the FACIT
system, is a tool that was designed to assess anemia (FACT-An) in individuals
undergoing treatment for cancer. Contained within the FACT-An is a 13-item subscale
designed to assess cancer-related fatigue since fatigue is a foremost distinguishing
symptom of anemia. Subsequent research validated the FACT-F as a separate
assessment instrument from the FACT-An questionnaire that can be used across the
cancer spectrum to assess fatigue-based symptoms (Van Belle et aI., 2005; Hwang et
aI., 2003; Passik et aI., 2002; Yellen et aI., 1997). The 4th version of the 13-item scale,
titled the FACIT-Fatigue on the publisher's site is also referred to as the FACT-F in
research studies (Santana et aI., 2009). For the purpose of consistency within this
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project, the tool will be referred to as the FACIT-F, except when describing other
research studies that utilized the original FACT-F label.
The FACIT-F is composed of the same 13-item fatigue subscale described in the
FACT-An, as well as in questions from the FACT-G on information related to the impact
of fatigue on quality of life concerns such as physical, socia.!, emotional, and functional
status (Cella, Eton, et aI., 2002; Yellen et aI., 1997). Each item retrospectively assesses
the experience of fatigue over the past seven days and is rated on a 5-point Likert
scale, from 0 "not at all" to 4 "very much so" (Cella, Eton et aI., 2002; Van Belle et aI.,
2005). Scores range from 0 to 52; during data analysis items are reverse coded,
therefore higher scores are indicative of better health and less fatigue, and lower scores
indicate more fatigue and lower HRQOL (Yellen et aI., 1997; FACIT.org, 2012).
Estimated completion time for the FACIT-F is 2-3 minutes (FACIT.org, 2012). It has a
reading level of 4.0, making it suitable for a range of populations and can be self
administered using computer-based testing (Yellen et al.; FACIT.org, 2012). The
FACIT-F has been documented as a suitable measure of self-perceived fatigue in
populations with cancer, including cancer survivors (Mustian et aI., 2004; Bennett et aI.,
2004; Stasi et aI., 2003; Yellen et aI., 1997). Permission was granted by the FACIT
organization to use this tool and place the questionnaire on a Survey Monkey web
based platform. The organization noted that the FACIT-F has been utilized in previous
studies in virtual environments for linguistic validation and research (J. Bredle, personal
communication, January 9,2009)
Yellen et aI., found that the FACT-F fatigue subscale demonstrates validity as an
independent measure of cancer fatigue, construct validity, good test-retest reliability
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over a 7-day period (r =0.90) and internal consistency (alphas

=0.93 and 0.95) (p.68),

with discriminative validity for hemoglobin levels and better functional performance
(1997, p.71). Higher scores in the FACT-F, which indicate higher functioning, were
correlated with higher quality of life scores (Yellen et aI., 1997). Bennett et al. (2004)
found internal consistency for the FACT-F, demonstrated a Cronbach's alpha coefficient
of 0.94.
Cella and Eton et al. (2002) evaluated the reliability of the FACT-F, finding that
scores demonstrated high internal consistency in three different population samples (>
0.85), good test-retest stability in Sample 1 (n = 50) over a 7-day time period (r> 0.80)
and good stability for intraclass correlation coefficients (ICC) of at least 0.85 in all
samples (Cella, Eton et aI., 2002, p.553). The likely MICD, based on the mean
differences for the three populations when retested on the fatigue scale, was 2.7 points
(Cella, Eton et aI., 2002, p.557). This is the scoring difference that would need to be
achieved in order to estimate whether an intervention demonstrated a clinically relevant
score change. It was further recommended that a conservative estimate of MICD for the
FACT-F be rounded to the nearest whole number, or 3 points (Cella, Eton et aI., 2002,
p.559).
Van Belle et al. (2005) established that a cut-off score of 34 allowed for
prediction of P-ICD-10 status in 93% of 470 patients (sensitivity 0.91, specificity 0.75) to
define significant fatigue on the FACT-F (2011, p.251). This score meets the criteria for
the diagnostic classification of neoplastic related fatigue in the ICD-10 (Van Belle et aI.,
2005). Normative values were also established for the FACIT-F for the general United
States population using randomized digital dialing sampling methods and compared to
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FACIT-F responses from anemic and non-anemic patients with cancer (Cella, Lai et aI.,
2002). The mean score for the general population (n = 1010) was 43.6 +/- 9.4; 40.0 +/
9.8 for the non-anemic patients with cancer, and 23.9 +/- 12.6 for the anemic patients
with cancer (Cella, Lai et aI., 2002, p. 533). Using the findings from this study, a cut-off
score of 43 was used to compare the study sample to the general U.S. population, as
this provides "sensitivity of 0.92 and a specificity of 0.69", accurately predicting 84% of
group assignment (Cella, Lai et aI., 2002, p. 537). Both these values, 43 (Cella, Lai et
aI., 2002) and 34 (Van Belle et aI., 2005), were used to compare the study sample to
the normative values in order to assess the relationship of the sample to normative and
diagnostic criteria. Webster, Cella, and Yost (2003) also reported that the FACIT-F
could be self-administered via computer.
Data Analysis
Data analysis was conducted using SPSS version 18.0 software for Windows.
Data was downloaded from Survey Monkey into SPSS software, coded and analyzed.
Examination and analysis of the pilot and final data sample populations indicated that
the pilot data for women meeting the inclusionary criteria could be safely aggregated
with the larger sample of eligible respondents and is described in Chapter IV. All
statistical tests were two-sided and a P value of < .05 was deemed to be statistically
significant, unless otherwise stated. Confidence intervals of 95% were also computed
by SPSS where appropriate.
Descriptive statistics, including frequencies, percentages, means and standard
deviations were computed to describe the study population characteristics and assess
variability in demographic and self-reported health data. Categorical demographic data
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(race, marital status, education, employment status, impact of the economy), health
factors (hand dominance, breast tumor location, surgical intervention, node dissection
status, cancer treatment received, lymphedema

di~gnosis

and treatment, use of

compression sleeves), and activity and participation factors (perceived impact of fatigue
on daily function and participation, and caregiver status for dependent children) were
analyzed using frequencies and percentages. Participant age, tumor stage at diagnosis,
year of treatment completion, and ages of dependent children were analyzed using
frequencies, percentages, means, and standard deviations.
An evaluation of the relationship between perceived fatigue and perceived upper
extremity function was measured using Pearson's correlation. Pearson's was chosen
since normative data on the United States population was available for the FACIT
fatigue and the DASH, as well as cut-points to examine the relationship between the
study sample and the population norms, as well as normative data for cancer survivors
with and without anemia. One sample Student's t-tests were performed to test the
hypotheses that the means of the normative scores for the FACIT-fatigue and the DASH
respectively were not significantly different from the study sample means.
A Kruskal-Wallis was used to test the hypothesis that there were no differences
on average in perceived CRF and perceived upper extremity function respectively
between BCS who underwent sentinel node biopsy, axillary node biopsy or both types
of node biopsy. Relationships between the FACT-fatigue, DASH, and continuous
demographic data were explored using Pearson's product-moment correlation
coefficient for normally distributed data. Statistically significant results from the
correlational analysis were analyzed using regression analysis to determine the
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presence of any predictive models. Categorical demographic data was analyzed using
chi-square analysis. Ordinal non-normally distributed data was analyzed using Mann
Whitney U tests, and ratio level demographic data was analyzed using t-tests. An
analysis was conducted using a Kruskal-Wallis to assess the difference in perceived
upper extremity function and fatigue between survivors who underwent radiation,
chemotherapy or combination adjuvant cancer therapies. An analysis was also
conducted using an independent sample t-test was used to assess the difference in
perceived upper extremity function and fatigue between survivors with dependents living
at home and those without dependents living at home. Independent sample t-tests were
also used to compare the results on the DASH and FACIT-F scores with the U.S.
population or cancer-specific normative values.
Additional Questions
The Optional Work Module of the DASH was used in the survey as a brief
measure of perceived physical function in the workplace. Independent sample t-tests
were used to compare the results of the DASH Optional Work Module with the U.S.
population normative values. Employment information was collected in the demographic
survey. In addition, two questions on the demographic survey questioned participants
about whether their employment situation had changed as a result of the breast cancer,
and whether their employment status had changed as a result of the U.S. economy.
Primary work roles described by participants as part of the DASH Work module were
coded and stratified using the Standard Occupational Classification (SOC) system, a
U.S. Department of Labor categorization system designed for the compilation and
dissemination of employment-based data (U.S. Department of Labor, 2010). Descriptive
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statistics for categorical variables including frequencies and percentages were used for
analysis of demographic data.
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Chapter IV
RESULTS

Sample and Participant Selection
For the pilot study, 494 initial e-mail requests to participate were forwarded,
asking individuals who received the e-mail to forward the study invitation to potential
respondents if they were not eligible. Additional information directed specifically toward
BCS was included in the same e-mail. Invitations were sent to 7 Seton Hall University
administrators, 8 staff, 41 faculty (N. Blazka, personal communication, February 23,
2012), and 428 students through department secretaries. An additional 7 personal
contacts, an oncology nurse specializing in breast cancer and two oncology social
workers were also contacted. Fifty-two BCS responded to the invitation and completed
the on-line survey for a response rate of 10.5%. Forty-two BCS met the inclusionary
criteria and completed sufficient data points for data analysis.
For the second data collection, 32,663 initial e-mail requests were sent asking
individuals to forward the survey information to other personal and professional
contacts, resulting in 133 respondents for a .4% response rate. Snowball recruitment
invitations were sent to 506 administrators, 341 staff, and 455 faculty on the Seton Hall
University South Orange Campus, and 43 administrators, 42 staff, and 81 faculty at the
Newark Law School Campus (M.J. Hudson, personal communication, February 23,
2012). Additionally, 5300 undergraduate students and 4400 graduate students on the
South Orange Campus received the e-mail invitation to forward study information or
participate if eligible. An additional 21 ,495 Seton Hall University alumni also served as
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initial contact sources (D.P. Nugent, personal communication, February 16, 2012),
along with 300 personal and professional contacts, solicitation of cancer support
organizations serving breast cancer survivors, and three physician practices willing to
forward the survey information or place the IRB approved paper recruitment flyers in
their offices. In December 2011, a second request for participation was forwarded to the
South Orange Campus only through the Seton Hall University Campus Digest, a
university news and event e-newsletter that replaced the Broadcast e-mail system for
non-administrative contact with faculty, staff and students. The e-mail and paper
recruitment letters included an e-mail address and phone number in the event that
contact with the PI or IRB was desired.
In order to protect the anonymity of the participants as approved by the Seton
Hall University Institutional Review Board (lRB), no contact data was collected from
individuals who forwarded the e-mail invitation to other contacts or from survey
respondents, therefore it was not possible to contact participants who did not complete
the entire survey in order to request clarification of responses. The mean time for survey
completion time was 15.29 (N = 185) minutes.
Data from eligible respondents in the pilot study was compared to data from
eligible respondents from the final data collection sample. No statistically significant
differences were found between the two groups on general demographic or health
related variables. Due to the lack of significance on any of these variables, the decision
was made to aggregate the data from the pilot study and the final data collection sample
since it was believed that both samples were drawn from the same larger population of
BCS meeting the inclusionary criteria. Data from the aggregated sample population of
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185 BCS from the aggregated sample was then reviewed for eligibility. Twenty-one
participants with completed surveys were ineligible based on number of years since
diagnosis; 6 were diagnosed in 2011 and 21 were diagnosed before 2004. Final data
analysis was conducted on 158 eligible respondents.
Changes that were made in the demographic and health-related variables
following the pilot study, as described in Chapter III, were designed to ease respondent
burden but the information obtained was unchanged between the two data collection
periods. Only one additional question added to the demographic survey following pilot
data collection, asking about breast cancer recurrence within the eligible time period.
Only 6 respondents from the second data collection point (n

= 113) indicated that they

had recurrence; 5 (3.2%) on the ipsilateral side and 1 (.6%) on the contralateral side of
the original BC (n = 113). The question was eliminated from further data analysis due to
the lack of data for the entire sample. The two open-ended questions inquiring about the
impact on other daily activities on fatigue and upper extremity function were not asked
during the pilot data collection. This question was optional for respondents in the
second data collection. Data analysis from those responses is detailed later in this
chapter.

Demographics
The average age of the participants was 52 (N

= 158, SD 8.08), ranging in age

from 32 to 65. Eleven respondents were between ages 32 - 39 (7.1 %), 45 respondents
were between 40 - 49 years of age (28.4%), 72 were between 50 - 59 (45.5%), and 30
were between 60 - 65 (36.1 %). Respondents were more likely to be highly educated
with 71 respondents holding a graduate degree (44.9%), married (n = 112, 70.9%),
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employed full-time;:: 35 hours per week (n

=98, 62.0%), and Caucasian (n =147, 93%).

Table 1 presents the demographic characteristics of the BCS.

Table 1
.-Earficipan(Characteristics (N

=158)

Race
White/Caucasian
Black/African American
Hispanic/Latino
Asian
Education
Graduate degree or higher
College degree
Associate's degree/some college
High school degree
Marital Status
Married
Never married/single
Widowed
Divorced
Living with a significant other
Separated
Employment Status
FUll-time employed (~ 35 hours)
Part-time employed « 35 hours)
Full-time homemaker
Retired
Unemployed
Leave of absence
On disability
Full-time student
Part-time student

n

Percent

147
5
5
1

93.0
3.2
3.2
0.6

71
52
21
14

44.9
32.9
13.3
8.9

112
15
13
11

70.9
9.5
8.2
7.0
2.5
1.9

4
3

98
21
16
11
6
2

2
1
1

62.0
13.3
10.1
7.0
3.8
1.3
1.3
0.6
0.6
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Table 2
Region and State a (N

= 158)

Middle Atlantic (NJ, NY, PA)
South Atlantic (DC, FL, GA, MD, NC, VA)
New England (CN, MA, NH, Vi)
Pacific (CA, OR, WA)
East North Central (IL, OH)
West North Central (MN)
Mountain (AZ, NV)
East South Central (MS)
Unknown
a Respondents by U.S. Census Bureau Regions (n.d.)

n
104
23
10
11
4
2
2
1
1

Percent
66.2
14.7
6.3
6.9
2.5
1.3
1.2
0.6
0.6

Respondents identified 21 states of residency plus the District of Columbia, with
the majority living on the East coast of the United States (n

= 127,80.9%) in the Middle

and South Atlantic regions (U.S. Census, n.d.). The largest number of respondents
lived in NJ (n

=74, 47.1 %), NY (n =24, 15.3%), and CA (n =9, 5.7%) (Table 2).

Health and treatment demographics. The majority of respondents were right-

dominant (n

= 146,92.4%). As data collection took place over the course of 13 months,

year of diagnosis ranged from 2004 - 2010 (Table 3). Tumor stage at diagnosis was
most likely to be Stage I (n = 60, 38.0%) or Stage II (n = 49, 31.0%). There were equal
numbers of BCS identifying the original tumor location as right versus left sided with 6
BCS identifying bilateral tumor identification at diagnosis (3.8%). Eighty-six participants
(54.4%, N

= 158) listed the number of nodes removed during diagnostic procedures for

tumor staging. The average number of nodes removed was 8.87 (S.D. 8.122, range 1 
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33) (Table 4). Sentinel node dissection was the most frequent staging procedure
identified by a ratio of 4.5:1.

Table 3
Year of Diagnosis (N
2004
2005
2006
2007
2008
2009
2010

=158)
n

Percent

18
20
20
39
35
19

11.4
12.7
12.7
24.7
22.2
12.0

Table 4
Type of Node Dissection (N =_1_5_8-,-)_ _ _ _ _ _ _ _ _ _--=-_ __
Percent
n
None
12.0
19
Axillary Node
18
11.4
51.3
81
Sentinel Node
Both
30
19.0
Do not know
10
6.3

Additional health and treatment characteristics are presented in Table 5. Of the
69 BCS who underwent lumpectomies (43.7%), none had reconstructive surgery. Of the
68 respondents who underwent mastectomies (36.7%), 45 had undergone
reconstructive surgery (66.1 %). Twenty BCS had lumpectomies and mastectomies
(12.6%). Of those BCS who underwent both procedures, 15 had reconstruction (75%).
Twenty-five women identified a diagnosis of lymphedema (15.8%); 7 (39%) BCS
with axillary node dissection, 12 (15%) BCS with sentinel node biopsy, 4 (13%) BCS
who underwent both types of node biopsies and 2 (20%) BCS who did not know the
type of node biopsies they received. Ten (6.4%) were receiving treatment for the

111
lymphedema from an occupational or physical therapist at the time of survey
completion; 4 (40%) with axillary node dissection, 4 (40%) with sentinel node biopsy
and 2 (20%) with both types of node biopsies. Eleven (7.2%) BCS used compression
wrapping to treat the lymphedema.
Additional questions were asked about the use of compression garments
(sleeve) during daily tasks to manage or prevent lymphedema. Compression sleeves
were worn by 33 BCS during air travel (n
14.6%) while exercising, by 14 (n

=98, 33.7%), by 12 participants (n =82,

=86, 16.3%) when performing heavy housework, and

4 wore the compression garment at all times (n = 76, 5.3%). Of the 25 BCS reporting
diagnosed lymphedema, 86% wore their garment during air travel, 75% during exercise,
71 % during heavy housework, and 40% at all times.
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Table 5
Health and Treatment Characteristics (N

= 158)

=

Hand dominance (n 158)
Right
Left
Tumor location (n 158)
Right
Left
Both sides
Tumor stage at diagnosis (n 158)
0
I
II
III
Do not know
Type of surgery (n 158)
Lumpectomy
Mastectomy
Both
Breast reconstruction
None
Diagnosed with Lymphedema (n 157)
Yes
No
Receiving treatment for lymphedema (n 157)
Yes
No
Compression wrap lymphedema bandages
(n 153)
Yes
No

=

=

=

=

=

n

Percent

146
12

92.4
7.6

75
75
6

47.5
47.5
3.8

25
60
49
22
2

15.8
38.0
31.0
13.9
1.3

69
68
20
65
1

43.7
36.7
12.7
41.4
0.6

25
132

15.8
83.5

10
147

6.4
93.6

11
142

7.2
92.8

=

Childcare responsibilities. Respondents were asked to list the ages of children

living in the household who were dependent upon them for assistance with daily life
activities, including self-care, chores, school activities or play. Ninety-eight respondents
(N = 158,60.8%) had at least one child who depended upon them for assistance with
daily tasks. The mean ages for all dependent children are described in Table 6. Sixty
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one BCS had one child; 15 were s; 10 years of age, 37 were between 11 and 20, 8 were
between 21 and 30, and 1 was younger than 40. Thirty BCS had 2 children; 14 were
10 years of age and 16 were between 11 and 20. Six BCS had 3 children; 3 were

S;

S;

10

years of age and 2 were between ages 11 and 20. One BCS had four children; that
child was between 11 and 20 years of age.

Table 6
Number of Children Dependent on BCS for Daily Activities (n = 98)
n
Percent
Mean Age
Child 1
61
62.9
14.64
Child 2
30
30.9
11.64
Child 3
6
6.2
9.2
Child 4
1
1.0
14.0

SO
6.86
4.87
4.75

o

Fatigue during daily activities. The FACIT-F focuses on the perceived
experience of fatigue, however the impact of fatigue on specific daily activities with the
exception of eating, sleep, "usual activities" (Yellen et aI., 1997), and socialization are
not delineated. Investigator designed questions on the demographic portion of the
survey therefore queried respondents about the following using categories from the
International Classification of Function [ICF] (WHO, 2001) and the Occupational
Therapy Practice Framework [OTPF], 2 nd edition (AOTA, 2008): "Do you have fatigue (a
tired feeling) at least twice a week that keeps you from completing any or all of these
daily activities?" Fatigue was reported most often while performing household tasks (56
BCS, n = 157, 35.7%), when attempting to socialize with friends and family (38 BCS, n
= 154, 24.7%), while shopping or running errands (45 BCS, n = 154, 29.2%), during
leisure or socialization (33 BCS, n = 150,22%), at work (26 BCS, n = 148, 17.6%),
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while taking care of others (25 BCS, n = 153, 16.3%), and least often during self-care
(16 BCS, n = 151,10.6%).

Outcome of Cancer-Related Fatigue and Upper Extremity Function
RQ1. Is there a relationship between self-reported cancer-related fatigue and
perceived upper extremity functional deficits in breast cancer survivors (BCS)?
Ha.1. There is a relationship between self-reported cancer-related fatigue
and perceived upper extremity functional deficits in BCS

An analysis using Pearson's correlation coefficient demonstrated that there was
a moderate statistically significant inverse relationship between CRF and upper
extremity function, r

=-.661 (two-tailed), p < .001, such that women who had low scores

on the FACIT-F (more disability or decreased health-related quality of life [HRQOLD had
higher scores on the DASH (more disability or decreased HRQOL). For these data, the
FACIT-F mean score was 41.25 (SD = 10.419, n = 157), and the DASH mean score
was 11.77, SD 13.850, n = 153).
A simple linear regression analysis was used to further determine if the overall
model was predictive. The regression model was negative and significant F(1, 150) =
116.617, P < .001, with 43.4% of the variance in fatigue accounted for by perceived
upper extremity function. The model indicated that as DASH scores increased by 1
point, indicating higher levels offunctional disability in the extremity, FACIT-F scores
decreased by .05 points, also indicative of higher levels of fatigue and disability (f3 =
.504, t = -10.799, P < .001).
A one-sample student t-test compared the study sample to the FACIT-F
normative score for the general United States population using the raw cut-off score of S

115

43 established by Cella, Lai et al. (2002). The study sample, on average, was
significantly more fatigued than the expected fatigue level for the general U.S.
population (M

=41.25, SO =10.41), t (156) =-2.10, P =.037 (two-tailed). A one-sample

student t-test was also used to compare the study sample to the cut-off raw score of 5
34 defined by Van Belle et al. (2005) as the score on the FACIT-F that would meet the
proposed diagnostic ICD-10 criteria for cancer-related fatigue. The BCS, on average,
exceeded the proposed diagnostic score (t(156)

=8.724, P < .001), indicating that on

average the study sample had less fatigue than those individuals who would meet the
ICD-10 diagnostic cut score. However, a subset of the population, 22.3% (n

=25),

demonstrated scores of 34 or less, thus meeting the criteria for a diagnosis of CRF.
A one-sample student t-test used to compare the DASH scores for the study
sample (n

=153, M =11.77, SO =13.85) to the general U.S. population of women using

a cut-score of 2:11.96 (Kennedy et aI., 2011), found that on average, BCS in the study
sample experienced less disability than the U.S. normative sample, t(153)

=7.953, P <

.0001 (two-tailed) for upper extremity function. It is noteworthy that of the 22.3% of BCS
who scored below or equal to 34 on the FACIT-F thus meeting the diagnostic criteria for
CRF, 45.5% also had higher DASH scores indicating that this subset of the study
sample exhibited greater disability or lower HRQOL on both measures (Figure 1).
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Figure 1
BCS with Increased CRF and Upper Extremity Disability
(N=158)
DASHscOfe
>= 11.96

100.

(FILTER)
.Not Selected
• Selected

so.

60.

40.

~o.

Not Selected

Selected

FACITFscore <= 34 (FILTER)

Outcome of Node Dissection Status
RQ2. Is there a difference in perceived upper extremity function and fatigue
between breast cancer survivors (BCS) who underwent sentinel node dissection
and those who underwent axillary node dissection?
Ha.2.1: There is a difference in perceived upper extremity function
between BCS who underwent various node dissection procedures,
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including axillary node dissection, sentinel node dissection and both
axillary and sentinel node dissection.
Ha.2.2: There is a difference in perceived cancer-related fatigue between
BCS who underwent various node dissection procedures, including
axillary node dissection, sentinel node dissection and both axillary and
sentinel node dissection.
A nonparametric Kruskal Wallis test was used to test for differences in node
dissection status and perceived upper extremity function and cancer-related fatigue
respectively because normality was questionable and unequal sample sizes violated the
use of an ANOVA. The equality of the reported node dissection procedures was skewed
with 51.3% of BCS undergoing 'sentinel node biopsy. Results indicated that there was
not a statistically significant difference in the distribution of the fatigue scores of BCS

=2.46, p =.292). There was also
not significant in the distribution of scores measuring upper extremity function l(2) =
4.67, p = .097). Node dissection status in this sample was not related to perceived
undergoing various node dissection procedures l(2)

fatigue or upper extremity function.
Outcome of Adjuvant Cancer Therapies
RQ3. Is there is a difference in perceived upper extremity function and fatigue
between breast cancer survivors (BCS) who underwent differing types of
adjuvant cancer therapies, including chemotherapy, radiation, or combination
therapies?
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Ha3.1: There is a difference in perceived upper extremity function
between BCS who underwent chemotherapy, radiation, immunotherapy,
hormone therapy or combination therapies.
Ha3.2: There is a difference in perceived cancer-related fatigue between
BCS who underwent chemotherapy, radiation, immunotherapy, hormone
therapy or combination therapies.
One hundred and forty-five BCS reported receiving adjuvant treatment, with 13
women recording no adjuvant therapies following diagnosis and surgical intervention
(Table 7). A nonparametric Kruskal Wallis test was used to test for differences in cancer
treatment and perceived upper extremity function due to violations of the distribution
across all adjuvant therapies resulting in non-normality of the sample. Results indicate
that there was not a statistically significant difference in upper extremity function in BCS
who received adjuvant cancer therapies, X2 (2)

=1.057 and p =.590.

The Kruskal

Wallis analysis indicated that there was also not a statistically significant difference in
the distribution of the fatigue scores of BCS undergoing various adjuvant therapy
procedures l(2)

=.558, p =.757).
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Table 7
Number and Type of Adjuvant Cancer Therapies (N = 158)

o Modalities (no treatment) (N = 13)a
1 Modality (N = 44)a
Radiation
Chemotherapy
Hormone Therapy
2 Modalities (N 75)a
Chemotherapy + Radiation
Radiation + Hormone Therapy
Chemotherapy + Hormone Therapy
Chemotherapy + Immunotherapy
3 Modalities (N = 25)a
Chemotherapy + Radiation + Hormone
Chemotherapy + Radiation +
Immunotherapy
Chemotherapy + Immunotherapy +
Hormone
4 Modalities (N 1)a
Chemotherapy + Radiation +
Immunotherapy + Hormone therapy
a Percentages based on total respondents

=

n
13

Percent
8.2

21
12
11

13.3
7.5
7.0

43
16
15
1

27.3
10.1
9.5
0.6

20
3

12.7
1.8

2

1.3

1

0.6

=

Outcome of Dependent Caregiver Responsibilities
RQ4. Is there a difference in perceived upper extremity function and fatigue
between breast cancer survivors (BCS) who have dependent caregiver
responsibilities and those without dependent caregiver responsibilities?
Ha4.1: There is a difference in perceived upper extremity function
between BCS who have dependent caregiver responsibilities and those
without dependent caregiver responsibilities.
An independent sample t-test was used to assess the difference in upper
extremity function and fatigue in BCS with and without caregiver responsibilities. On
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average, women with at least one child experienced slightly higher upper extremity
disability (M = 13.87, SE = 1.945) than those without children (M = 10.41, SE =
1.338), however the results were not statistically significant, t(df =151) = -1.515, p =
.132).
Ha4.2: There is a difference in perceived cancer-related fatigue between
BCS who have dependent caregiver responsibilities and those without
dependent caregiver responsibilities.
On average, BCS who had at least one child experienced greater fatigue than

=2.089, p =.038. Mean fatigue values were lower
for women with children (M = 39.10, SE = 1.453) than those without children (M = 42.63,
SE = .979), signifying greater disability or decreased HRQOL.

women without children, t (df = 155)

Impact of Upper Extremity Function and Fatigue on Other Activities

Twenty-two BCS (N = 133, 16.5%) responded to the optional question, "Are there
any other daily activities that have been impacted by problems with arm function
(Please list)?" The most frequent impact (n = 11, 8.3%) was related to physical
symptoms such as pain, diminished strength particularly when performing heavy tasks,
decreased speed of performance, and swelling. Addition impact was found in IADLS (n
= 7, 5.3%), including caregiving of young and adult disabled children, and work-related
tasks (n

=6, 4.5%). The least frequent impact statements were in sleep and leisure.

See Table 10, Appendix C for a complete listing of verbatim comments detailed
according to ICF (WHO, 2001) and OTPF (AOTA, 2008) classifications.
Twenty-nine BCS in the second data collection (n = 133, 21.8%) responded to
the optional question, "Are there any other daily activities that have been impacted by
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having fatigue (Please list)?" with one respondent indicating no other activities impacted
by fatigue. The most frequent impact from fatigue reported by the respondents involved
generalized feelings of fatigue that interfered with the timing and completion of a
multitude of tasks (n

=9, 6.8%), exercise (n =5, 3.8%), work (n =4, 3.0%), sleep and

IADL activities, including caregiving (n

=3 respectively, 2.3%). The least frequently

mentioned daily activities impacted by fatigue involved ADL activities (self-care) and
socialization. See Table 11, Appendix C for a complete listing of verbatim comments
detailed according to ICF (WHO, 2001) and OTPF (AOTA, 2008) classifications.

Outcome of Employment
Although employment was not the primary area of focus of this study, several
questions were asked regarding work status in order to more fully understand the
impact of breast cancer survivorship on this critical area of occupation. Respondents
were asked, "Has your work situation changed as a result of problems from your breast
cancer?" Twenty-two BCS (N

=158,13.9%) reported that there had been employment

changes following breast cancer. Respondents were also asked, "Has your work
situation changed as a result of the economy?" Twenty-three BCS (N

=158, 14.6%)

identified changes in their employment as a result of the current state of the U.S.
economy, although only 6 women (3.8%) were unemployed.
A one-sample student t-test used to compare the DASH Optional Work Module
(DASH-W) scores for the study sample (n = 134, M = 7.99, SO = 15.45) to the general
U.S. population of women using a cut-score of ~11.96 (Kennedy et aI., 2011), found that
on average, BCS in the study sample experienced less disability than the U.S.
normative sample, t(133) = - 2.974, P = .003 (two-tailed) for upper extremity function.
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Data from the DASH Optional Work Module (DASH-W) was analyzed relative to
node dissection status and number of adjuvant therapies received. A nonparametric
Kruskal Wallis test was used to test for differences in the type of node dissection
performed during diagnosis and perceived ability to complete work-related tasks due to
violations of the distribution across node dissection categories, resulting in non
normality of the data, as well as non-normality of the DASH-W data. Results indicated
that there was no significant difference in perceived physical abilities during work based
on node dissection status, n

=111, x2 (2) =3.88, P =.14.

A non parametric Kruskal Wallis test was used to test for differences in number of
adjuvant cancer treatments and perceived physical ability to complete work-related
tasks due to violations of the distribution across node dissection categories, resulting in
the non-normality of the data. Results indicated that there was a positive trend in the
data, but not a statistically significant difference in perceived physical abilities during
work in BCS who received adjuvant cancer therapies, n

=122, X2 (3) =7.81 and p =.05.

Job classification by SOC category. The Standard Occupational Classification
System (SOC) (U.S. Department of Labor, 2010) was used to categorize responses
from participants to the Optional Work Module of the DASH. The question, "please
indicate what your work/job is" precedes the four DASH questions assessing perceived
impact of arm function on work activities. The SOC is the preferred job classification
system used by federal agencies to aggregate job-related statistical data (U.S.
Department of Labor, 2010). The 23 major classifications and 97 minor classification
categories were used to sort participant responses into meaningful occupational
categories.
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Seventeen participants (14.5%, n

=117) were employed in Management

Occupations (11-0000): 2 in Top Executive positions; 4 in Management Occupations; 3
in Advertising, Marketing, Promotions, PR, or Sales Manager positions; 4 as Operations
Specialties Managers; and 4 in Other Management Occupations.
Five participants (4.2 %, n = 117) were employed in Business and Finance
Operations Occupations (13-0000): 3 as Business Operations Specialists; and 2 as
Financial Specialists. Three participants (2.5%, n

= 117) were employed in Computer

and Mathematical Operations (15-000); all were employed in Computer Occupations.
Four participants were employed in Life, Physical, and Social Science Occupations (19
000); all were employed as Social Scientists and Related Workers. Five participants
were employed in Community and Social Service Occupations: all were employed as
Counselors, Social Workers, and Other Community and Social Service Specialists. One
participant (.8%, n

=117) was employed in Occupations (23-000); that participant was

employed under Lawyers, Judges, and Related Workers.
Twenty participants (17.1%, n

= 117) were employed in Education, Training, and

Library Occupations (25-000): 2 as Postsecondary Teachers; 10 as Preschool, Primary,
Secondary, and Special Education Teachers; 4 as Other Teachers and Instructors; 3 as
Librarians, Curators, and Archivists; and 1 as Other Education, Training, and Library
Occupations. Seven participants were employed in the Arts, Design, Entertainment,
Sports, and Media Occupations (27-000): 2 as Arts and Design Workers; 1 in
Entertainers, Performers, Sports, Sports and Related Workers; and 4 as Media and
Communications Workers.
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Sixteen BCS (13.7%, n

=117) were employed in Healthcare Practitioners and

Technical Occupations (29-000); all were employed in Health Diagnosing and Treating
Practitioners. Five participants (4%, n = 117) were employed in Personal Care and
Service Occupations (39-000): 3 were employed as Personal Appearance Workers, and
2 were employed as Other Personal Care and Service Workers.
Seven participants were employed under Sales and Related Occupations (41
000): 1 was employed as a Supervisor of Sales Workers; 2 were employed as Sales
Representatives, Services; and 4 were employed as Other Sales and Related Workers.
Twenty participants (17%, n = 117) were employed as Office and Administrative
Support Workers (43-000): 3 as Supervisors of Office and Administrative Support
Workers; 1 in Financial Clerks; 1 in Information and Record Clerks; 9 in Secretaries and
Administrative Assistants; and 6 in Other Office and Administrative Support Workers
positions.
One person (.8, n = 117) could not be formally classified since she listed her
employment as "consulting", a descriptor that falls within numerous SOC categories. Six
women (5.1 %) listed their primary occupation as homemaker, an appropriate response
for the DASH Optional Work Module but not one that can be classified using SOC
categories.

Ceiling and Floor Effects of Instrumentation
Ceiling and floor effects were examined. Twenty-one BCS (n

= 153, 13.7%)

reached the ceiling on the DASH, producing a score of 0, indicating maximum upper
quadrant functioning or least disability, although none reached the floor indicating
maximum disability. On the DASH-W, the Optional Work Module, 88 BCS (n

= 134,

I

I
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55.7%) scored at the ceiling indicating no disability during physical tasks at work, with
none reaching the floor indicating maximum disability performing physical work tasks.
The FACIT-F scores revealed only 6 BCS (3.8%) who scored at the ceiling, indicating
least fatigue and no participants scored at the floor indicating maximum fatigue.
Summary

The data revealed a statistically significant inverse relationship between CRF and
upper extremity function in a bivariate correlational analysis. This result indicated that
BCS in this sample who perceived higher levels of CRF, indicating higher levels of
disability or decreased HRQOL, also perceived higher levels of disability or decreased
HRQOL in upper extremity function. The simple regression model was predictive,
finding that an increase of 1 point in perceived upper extremity function as measured by
the DASH, indicating higher levels of disability, results in a decrease on the FACIT-F of
.05, indicating higher levels of fatigue and increased disability. In addition, BCS who had
at least one child dependent on them for caregiving tasks reported higher levels of
fatigue than respondents who did not have dependent children living at home.
When compared to normative national cut-off scores for fatigue using the FACIT
F, the study sample exhibited statistically significant higher scores than the general U.S.
population, although they exhibited better perceived arm function than the general
population of women on the DASH. There was a subgroup of 22.3% BCS (n

=25) who

exhibited increased fatigue, meeting the ICD-10 diagnostic criteria for CRF. Of this
subgroup, 45.5% (n

=11) also had higher DASH scores indicating there was a small

group of BCS who exhibited greater disability or lower HRQOL on both measures.
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There were no significant differences in fatigue or upper extremity function
between node dissection status or adjuvant therapies received during cancer treatment.
DASH-Work scores did not identify significant differences in fatigue or upper extremity
function between node dissection status or number of adjuvant therapies received
during cancer treatment, although there was a positive trend (p = .05) toward
impairment in perceived function during physical work tasks with an increasing number
of adjuvant cancer modalities.
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Chapter V
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DISCUSSION

1
.~
1

I

I

1

Upper extremity functional deficits and cancer-related fatigue, the two most
common symptom complexes facing women following breast cancer diagnosis and
treatment, have the potential to limit performance of daily tasks and resumption of life
roles. Both problems can challenge the daily lives of BCS, however it is not known if
these two underreported and underdiagnosed concerns indeed represent separate
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entities as described in the majority of the literature, or if some women perceive late
effects from both symptoms complexes. Breast cancer survivorship is accompanied by
a myriad of unique challenges across the trajectory of the survivor's lifespan, including
potential physical, psychosocial and economic consequences. Diagnostic procedures
and treatment may result in late or persistent problems that continue to impact the
survivor for years or decades after surgery or the conclusion of adjuvant therapies
(CDC, 2012; Sadler et aI., 2002, Portenoy & Itri, 1999, Andrykowski et aI., 1998).
This exploratory cross-sectional study examined the relationship between these
two multifaceted constructs and further examined the impact of node dissection, number
of adjuvant therapies received, and caregiving responsibilities in a convenience sample
of 158 BCS who completed all surgery and treatment and were between 1 year and 6
years post-diagnosis. Additional information on the impact of fatigue and upper
extremity morbidity was also explored by examining these key constructs in relation to
physical work tasks. This chapter discusses the findings of the study within the broader

I

II

128
context of the biopsychosocial model, ICF, and permanent survivorship (Mullan, 1985;
Miller et aI., 2008; WHO, 2001).
The findings from this study appear to provide primary outcome findings for the
first time describing a statistically significant bivariate relationship between CRF and
upper extremity function. Survivorship numbers are increasing with population estimates
of 18.1 million individuals by 2020 (Mariotto et aI., 2011), the majority of whom will be
female breast cancer survivors if current trends continue. Indeed, one in eight American
women will be diagnosed with breast cancer in her lifetime (National Cancer Institute,
2011). Persistent problems during post-treatment survivorship can interfere with daily
task performance, particularly for instrumental activities of daily living, which includes
household management and caregiving tasks, as well as impair socialization and
employment (de Boer et aI., 2009; Obserst et aI., 2010; Stone et aI., 2000; Servaes,
Verhagen, S., & Bleijenberg, 2002). A more thorough understanding of these two
symptom complexes and the accompanying activity performance limitations may assist
healthcare professionals to screen and identify BCS in need of services.

Demographics
This group exhibited demographics that were typical of respondents to other
breast cancer studies with a high percentage of educated BCS (Collins et aI., 2004;
Dhruva et aI., 2010). The inclusionary criteria excluded women over 65 since
caregiving responsibilities for dependent children and employment were variables of
interest, therefore it was anticipated and confirmed that the mean age of the sample, 52,
would include some younger survivors. The majority of respondents were Caucasian (n

=147,93%), educated at the graduate (n =71,44.9%) or college level (n =52, 32.9%),
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married (n = 117, 70.9%), and employed full-time (n = 98, 62.0%). Women who
completed the study resided in 21 different states, plus the District of Columbia. They
resided most often in the Middle Atlantic (n = 104,66.2%) and South Atlantic (n = 23,
14.7%) regions of the country with the largest number of respondents identifying NJ (n =
74,47.1%), NY (n = 24, 15.3%), and CA (n = 9,5.7%) as their state of residency.
Respondents were primarily right-dominant (n = 146,92.4%) identified the tumor
stage at diagnosis as Stage 0 (n
31.0%), Stage III (n

=25, 15.8%), Stage I (n =60, 38.0%), Stage II (n =49,

=22, 13.9%), and 2 women (1.3%) reported that they did not know

the stage of the tumor. There were equal numbers of BCS identifying the original tumor
location as right versus left sided (75, n = 47.5) respectively and 6 women (3.8%)
reported bilateral tumors at diagnosis. Of the 69 BCS who underwent lumpectomies
(43.7%), none had reconstructive surgery. Of the 68 respondents who underwent
mastectomies (36.7%), 45 had undergone reconstructive surgery (66.1%). Twenty BCS
had lumpectomies and mastectomies (12.6%). Of those BCS who underwent both
procedures, 15 had reconstruction (75%), and 1 BCS had no surgery.
Women in this study had surprisingly high rates of mastectomy compared to
breast conserving surgery and the majority of women who underwent dual procedures,
lumpectomies and mastectomies, had breast reconstruction. Two recent studies
documented the increase in mastectomy rates following several years of decline
(McGuire, 2009, Katipamula et al. 2009). Identified factors accounting for this
unexpected rise include an increase in contralateral prophylactic mastectomies as
genetic testing provides women with increased information that may alter their
collaborative decision-making with the oncology team, as well as decisions by women to
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request more extensive surgery in order to try to avoid or decrease radiation or
chemotherapy (McGuire et at, 2009). It is difficult to ascertain why the mastectomy
incidence rates were high in this sample. It is possible that the purpose of the study
attracted respondents who had undergone more extensive surgery, as noted in the high
number of women who reported having undergone both lumpectomies and
mastectomies, or BCS who might experience persistent symptoms. It could be
suggested that the higher education level of the BCS with the majority of women holding
graduate degrees led women to make alternative decisions about surgical options, or
that the Northeast geographic region with access to major research cancer centers may
offer a different array of surgical and treatment options. Diagnostic information on type
of breast cancer, exact TMN staging, number of positive lymph nodes, and potential
genetic variations were unavailable for analysis and this might also influence decision
making for surgical options. Despite these increased incidence numbers, mean DASH
scores were high indicating lower levels of arm morbidity and higher reported levels of
HRQOL.
Lymphedema. Twenty-five women identified a diagnosis of lymphedema
(15.8%); 7 (39%) BCS with axillary node dissection, 12 (15%) BCS with sentinel node
biopsy, 4 (13%) BCS who underwent both types of node biopsies and 2 (20%) BCS who
did not know the type of node biopsies they received. Ten (6.4%) were receiving
treatment for the lymphedema from an occupational or physical therapist at the time of
survey completion; 4 (40%) with axillary node dissection, 4 (40%) with sentinel node
biopsy and 2 (20%) with both types of node biopsies. Eleven (7.2%) BCS used
compression wrapping to treat the lymphedema. The findings for this sample
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documented mean levels of self-reported lymphedema in BCS who underwent ALND,
SLNB or both that were reported in some previous studies (Penha, Siangen, Heuts,
Voogd, & Von Meyenfeldt, 2011; Gartner et aI., 2010).
Prevalence statistics for lymphedema vary dramatically, depending upon whether
lymphedema was measured through objective measures or self-report, as well as when
in the time period post-diagnosis this information is obtained. BCS were asked whether
they had received a diagnosis of lymphedema, rather than whether they had noted
signs of swelling indicative of lymphedema, as have been previously documented in the
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self-report literature on lymphedema prevalence, however as this information could not
be confirmed through medical records it was treated as self-report data. The selfreported lymphedema prevalence rate of 15.8% from this study fall within the range of 8
- 17% reported by Pen ha et al. (2011) from a cross-sectional study of 145 BCS using
multiple assessment modalities. McLaughlin et al. (2008) reported that prevalence rates
calculated on less than 5 years of survivorship may underestimate the size of the
population with lymphedema since lymphedema rates increase during the first few
years post-diagnosis and treatment. Self-report rates in the literature may document
estimated prevalence rates that exceed the objective measurements in the same study,
possibly due to persistent sensory changes in the affected limb that alter BCS
perceptions of arm swelling (Hayes et aI., 2008; Haid et aI., 2002), however other
studies document reliable self-reporting in that individuals who underwent SLNB
appropriately reported Significantly less symptoms, including swelling, than individuals
who underwent ALND when objective measures con'firmed these results (Schrenk,
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Rieger, Shamiyeh, & Wayand, 2000).
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Compression Sleeves. Compression sleeves were worn by 33 BCS during air
travel (n = 98,33.7%), by 12 participants (n = 82, 14.6%) while exercising, by 14 (n =
86,16.3%) when performing heavy housework, and 4 wore the compression garment at
all times (n

=76, 5.3%). Of the 25 BCS reporting diagnosed lymphedema, 86% wore

their garment during air travel, 75% during exercise, 71 % during heavy housework, and
40% at all times. Only one study was located describing compression sleeve use
patterns in BCS diagnosed with lymphedema. Ridner, Dietrich, and Kidd (2011)
documented frequencies for self-care behaviors, including compression garment use, in
51 BCS with lymphedema in a cross-sectional study and found that 92% reported

J

wearing their compression garments during the day and 49% at night (p.634). In this

1I

study, BCS with lymphedema reported lower percentages of garment use than noted in

1

j

Ridner et al. (2011) in relation to garment use during specific daytime activities typically

I

associated with recommendations for BCS (National Lymphedema Network, 2012). Use

1

during sleep was not queried in this study due to the focus on functional performance.
Based upon these inconsistencies one must question what recommended guidelines
were provided to previous and current study participants and what happens to use
patterns over a period of years following initial recommendations. Results from a
qualitative study of 24 BCS in Australia found that women were confused about
compression sleeve use since BCS are commonly cautioned to avoid compression of
the ipsilateral arm through tight garments, jewelry or blood pressure cuffs, and the
compression garments are designed to provide consistent compression to the extremity
when worn (Collins et aI., 2004).
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Compression sleeves are one aspect of self-care advice management strategies
provided to BCS to prevent or manage lymphedema. The National Lymphedema
Network recently updated their risk-reduction practices information for lymphedema
prevention (NLN Medical Advisory Committee, 2012) alerting BCS with lymphedema to
follow the manufacturer's guidelines for wear and replacement with suggested use
during "air travel, exercise and exertion" (p.2). The same organization also updated
recommendations for those at risk of lymphedema but not yet diagnosed (Thiadens,
2011), suggesting that compression garments, if worn, can be used for "strenuous
activity" and "air travel" (p. 2). The organization documented a disclaimer on the site
stating that the evidence in the research literature supporting or refuting preventive selfcare strategies is insufficient (Thiadens, 2011). Information on compliance with
compression garment use is also lacking in the literature, although these garments are
regularly recommended by clinicians for prevention of lymphedema. Assessed in its
totality, the data from this and previous studies supports the importance of clinicians
assisting survivors to continually assess and appropriately weigh the risk factors and
evidence surrounding garment use for self-care prevention or lymphedema
management.
Caregiving for Dependent Children. Participation in caregiver roles were noted
by the majority of the study sample. Ninety-seven BCS (N = 158, 61.4%) reported
responsibilities for at least one child who was dependent upon them for assistance with
daily life activities, 30 BCS had two children, 6 BCS had 3 children and 1 BCS had 4
children. Mean ages for the children were from 9.2 years to 14.64 years, but ranged
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from 1 - 38. One participant reported caring for an older adult son, age 38, with a
disability.
While we utilized the FACIT-F to assess key information about perceived fatigue,
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it offers little insight into specific activities that are impacted by persistent fatigue
symptoms. Categories from the International Classification of Function [ICF] (WHO,
2001) and the Occupational Therapy Practice Framework [OTPF], 2 nd edition (AOTA,
2008) support that fatigue was reported most often while performing household tasks
(56 BCS, n = 157, 35.7%) and least often during self-care (16 BCS, n = 151, 10.6%).
Household tasks, errands and caregiving fall under the category of instrumental
activities of daily living (IADLs). These higher order life tasks require additional and
more complex skill sets, including more physical capacity, to complete than self-care
(ADL) tasks. It was surprising that reported fatigue during caregiving on the
demographic survey was limited (25 BCS, n = 153, 16.3%) since findings from the study
demonstrate that increased fatigue during dependent caregiving, as measured by the
FACIT-F, was statistically significant. It is possible that BCS did not report fatigue when
faced with the dichotomous question on caregiving on the demographic survey versus
choosing from the potential range of responses on the Likert scale used in the FACIT-F.
Dhruva et at (2010) assessed diurnal fatigue levels in BCS before and after
radiation therapy and revealed that women with children at home and employed women
experienced higher levels of fatigue. Their research indicated that evening fatigue in this
population might be impacted by "behavioral factors" (Dhruva, 2010, p. 210). This was
the only study located that examined caregiving as a predictive factor in fatigue in
breast cancer survivors. Many of the women in this study were also employed, had
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received radiation therapy and had dependent children at home. If behavioral factors or
lifestyle factors are partially responsible for fatigue, it is possible that non
pharmaceutical interventions that address energy conservation, work simplification and
pacing could be initiated to address the fatigue.

Occupational Performance. Rates of impairment in the ability of BCS to
complete daily activities range from 13% - 51% (Lash & Stillman, 2002) with activities
requiring heavy work by the upper extremity musculature most often implicated as
problematic. The findings of this study supported results from Fu and Rosedale (2009),
demonstrating that basic self-care was not identified as problematic by survivors. The
impact of fatigue on specific IADL tasks is not well described in the literature (Collins et
a!., 2004). An examination of the questions from the investigator-designed fatigue
survey questions and the FACIT-F revealed that the FACIT-F examines more global
aspects of fatigue and energy, whereas the investigator-designed questions queried
participants about ICF activity categories. It is possible that perceptions of fatigue are
not related to task-specific behavior, distinct for example from awareness of upper arm
function where difficulties can be easily ascertained when it is not possible to open a jar
or vacuum the house. It is possible that the investigator-generated questions may not
have captured the key tasks that are most impacted by fatigue, despite covering major
activity areas from the ICF that have been documented in the breast cancer core sets
and research literature.

CRF and Upper Extremity Function
The first question explored the relationship between the two most common
symptom complexes experienced by BCS; CRF and upper extremity function. Findings
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supported the hypothesis determining that there was a moderate significant inverse
relationship between CRF and upper extremity function, r

=-.661, P < .001, such that

BCS who perceived increased levels of fatigue, producing lower scores on the FACIT-F
scale, also perceived increased arm dysfunction, thereby producing higher scores on
the DASH. A simple linear regression analysis further determined that the overall model
was negative and significant (p < .001), with 43% of the variance in fatigue accounted
for by perceived upper extremity function. For this sample population, the model
indicated that as DASH scores increase by 1 point, indicating higher levels of functional
disability in the extremity, FACIT-F scores decrease by .05, also indicative of higher
levels of fatigue and disability (p < .001). Since other key variables of interest did not
further explain the model, it is likely that the variance is accounted for by other factors.
The multifactorial nature of these two symptom constructs confounds efforts to
discern the exact underlying etiologies with any certainty. Studies on CRF have
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implicated other factors in the development of CRF that were not examined in this
study, such as underlying inflammatory markers including C-Reactive Protein
(Alexander et aI., 2009), other immune system dysfunction, sleep dysfunction, additional
disease comorbidities, and medication use (Mortimer et aI., 2010; Portenoy & Itri, 1999;
Yellen et aI., 1997). Gerber et al. (2010) noted significant correlations between fatigue
and white blood cell values >8,000. Other co-morbidities, such as arthritis that may limit
arm function or increase fatigue, and an increased BMI (Gerber et aI., 2010) were not
documented for this study sample and remain a limitation of the study.
Pain emerged in the literature as a factor in the development of CRF and upper
extremity morbidity (Hack et at, 2010; Peuckmann et aI., 2009), however the only
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questions regarding pain for this study were part of the DASH questionnaire which
required retrospective examination of perceived pain over the course of one week
located anywhere in the upper quadrant. or pain experienced during activity in the upper
quadrant (Kennedy et aI., 2011). Despite high overall mean DASH scores that
exceeded the national normative values indicating lower levels of disability, 47% of the
BCS reported mild to extreme pain in the arm, shoulder, or hand during activities and
42.8% of the sample experienced mild to severe pain in the arm, shoulder, or hand in
general. Other upper extremity symptoms were revealed by the DASH, including 46.7%
reporting mild to severe stiffness, 44.4% of the same sample identifying mild to extreme
weakness in the affected extremity, and 40.8% reporting mild to extreme tingling.
Some researchers have proposed the development of separate scales within the
DASH to examine facets of upper quadrant function (Dixon et aI., 2008; Lehman,
Woodbury, & Velozo, 2011). The five symptom questions, currently clustered on the
DASH questionnaire, have the potential to be aggregated as a subscore that could be
used by researchers to consider contributing factors to upper extremity dysfunction. As
43% of the variance in fatigue in this sample was explained by upper extremity function,
it is possible that perceived pain and other persistent upper extremity physical
symptoms identified by Dixon et al. (2008) and categorized under the impairment
construct of the ICF, contributed to perceived fatigue.
Comparison of the study sample to the FACIT-F normative score for the general
United States population using the raw cut-off score of S 43 established by Cella and
Lai et al. (2002) revealed that the study sample, on average, was significantly more
fatigued than the expected fatigue level for the general population (p

=.037). Further
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comparison of the study sample to the raw cut-off score of s 34, defined by Van Belle et
al. (2005) as the score on the FACIT-F that would meet the proposed ICD-10 criteria for
CRF, indicated that the study sample, on average, was significantly less fatigued than
those cancer survivors who would meet the diagnostic definition for CRF (p < .001).
However, a subset of the study sample, 22.3%, did meet the criteria for CRF. The
finding of a subset of BCS experiencing higher levels of fatigue representing
approximately one-quarter of the overall sample is consistent with the research
literature (Bower et aI., 2006; Servaes, Verhagen, S., & Bleijenberg, 2002; Bower et aI.,
2000). These BCS do not represent outliers in the data set. They are part of a
consistently documented subset of cancer survivors experiencing fatigue as an ongoing
concern. While attention needs to be directed toward all survivorship concerns, it is
imperative that this subset receive better identification and delivery of services to
address their needs.
In addition, the study sample responses to perceived arm function using the
DASH were compared to established normative values for women in the U.S.
population using a cut-score of ~ 11.96 (Kennedy et aI., 2011). This comparison found
that, on average, the BCS in the study sample experienced significantly less disability
than the reference sample (p < .001). Of the subset of 22.3% of the sample that met the
criteria for CRF, it is noteworthy that 11 participants (45.5%) of the fatigued subset also
exhibited greater disability on the DASH as well.
The second research question examined differences in perceived upper
extremity function or fatigue in BCS who underwent node dissection procedures,
specifically sentinel node biopsy, axillary node biopsy, or both sentinel and axillary node
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biopsy. The hypothesis was not supported for differences in upper extremity function or
fatigue based on the node dissection procedures reported by the BCS. The majority,
51.3%, of BCS underwent sentinel lymph node biopsy (n = 81) and 19% (n = 30)
underwent both SLNB and ALND. SLNB is considered to be the standard of care for
BCS who have negative nodes with increasing evidence that there are no differences in
locoregional recurrence between those BCS with negative nodes who have early stage
disease and will undergo adjuvant therapies, versus the use of ALND (Giuliano et aI.,
2010). The literature suggests that SLNB causes less upper extremity disability than
axillary node dissection (Hack et aI., 2010; Schrenk et aI., 2000) with the result that

SLNB is increasingly the standard of care for node dissection. The higher number of
women who underwent sentinel node biopsy may suggest one reason why differences
were not detected for upper extremity function since less invasive surgical procedures
were used in the axillary region. It is also plausible that the higher number of women
who underwent SLNB suggests a higher proportion of node-negative respondents; none
of the women with SLNB had mastectomies also suggesting less invasive disease at
the time of diagnosis.
The third research question examined differences in perceived upper extremity
function and fatigue in BCS who underwent adjuvant therapies including chemotherapy,
radiation therapy, immunotherapy, hormone therapy or combination therapy. The
hypothesis was not supported for differences in upper extremity function or fatigue
based on the number of adjuvant modalities that were reported by the BCS. One
hundred and forty-five BCS received adjuvant therapies, with 13 women reporting no
use of adjuvant therapies following diagnosis and surgical intervention. The majority of
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women (n = 43,27.3%) received chemotherapy and radiation, with the next most
frequent treatment as radiation only (n
radiation and hormone therapy (n

=21, 13.3%), followed by chemotherapy,

=20, 12.7%).

The research literature examining the relationship of radiation and chemotherapy
to upper extremity function and fatigue has been inconclusive and the results of this
exploratory study do not further clarify these inconsistencies. Women in this study
received a variety of adjuvant therapy combinations and the study sample was too small
to explore the results from each adjuvant modality in relation to arm function and
fatigue, therefore the overall number of adjuvant modalities received was examined in
relation to CRF and upper extremity function. It is of interest that the majority of women
(n

= 101) were treated with two or more adjuvant modalities, most receiving

chemotherapy and radiotherapy (27.3%). Prior studies have indicated that radiotherapy
is more often associated with long term sequelae in the upper extremity than
chemotherapy (Peuckmann et al., 2009) and that chemotherapy (Broeckel et aI., 1998,
Bower et aI., 2000), radiotherapy (Lee et aI., 2007), or combined adjuvant therapies
(Jacobsen, Donovan et aI., 2007; Bower et aI., 2006) have been associated with higher
levels of fatigue in early stages of the survivorship process.
In a case-control study, 1,929 German BCS retrospectively rated fatigue and
quality of life before, during and following adjuvant therapies approximately 6 years
post-surgery; findings revealed slightly higher fatigue levels for women who received
both chemotherapy and radiation among women with chemotherapy emerging with the
highest fatigue ratings (Schmidt et aI., 2012). BCS who had more fatigue one year post
surgery also reported more symptoms in the surgical side and affected arm, including
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pain, and decreased overall functioning; those who had persistent fatigue up to six
years post surgery had reduced QOL ratings and reported worse functioning in all
dimensions (Schmidt et aI., 2012). This is one of the few studies to describe persistent
arm morbidity in relation to CRF (Schmidt et aL, 2012) and is supported by the findings
in this study that there is a subset of women whose combined symptoms diminish
HRQOL This study lends credence to the idea that there are multiple trajectories for
women who have persistent fatigue post-surgery and treatment
The fourth research question examined differences in perceived upper extremity
function and fatigue in BCS who reported caregiving responsibilities for dependent
children living at home who required assistance with daily activities. The hypothesis was
not supported for the difference in upper extremity function between women who do and
do not have caregiving responsibilities, although mean scores on the DASH indicated
that women with at least one child experience slightly higher upper extremity disability
than those without children. Round, Hayes, and Newman (2006) found that women with
children under the age of 14 reported more upper extremity disability than women
without children using the DASH as a measure of arm function. Their findings were not
fully supported by this study which failed to find increased upper extremity disability in
relation to care of dependent children. Two BCS provided optional comments identifying
difficulties with childcare responsibilities.
"Helping my disabled son is sometimes painful, so I ask my husband for help."
"Lifting my children, moving things."
However, results supported the hypothesis that there is a difference in perceived
fatigue between BCS who have dependent caregiver responsibilities and those who do
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not (p = .038). Mean fatigue values were lower for women with children than those
without children signifying greater disability for women with caregiver roles. Only one
mother reported a comment in the optional query on other daily activities that are
impacted by fatigue, noting that:
"[It is] challenging to take care of three small children and I am exhausted driving
them to school, extra-curricular activities, etc."
This was an unexpected finding in the study. On average, the BCS in this sample
experienced higher levels of fatigue than the national normative values, even though the
majority did not reach a level that would warrant a diagnosis of CRF. Most women were
also employed full or part-time. It is possible that the increased demand for energy
output from responsibilities at home and at work throughout the course of the week-long
retrospective reporting on the FACIT-F increased reports of perceived fatigue.
Little is reported about the impact of dependent childcare responsibilities on
fatigue and arm function after breast cancer. Research describing dependent children is
more likely to report the psychoemotional responses of women recently diagnosed or
undergoing adjuvant therapies in relation to talking to children about the cancer or
concerns about mortality, rather than focusing on the impact of reduced energy or
diminished arm function on caregiving responsibilities. Round et al. (2006) generated
one of the few studies to document outcomes related to caregiver roles, but only
focused on upper extremity use. Dhruva et al. (2010) focused on the impact of radiation
therapy on diurnal fatigue noting caregiving of dependent children as a predictive factor
for evening fatigue.
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Employment
Efforts to explore the experience of work in BCS were preliminary and are
regarded as secondary findings of the study. However, work is important to BCS and
resumption of work is often viewed as sign of recovery from cancer (Maunsell et ai,
2004). The optional work module for the DASH, the DASH-W, was used to assess
physical aspects of work in relation to node dissection status and number of adjuvant
therapies received. Results indicated that there was no significant difference in
perceived physical abilities during work based on node dissection status. However,
results did demonstrate a positive trend in the data, but not a statistically significant
difference, in perceived physical abilities during work in BCS who received adjuvant
cancer therapies (n

=122, P =.05).

Cancer survivors may report changes in employment status as a result of a
cancer diagnosis or persistent changes following cancer treatment. In this study, 22
BCS (13.9%) reported that there had been employment changes following their breast
cancer. Due to major changes in the U.S. economy impacting a large number of
employed Americans, respondents were also asked if changes in the economy had
altered their work situation. Twenty-three BCS (14.6%) identified changes in
employment as a result of the current state of the U.S. economy, although only 6
women (3.8%) were unemployed and only 2 (1.3%) were on disability. The U.S. jobless
rate during the same period was 8.9% (U.S. Department of Labor, 2012), indicating that
this study sample experienced less unemployment than the U.S. population during the
data collection time period. It was not possible to clarify the reason for changes in
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employment secondary to the breast cancer however this is an area that requires
additional research.
DASH-W scores for the study sample were compared to the general U.S.
population scores for women using a cut-off score established by Kennedy et al. (2011).
On average, BCS in the study sample experienced less disability performing upper
extremity physical work tasks than the U.S. normative sample (p = .003).
Data from the DASH-W was also analyzed relative to node dissection status and
number of adjuvant therapies received. Results indicated that there was no significant
difference in perceived physical abilities during work based on node dissection status.
Results examining differences in the number of adjuvant cancer treatments received
and perceived physical ability to complete work-related tasks indicated that there was a
positive trend in the data, but not a statistically significant difference in perceived
physical abilities during work in BCS who received adjuvant cancer therapies (n = 122,
p

=.05).
The first question of the DASH-W asks a general question requesting

identification of the participant's work or job. One-hundred and seventeen responses
were analyzed using the Standard Occupational Classification System (SOC) (2010),
the preferred job classification system used by federal agencies to aggregate jobrelated statistical data (Department of Labor, 2010). The 23 major classifications and 97
minor classification categories were used to sort participant responses into meaningful
occupational categories. Participants' employment situations were represented by 10 of
the 23 major classification areas (Department of Labor, 2010): management
occupations; business and finance operations; computer and mathematical operations;
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life, physical and social science occupations; occupations (law); education, training and
library professionals; office and administrative support work; arts, design, entertainment,
sports, and media occupations; healthcare practitioners and technical occupations;
sales and related professions; and one person could not be classified.
The optional question requesting comments about other daily activities that are
impacted by fatig ue or upper extremity yielded remarks about work-related activities
impacted by arm function:
"I used to take care of a patient who was semi-comatose and I had no mobility.
Because of my diagnosis and subsequent physical limitations (could lift no more
than 5 - 10 Ibs with my left arm), I had to leave my job."
"Working at my desk is sometimes uncomfortable because of arm, shoulder
pain/pins and needles."
"Trying to close a padlock or a 3-ring binder."
Work activities were also impacted by fatigue.
"I am a lecturer/teacher - I tire more easily so while it does not affect work, when
I am done. I am very tired."
"Going out for long periods of time. Just can't. Night deliveries (babies) tire me
out much more now."
The comments may increase our understanding of the differences between
perceptions of arm function versus perceived fatigue. Comments responding to the
question about other areas impacted by changes in arm function revealed specific
observations related to task behaviors, specific job tasks that were more difficult to
complete. Documented remarks about fatigue appeared to express a more global
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viewpoint about the impact of this symptom on work, i.e., impacting time spent on task
rather than the tasks themselves and may suggest one reason why the investigatordesigned questions on fatigue produced lower frequencies than would have been
expected based on the FACIT-F scores. Insights gleaned from this information can
assist in the development of further research, but may also assist clinicians to ask
different questions when addressing fatigue or upper extremity morbidity.
The biopsychosocial model approaches survivorship as a complex, multifactorial
entity unique to each survivor but identifies commonalities experienced by this
population. The ICF Core Sets for Breast Cancer (Brach et aI., 2004) describe the
consensus document of ICF categories specific to breast cancer survivors. Activities
identified as critical to this population that coincided with results from this study included
"family relationships, hand and arm use, carrying out daily routine, doing housework,
remunerative employment and lifting and carrying objects" (Brach et aI., 2004, p. 124).
While the majority of women in this study were able to function in multiple life spheres,
there were others who identified mild to severe difficulties completing daily life tasks.
This study affirms results from previous research that subsets of BCS are continuing to
experience mild to significant problems in daily function, even long after surgery and
adjuvant therapies conclude. Limitations at the ICF activity and participation level
disrupt quality of life.
Limitations
Design and instrumentation. CRF is not a stagnant entity and therefore the
cross-sectional design had inherent limitations in describing the fatigue experience for
this sample of respondents. The FACIT-F captures the perceived average fatigue
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experience over the course of one week, but does not distinguish self-reported fatigue
variability that may occur during a given day or week. Recall error is possible since
responses to the FACIT-F are assessed retrospectively.
There are questions that were not asked as part of the cross-sectional design
due to the inability to have direct contact with participants or access medical records for
data accuracy, including body mass index (BMI), comorbidities that could impact fatigue
or upper extremity function such as arthritis, cardiovascular disease or the influence of
proinflammatory biomarkers.
While self-perception is well accepted as a measurement of fatigue, research on
upper extremity morbidity typically includes actual measurement of ROM through
goniometry and arm circumference by tape measure, volumetric or bioimpedence
technology although significant inconsistencies in measurement methodology limit study
comparisons (Hayes et aI., 2008; Haid et aI., 2002; Schrenk et aI., 2000). Some studies
found that self-report of lymphedema, for example, resulted in increased percentages of
women reporting this condition versus actual measurement of the extremity compared
to the unaffected limb (Hayes et aI., 2008; Haid et aI., 2002). Participants in this study
were asked if they were diagnosed with lymphedema, rather than their opinion
regarding the presence of lymphedema, but there was no ability to confirm the
diagnostic information.
Internal validity. The survey was brief with limited participant burden and was
completed, on average, in 15 minutes. However, it is noteworthy that individuals
answered the survey at various times of day, including in the middle of the night and
close to typically scheduled mealtimes, and therefore BCS may have experienced
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maturation effects due to hunger, fatigue or competing interests for their time.
Distraction is also a potential factor in internet-based research methodology. It is not
known if BCS were attending to other on-line or real time activities during completion of
the survey.
Typically, cross-sectional studies collect data at one data point. This study was
deployed at two different times of year with the pilot study deployed in February of 2011
and the final data collection deployed in October 2011 during Breast Cancer Awareness
Month with data collection continuing until January 2012. While deployment during
October was intentionally designed, it is also a consideration that individuals might have
reached saturation from breast cancer media awareness campaigns, requests for
donations or event participation requests that might have resulted in a negative impact
to receipt of the study invitation.
External validity. The potential for sampling bias must be explored. A
convenience sample was used for this study and required access to the internet as part
of the inclusionary criteria. It is therefore anticipated that there was sampling bias within
the pool of respondents. The internet divide continues to be a limiting factor in internet
based research and was a known limitation of the study at its inception. The Pew
Research Organization recently noted that 78% of women had access to the internet as
of August 2011, noting that significant factors in on-line use included being younger
than 65, having a minimum of a high school education and reporting an annual
household income of greater than $30,000 (2011). Race emerged only as an issue in
terms of access to sufficient broadband (Pew Research Organization, 2011). They
further noted that despite improvements over the past decade, 20% of Americans
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choose not use the internet (Pew Research Organization, 2011), further limiting the pool
of potential respondents in the sampling frame and potentially creating non-sampling
bias. Therefore respondents who chose not to participate for any reason may represent
a different facet of the larger population.
The response rate was extremely low for the final data collection (10.4% for the
pilot study and 0.4% for the final data collection), although this was anticipated based
on the decision to use snowball recruitment sampling with a large non-targeted
population as the primary contact to locate partiCipants via the study invitation. It is not
possible to know how many BCS received the original invitation from the PI, versus how
many received a forwarded e-mail from a second or third-level contact. It is also not
possible to know whether individuals receiving the e-mail from a known contact
influenced response rates, or how many initial contact recipients decided to forward the
invitation to others. Individuals can also change e-mail addresses and initial forwards
may not have reached respondents, even if primary recipients of the participation
invitation attempted to forward the information to an eligible BCS. It was also possible
that the invitation to participate was forwarded to a spam file, thus removing the e-mail
from an eligible respondent's mailbox.
It was not feasible to authenticate the eligibility of the respondents since contact
information was not obtained and additional anonymity controls, such as discarding IP
addresses collected by SurveyMonkey immediately following data downloads, were
practiced. Three participants contacted the investigator via e-mail with problems related
to the link to the survey. No errors were found in the SurveyMonkey mechanism, but
broadband differences, user error and browser conflicts could have reduced response
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rates. It is therefore likely that there were other women who experienced difficulty and
chose not to take the additional step to contact the investigator to receive assistance.
Furthermore, twenty-seven participants were ineligible to participate once their
demographic data was reviewed due to failure to meet the time-since-diagnosis
inclusionary parameter.
While minority access to the internet has increased, it was extremely difficult to
recruit a representative sample of BCS approximating U.S. minority population
estimates for this population. Only 3.2% of the study sample self-identified as
Black/African American (n

=5) or Hispanic (n =5) respectively, and only 1 person

identified herself as Asian (0.6%). 1m and Chee (2005) in a study on internet recruitment
for breast cancer research, reported significant difficulty recruiting BCS in minority
communities due, in part, to the inability to establish trust since the researchers
remained outside the organizational structure and lacked the face-to-face contact of
traditional research methods. Experiences in recruitment for this study mirror their
findings. Attempts to secure participants from breast cancer support groups serving
minority communities were unsuccessful; multiple organizations in NY and NJ simply
did not respond to outreach efforts. Anecdotally, two key stakeholders in non-profit
organizations serving minority members told the PI that they have increasing requests
from researchers asking for internet or direct access to their members. They further
reported that their non-profit organizations, struggling with reduced budgets, limited staff
and a primary mission of service delivery, do not always have time to vet requests and
decide on the merit and benefits of a particular study to their members. The racial
background of the researcher must be considered as well when using snowball
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recruitment to obtain a convenience sample. The majority of the primary personal and

I

professional contacts requested to forward the study invitation were Caucasian. While

1

the Seton Hall recruitment announcements to the South Orange and Newark campuses

J

reached a diverse population, it is also more likely that individuals who knew the primary
investigator directly or peripherally would be more responsive to forwarding the
recruitment announcement to others. This was confirmed by examining the survey
collectors on Survey Monkey. Individual URLs were generated by the software in
response to naming the origin point for the collector. As an example, support groups
from cancer organizations yielded 4 responses, whereas professional contacts known to
the investigator yielded 36 responses.

I]

It is also possible that self-selection bias occurred. The study invitation asked all
BCS meeting the eligibility criteria to participate, regardless of whether they were
experiencing symptoms at the time of survey completion. It is possible that women who
experienced some difficulties now or in the recent past might have been more likely to
complete the survey. In light of these factors, interpretation of the data must be
considered with caution.
The free-text comments for the optional questions could not be used to generate
inferences about the needs of the population due to the limited number of responses but
did provide an opportunity to obtain additional information about the impact of fatigue
and upper extremity function on daily activities. Garcia, Evans, and Reshaw (2004)
noted that free comments tend to contain more negative than positive statements but
may be used to generate ideas for future research. In this study, the investigator also
could not request clarification of responses generated in the optional questions, the
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majority of which were single word responses. In a study designed for direct contact
with the respondents, additional questions requesting elaboration would have been
posed. As a result, the limited data received from the participants could only be coded
into key ICF and OTPF categories, but the opportunity to explore these responses in
greater depth was not possible.

Selection-instrumentation interaction. The FACIT-F and the DASH offer wellestablished psychometric properties that have been documented in other research, as
well as nationally normative scores that are described earlier in this thesis. However,
there are some concerns about the observation of floor and ceiling effects for the scores
in this sample of BCS, particularly for the DASH-W, the optional work module. Ceiling
effects result from test items or scales that are not sufficiently difficult for the
respondents, resulting in a subset of individuals attaining the highest possible score that
indicates maximal functional ability (Canadian Stroke Network, 2012; Polit & Hungler,
1995; Portnoy & Watkins, 1993). Floor effects result from individuals scoring at the
lowest possible score that indicates least functional ability (Polit & Hungler, 1995;
Portnoy & Watkins, 1993). As noted, a Significant number of BCS reached the ceiling
scores for the DASH (n = 21, 13.7%) and DASH-W (n = 84, 53.2%) with the least
number of BCS reached the ceiling scores for the FACIT-F (n = 6,3.8%). Polit and
Hungler (1995) noted that the presence of ceiling and floor scores can decrease the
correlations between the test scores and other attributes of interest (p. 556). This was
not observed in this study since the only correlation performed was between the FACIT
F and DASH scores, resulting in a moderate correlation between CRF and upper
extremity function (p < .001). However, the number of ceiling scores observed on the
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DASH-W raises considerable questions about the ability to interpret the results for the
optional scale.
There are few studies that document use of the DASH Optional Work Module
(DASH-W) beyond the publisher's website. The DASH-W has been used in one study to
identify at-work disability, a concept that examines the impact of disability on individuals
while they engage in work as opposed to measuring out-of-work status of individuals
experiencing upper quadrant disability (Tang et aI., 2009). This study was of interest
since the majority of BCS were actively employed at the time of survey completion; 98
BCS (62.0%) were employed full-time

(~35

hours), 21 (13.3%) were employed part

time « 35 hours), and 16 (10.1%) were full-time homemakers which is considered an
employment category under the DASH-W.
Tang et al. examined the psychometric properties of the DASH and other at-work
instruments in a sample of 80 injured workers employed outside the home who were
working with adjustments to their job responsibilities or decreased working hours
secondary to their injuries (2009). The authors noted that the DASH-W performed as
well as two other work disability scales, the WLQ-16 (Work Limitations Questionnaire)
and the RA-WIS (Work Instability Scale for Rheumatoid Arthritis), but they felt that its
brevity poses a problem for the psychometric strength of the scale. Scoring is not
possible on the DASH-W unless all items are completed, whereas the DASH can be
scored if up to 3 responses are missing (Kennedy et aI., 2011). The limited number of
items on the optional DASH-W, compared to the core DASH evaluation tool, posed
interpretive challenges for this study. The small number of items, relative to the
comprehensiveness of the global DASH, did not appear to fully capture the work
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experiences of the respondents and ceiling effects were reached in 88 BCS (55.7%) of
the study sample, yet work was an area that generated additional comments from the
BCS in the optional questions. Brach et al. (2004) reported that BCS vocational and
financial concerns are areas that are not always adequately addressed in cancer
survivorship.

Survivorship Surveillance
The American Society of Clinical Oncology publishes recommended guidelines
for surveillance of cancer survivors. Recommendations for breast cancer survivors
include visits to a physician "every three to six months for the first three years after the
first treatment, every six to 12 months for years four and five, and every year thereafter"
(Cancer. Net, 2011, p.1). The guidelines focus on physician visits to monitor for
recurrence, encourage mammography, and the development of any new breast-related
symptoms or long term impact from adjuvant therapies.
A retrospective chart review examining the impact of physician specialty on
follow-up of breast cancer survivors revealed that adherence to the guidelines is
inconsistent, particularly when examining follow-up six years after initial treatment
concluded, and especially for patients followed for their breast cancer by primary care
practitioners (PCP) rather than oncology teams (Hollowell et aI., 2010). Hollowell et al.
(2010) further reported that due to increasing survivorship, it is likely that many BCS will
have their care transferred to a PCP after five years. The ASCO guidelines are unclear
as to the need for follow-up for any persistent symptoms resulting from the cancer or its
treatment, such as CRF or upper extremity function or difficulties in task performance. In
fact, the study by Hollowell et al. (2010) represented the only study available that
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researched documented follow-up efforts for BCS. Therefore, while guidelines from the
Fatigue Coalition, the National Cancer Institute (NCI) and others have strongly
recommended ongoing fatigue monitoring, the monitoring of persistent problems does
not appear to have been translated into documentation to assist patients or oncology
teams. Longitudinal monitoring for the development of upper extremity dysfunction is
not noted in these materials. Functional performance in critical areas of occupation is
not even alluded to, with the primary emphasis focused on body functions and
structures.
Engel's biopsychosocial model (1977) and the ICF (2001) were conceptualized
as broader holistic frameworks and taxonomies supporting health that require a
paradigm shift away from a biological focus. There is documented recognition for this
shift in the increasing number of published studies that integrate a HRQOL measure
into outcome variables (Gotayet aI., 2008), but the question remains as to whether this
recognition will be translated into clinical practice in a manner that meets the changing
needs of survivors.
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Chapter VI

Summary and Conclusions
Summary
This cross-sectional exploratory study of 158 BCS examined the relationship
between breast cancer survivors' perceptions of cancer-related fatigue (CRF) and upper
extremity function one year to six years post-diagnosis. The study further sought to
investigate the impact of multiple adjuvant therapies and node dissection procedures on
CRF and upper extremity function. In addition, the role of caring for children living at
home who are dependent upon the BCS for completion of daily activities was examined
using the same key constructs. Finally, the differences in multiple adjuvant therapies
and node dissection status on physical aspects of employment were explored.
Cancer-related fatigue and arm morbidity constitute the two most common
symptom complexes impacting breast cancer survivors following treatment (Sadler et
aI., 2002; Portnoy & Itri, 1999; Vogelzang et aI., 1997; Curt et aI., 2000, Bower et aI.,
2006; Collins et aI., 2004; Reitman et aI., 2003), but these multifaceted entities have
traditionally been researched as if they were separately occurring events in the
survivor's recovery. Many BCS, as noted in this exploratory study. have successfully
resumed life roles and desired activities in the years that follow the conclusion of
surgery and adjuvant therapies. Yet some women continue to struggle with fatigue and
arm morbidity that alter participation and quality of life.
A subset of women identified in this study and others, constituting approximately
17-25% of the overall population (Gerber et aI., 2010; NCCN, 2006; Young & White,
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2006; Sadler et al., 2002, Cella et aI., 2001) and 22% in this study sample, experience
prolonged or persistent fatigue symptoms that are significant, persistent and would fulfill
the criteria for a diagnosis of cancer-related fatigue. Forty-five percent of the fatigued
subset of BCS in this study also demonstrated significant limitations in upper body
function. In addition, the overall BCS in this sample demonstrated signi'ficantly higher
levels of fatigue when compared to a national representative sample of adults. Women
who continue to experience persistent fatigue, upper extremity symptoms or activity
limitations require more effective identification, follow-up and referral to facilitate
successful navigation of post-treatment permanent survivorship. The results from this
study support the need for additional research on the relationship between these two
common entities, as well as development of interventions that address the needs of this
growing population.
Researchers and policy makers, having taken note of the increasing number of
cancer survivors and anticipated survivorship population growth, have produced
statements supporting the need for healthcare practitioners and community agencies to
monitor and address the long-term needs of survivors living with persistent symptoms.
NCCN (2006) and the CDC (2005) have statements supporting the longitudinal
monitoring of cancer survivors as a chronic disease state. The American Society of
Clinical Oncology, 2006 (Cancer. Net, 2011), and the National Comprehensive Cancer
Network [NCCN] (2012) publish recommended guidelines for longitudinal clinical
surveillance of cancer survivors. Recommendations for BCS include visits to a
physician "every three to six months for the first three years after the first treatment,
every six to 12 months for years four and five, and every year thereafter" (Cancer.Net,
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2011, p.1); similarly the more recent NCCN guidelines recommend visits every "4 - 6
months for five years, then every 12 months" (2012, p. BINV-16). Surveillance visits to
oncologists or primary care practitioners offer a unique opportunity to identify
underreported and underecognized symptoms, such as CRF and arm morbidity. Based
on the results from this study, it is suggested that the goal of visits expand beyond
monitoring BCS for recurrence of cancer to inquire about the specific impact of any
residual symptoms on daily activities and life roles, including employment, socialization
and community participation. Assessments could be forwarded prior to patient visits or
completed in the waiting room and scored by trained office staff. Individuals who self
identify or are identified by the oncology team could then be referred to appropriate
medical services, nurse navigators, rehabilitation services such as occupational or
physical therapy, or community-based programming. Reviewing results from
assessments would afford the opportunity for a dialogue between the BCS and the
team.
The recent study by Thomas-Maclean et aL (2012) confirmed earlier findings
(Gerber et aL, 2010; Collins et aL, 2003; Stone et aL, 2003, Passik et aL, 2002;
Vogelzang et aL, 1997) that survivors do not discuss persistent symptoms with their
healthcare professional or feel as though they have received sufficient information.
Therefore it is imperative that healthcare practitioners and teams take responsibility for
asking questions during surveillance visits. The need for continued monitoring of these
two entities should not be viewed solely from the perspective of recording fatigue scores
or measuring limb circumference for potential lymphedema or ongoing pain in the
affected extremity. Moving beyond physiological and anatomical areas of concern that
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the ICF defines under body functions and structures (WHO, 2001) can increase the
conversation about the more pressing life concerns of BCS. It is of interest that
Thomas-Maclean et al. reported one reason for failure of patients to raise their
concerns with the treatment team was the "expectation that symptoms would abate if
certain activities were ceased" (2008, p. 69). As the focus of the ICF (2001) is to enable
individuals to increase participation in all life spheres, self-limiting activities due to
perceived impairments may further reduce participation, diminish HRQOl and may not
adequately address the experienced symptoms. As higher levels of self-reported
HRQOl have been linked in some studies to breast cancer survival (Gotay, Kawamoto,
Bottomley, & Efficace, 2008), it is important to be cognizant of women's perceptions of
persistent symptoms and their ability to function in daily life.
Limitations in internet recruitment, particularly the use of snowball methodology
as the primary source to obtain the sampling frame, posed substantial challenges
including a low response rate that left the sample vulnerable to selection bias. In order
to further our understanding of the relationship between CRF and upper extremity
function identified in this study, in-person population recruitment with a more diverse
BCS population is recommended for future research.
Clarification by expert panels is needed to identify gold standard measurement
tools for CRF and particularly for upper extremity morbidity in order to facilitate
comparisons between studies. Adoption of a gold standard reference tool for CRF is
also indicated in light of the anticipated ICO-10 diagnostic criteria for Neoplastic
(Malignant) Related Fatigue. There is a wide array of validated fatigue assessment tools
available, including the FACIT-F, but none have emerged as the benchmark tool for use
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with oncology patients. Unidimensional assessments such as verbal or visual
assessment scales are arguably more efficacious in clinical practice settings, but cannot
capture the breadth of the functional concerns of BCS or the variability of the fatigue
experience (Butt et aI., 2008; Schwartz et aI., 2002). The fatigue screening tool recently
developed by an expert panel at NCCN (2010) does not incorporate questions about the
impact of fatigue on daily performance that supports participation in all life spheres.
Similar dilemmas are found when considering standards for assessment of upper
extremity function as there are additional concerns about whether upper extremity
assessment for longitudinal surveillance should be measured by objective or subjective
means. The lack of congruence noted in some studies between measured arm function
and self-perceived function (Hack, 2010; Hayes et aI., 2010) is noteworthy. While many
studies support the use of objective measures as the gold standard for identification of
lymphedema, Park, Lee, & Chung (2008) posited that women may perceive changes in
arm function before current objective measures can accurately detect subtle changes.
The imperative to address upper arm morbidity systematically is pressing since
lymphedema incidence rates increase in the years post-treatment and this condition,
once acquired, cannot be cured (Park et aI., 2008).
However these two symptoms complexes represent only two facets of survivors'
concerns. Indeed, Huber et al. (2010) reminds us that the ICF "takes as its central tenet
the individual's experience with illness" (p. 1955). Seaburn (2005) admonishes us to
consider Engel's BPS model as a rationale for integrated, collaborative clinical care that
focuses on the patient's lived experience with the illness as "a whole fabric, indivisible"
(p. 398). Therefore to maintain a more holistic biopsychosocial approach, assessments
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and interventions should ultimately begin with the survivor's narrative and address all
components within a framework of the impact on daily living and participation in context.
In addition to concerns regarding instrumentation and ongoing surveillance, the
'findings suggest the need to further our understanding of the relationship of CRF and
upper extremity function, including the role of adaptation and compensatory strategies
on function. We do not yet understand the extent to which women may be
compensating, adapting or giving up activities in order to continue to meet task
demands and fulfill life roles. Several women indicated on the optional open-ended
questions that they had adapted their method of completing daily tasks at home or work.
Collins et al. (2004) noted that women reported using their contralateral extremity to
complete tasks, such as heavy household activities and specifically notes the use of
attempts to develop compensatory strategies in order to meet task demands. Further
elucidation of the extent and manner in which women are adapting, compensating for,
or eliminating desired or required occupations is indicated as this is not an area that has
been well explored in the literature.
Consequently, it is incumbent upon us to consider Frank's admonishment that
current health care practices do not assist the individual to live easily in the world
following life-threatening illness (1995). Mullan's (1985) visually compelling metaphor of
pulling the survivor out of the water only to leave the person floundering on the dock is
apt. There is a surfeit of core research demonstrating that CRF and arm morbidity are
present in sufficient numbers to warrant ongoing longitudinal monitoring. Additional
research on the development of interventions that address these problems and enhance
participation are needed.
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The education of BCS about CRF and arm morbidity can begin earlier in the
diagnostic and treatment continuum and should include assessment of fatigue and arm
function, with circumferential baseline measurements of the upper extremities before
surgery that could permit more effective monitoring and comparisons of symptoms that
persist over time.

Conclusions
Based on the review of the literature to date, this study constitutes the first
attempt to directly explore the relationship between CRF and upper extremity function
as a primary research outcome. A moderate significant relationship between these two
constructs was demonstrated in this small, exploratory cross-sectional study, as well as
an increase in perceived fatigue in women who care for dependent children. Exploration
of CRF and upper extremity function in relation to node dissection status and number of
adjuvant cancer modalities received resulted in insignificant findings. Exploration of the
number of adjuvant cancer therapies received and node dissection status in relation to
physical work tasks identified a positive trend for only the number of adjuvant cancer
therapies received, but did not reach significance. While the results from this study
cannot be generalized, the findings offer insights to stimulate further exploration.
Barriers and affordances to facilitate partiCipation of BCS in all environments should be
identified. A larger more representative sample is needed to confirm the findings and
better understand the factors contributing to these relationships.
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Definitions and Terminology
The following operational definitions for terminology related to functional activities
and occupational performance were used throughout the study.

!

Activities of Daily Living: "Activities that are oriented toward taking care of one's own
body (American Occupational Therapy Association [AOTA] Commission on Practice,
2002, p.620). These activities include the following: bathing, showering, bowel and
bladder management, dressing, eating, feeding, functional mobility, personal and
environmental device care, personal hygiene and grooming, toileting, sexual activity,
sleep and rest (American Occupational Therapy Association [AOTA] Commission on
Practice, p.620).

Functional status: "An individual'S performance of activities and tasks associated with
life roles" (Richmond, Tang, Tulman, Fawcett, & McCorkle, 2004, p. 84).

Instrumental Activities of Daily Living: "Essential self-maintenance activities that are
used to measure independent living capability that are not considered as basic daily
living activities of self-care tasks" (Jacobs, 1999, p.71). These activities include the
following: care of others, care of pets, child-rearing, communication device use,
community mobility, financial management, health management and maintenance,
home establishment and management, meal preparation and clean-up, safety
procedures and emergency responses, and shopping (American Occupational Therapy
Association [AOTA] Commission on Practice, 2002, p.620).
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Occupational performance: 'The ability to carry out the activities of daily life. including
activities in the areas of occupation: activities of daily living (ADL). instrumental activities
of daily living (lADL). education, work. play, leisure, and social participation (American
Occupational Therapy Association [AOTA] Commission on Practice, 2002, p.617).
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Table 8
DASH Functional Activity Items Exhibiting Highest Levels of Perceived Impairment (N =
153)
Activity
No Difficulty (Percent)
Mild Difficulty to
Unable (Percent)
Open a Jar
39.2
60.8
Recreational activities
51.0
49.0
requiring force or impact
54.9
Carry a heavy object (> 10
45.1
Ibs)
56.9
43.1
Heavy housework
41.8
Garden or yard work
58.2

Table 9
DASH Arm Symptoms Exhibiting Highest Levels of Perceived Impairment (N = 153)
Symptoms
None (Percent)
Mild to
Severe Difficulty (Percent)
47.0
53.0
Pain when performing
specific activity
46.7
Stiffness
53.3
44.4
55.6
Weakness
57.2
42.8
Pain
40.8
Tingling
59.2

188

Appendix C

Optional Questions: Daily Activities Impacted by Arm Dysfunction or Fatigue

189
Table 10
Optional Question: Daily Activities Impacted By Problems With Arm Function (n
22)
ICF and OTPF
Responses
Classifications
Domestic Life,
I cannot write with a pen for more than a few sentences so I no longer
household tasks,
keep a journal.
Caring for household
objects and assisting
My writing and drawing have changed.
othersa [IADL ~
Gardening. Housework. 1

=

Driving
Helping my disabled son is sometimes painful, so I ask my husband
for help.
Lifting my children, moving things.
Working with my dogs.
Work & Employmenta
[Work~

Since I have implants, my pectoral muscle function limits some
manual techniques I need for work as PT, but I have modified.
Working at my desk is sometimes uncomfortable because of arm,
shoulder pain/pins and needles.
Trying to close a pad lock or a 3-ring binder.
Delivering babies - some techniques I can't do.
I am taking anastrazole daily, and I find in the winter that I have
occasional pain in my wrists that makes typing and working out
somewhat uncomfortable. It comes and goes, typically indicating
when we are going to get rain or snow.
I used to take care of a patient who was semi-comatose and I had no
mobility. Because of my diagnoses and subsequent physical
limitations (could lift no more than 5 - 10 Ibs with my left arm) I had to
leave my job.

Recreation and
Leisurea
[Leisure b]
ICF classificationsa
OTPF categoriesb

Exercise (involving use of muscles across chest and heavy weights)1
Exercise - finding a type of physical activity that does not aggravate
my arm.

~
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Table 8
Optional Question: Daily Activities Impacted By Problems With Arm Function Symptoms
(n ;:: 22)
ICF and OTPF
Responses
Classifications
Sleep FunctionsS
The tissue expanders are uncomfortable - especially if I try to lay on
[Sleepb]
my side to sleep [waiting for reconstruction]
Body Functions and
StructuresS [Body
Functions and
Structures b]

Strength, rotation of shoulder.

I still do everything, but I do less of it at a time and much more slowly
than I used to.
Everyday, everything. The arm has lost a lot of power, strength,
energy ... I am lucky that my affected arm is my non-dominant
arm ... so the answers on any survey could change a bit.
Carrying anything heavy as dead weight. I need to support the weight
against my body or suffer increased symptoms.
No [problems], but wearing jewelry on my left hand/arm (rings/watch)
can be annoying depending on swelling.
Lifting.
Some pain in breast when opening heavy doors.
Most noted pulling heavy door, modify with body weight.
Cannot lift things as heavy as I used to.

I cannot lift as heavy an object as I used to because I lost some
muscle tone while going through treatments. I lost a lot of weight
including muscle while in treatment and have been working to get it
back. I'm lucky my arm function is fine.
Very mild occasional pain around reconstruction area but this does
not limit my activities.
ICF ""1",,,,,,,,·tl,...~.1'll"\n"'Y
OTPF categoriesb

191
Table 11
Optional Question: Daily Activities Impacted By Problems With Fatigue (n
ICF and OTPF
Responses
Classifications
Self-carea [ADL b]
Trying on tops and coats.

=29)

Getting ready in the morning takes much longer due to fatigue.
Domestic Life,
household tasks,
Caring for household
objects and aSSisting
othersa [IADL b]

Getting specific things done on time.
Challenging to take care of three small children and I am exhausted
driving them to school, extra-curricular activities, etc.
Cleaning my house, carrying bags or laundry.

Work & Employmenta
[Workb]

I am a lecturer/teacher - I tire more easily so while it does not affect
work, when I am done, I am very tired.
Going out for long periods of time. Just can't. Night deliveries (babies)
tire me out much more now.
Working.
It impacts my work.

Recreation and
Leisurea
[Leisure b]

Exercising.
Exercising.
Exercise, reading.
Trying to just sit and read a book.
Exercise classes.
Exercise and gym time.

Support and
Relationshipsa
[Communication and
Social Skills b]
OTPF categoriesb

Cancel scheduled appointments due to fatigue, social life is greatly
impacted by fatigue.
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Table 11
Optional Question: Daily Activities Impacted By Problems With Fatigue Symptoms (n 29)
ICF and OTPF
Responses
Classifications
Sleep Functions 8
Sleeplessness.
[Sleepb]
I cannot get as many things done as I used to because I get tired
easier and I need to rest. I need more sleep, and I go to bed earlier
than I used to, usually by 9 PM.

=

J

Sometimes for no reason I feel extremely exhausted. I need to nap
sometimes around 3 PM. I am also having trouble sleeping through
the night.

1

I
1

Body
Structuresa [Body
Functions and
Structuresb]

1

Walking due to the numbness felt on my feet.
This is affected by additional causes, like having a mild cold, for
instance.

1
j

HOT FLASHES.

1

Fatigue impacts everything.

I

I feel my fatigue is just related to working, house chores and running
around.

I
I

Fatigue is only that which is normal for a 58 year old with a fast paced
work schedule.

1
I
1
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I have slightly less energy than I used to, but it doesn't stop me from
doing anything in particular. I'm lucky.

I just don't have the energy to do anything.
I do almost anything I did prior to breast cancer however the fatigue
that follows often is limiting.
ICF classifications a
OTPF categories b
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Meryl Picard, MSW, OTR
31 Crest Drive
Murray Hill, NJ 07974
Dear Ms. Picard,
The Seton Hall University Institutional Review Board has reviewed your research
proposal entitled "The Relationship between Cancer-Related Fatigue and Upper
Extremity Function in Breast Cancer Survivors" and has approved it as submitted under
exempt status. Enclosed for your records is the signed Request for Approval form.
Please note that, where applicable, subjects must sign and must be given a copy of the
Seton Hall University current stamped Letter of Solicitation or Consent Form before the
subjects' participation: All data, as well as the investigator's copies of the signed
Consent Forms,nlust be retained by the principal investigator for a period of at least three
years following the termination of the project.
Should you wish to make changes to the IRB approved procedures, the following
materials must be submitted for IRB review and be approved by the IRB prior to being
instituted:
•

•
•

Description of proposed revisions;
If applicable, any new or revised materials, such as recruitment fliers, letters to
subjects, or consent documents; and
If applicable, updated letters of approval from cooperating institutions and IRBs.

At the present time, there is no need for further action on your part with the IRB.
In harmony with foderal regulations, none ofthe investigators or research staffinvolved
in the study took part in the final decision.

Sincerely,

~4~>fJlJb.

Mary F. Ruzicka, Ph.D.
Professor
Director, Institutional Review Board
cc: Dr. Genevieve Pinto Zipp

Presidents Hall· 400 South Orange Avenue • South Orange, New Jersey 07079-2641 • Tel: 973.313.6314 • Fax: 973.275.2361
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SETON HALL UNIVERSITY

September 28, 2011

Meryl Picard, MSW, OTR
31 Crest Drive
Munay Hill, NJ 07974

Dear Ms. Picard,
The IRB hereby approves the following requested amendments to your research protocoL
"The Relationship between Cancer-Related Fatigue and Upper Extremity Function in
Breast Cancer Survivors":
1. to change the wording of four questions in the original survey and adding three
new questions
2. anlending the recruitment e-email to reduce redundancies and alert potential
respondents that they may not complete the new survey if they were participants
in the data collection earlier this year
3. adding a paper· copy of the letter~ directed only.to breast cancer survivors, for
lcaving flyers with interested parties such as SUppOlt groups.
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Your stamped paper recruitmellt flyer is enclosed. Make copies only of this fonn.

Sincerely,
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Mary F. RUZIcka, Ph.D.
Professor
Director, Institutional Review Board
cc:

Dr. Genevieve Pinto Zipp

Presidents Hall ". 400 South Omnge Avenue • South Orange, New Jersey 07079-2641:" Tel: 973.313.6314 • Fax:973.275.2361
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RE:

Dear Breast Cancer Survivor,

My name is Meryl Picard and I am a doctoral student at Seton Hall University in South Orange, NJ. My
dissertation project explores the two most common problems, cancer fatigue and ann symptoms, that
affect some women after surgery and treatment. I need your help in understanding women's experiences
with these problems that might interfere with the ability to complete daily life activities that you want to
do or have to do.
At this time there is limited understanding of the relationship between these two problem areas.
Your responses are very important, even if you are not experiencing any ofthese problems at the present
time. You may participate in this research if you:
•
•
•
•

Are between 18 -65 years old
Can read English and have access to the Internet
Have had a diagnosis of breast cancer, Stage 0 - ill (please, no metastasis or Stage IV)
Completed all your surgery, radiation or chemotherapy a minimum of 1 year ago (> 12 months)
and less than 6 years ago « 72 months).

The questions will only take 15 minutes to complete. Your responses are completely voluntary and will
be kept confidential. This is a completely anonymous survey. Please do not (:cmp!ete the SUlTey ~1gal11
if yon responded earlier this year.
Click on the link below (or cut and paste the survey link into your Internet browser) to begin. This
research study has been approved by the Seton HalI University Institutional Review Board, which
monitors all research studies to protect human subjects. If you have any questions about your rights as a
participant in this study, please contact the Chairperson of the IRS at (973) 313-6314. Questions about
the research study can be answered by contacting Meryl Picard at (973) 275-2910,
meryl.picard@shu.edu.

Thank you for providing your valuable time to help us understand these symptoms in breast cancer
survivors.

Seton Hall University
Institutional Review Board

SEP 28 2011
Approval Date
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Meryl M Picard
From:
Sent:
To:
Subject:

Greer Palloo [gpalloo@iwh.on.ca]
Tuesday, January 26, 2010 12:41 PM
Meryl M Picard
DASH use permission

Dear Meryl,
The Institute for Work & Health is pleased to grant you permission to use its DASH Outcome Measure for your doctoral
study in the manner described on the user profile form dated and submitted on January 22, 2010.
We wish you all the best with your project.
Sincerely,

Greer
(Ms) Greer Palloo
Information & Events/DASH Coordinator
Knowledge Transfer & Exchange Department
Institute for Work & Health
481 University Avenue, Suite 800
Toronto, Ontario M5G 2E9 Canada
T 416-927-2027 x 2131 F 416-927-4167
gpatloo@iwh.on.ca
www.iwh.on.ca

This e-mail may contain confidential information for the sole use ofthe intended recipient.
Any review or distribution by anyone other than the person for whom it was originally intended is prohibited.
If you have received this e-mail in error please delete all copies.
Opinions conclusions or other information contained in this e-mail may not be that of the organization.
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FACIT-F Permission
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Meryl M Picard
From:

Sent:
To:
Subject:

FACIT [information@facit.org]
Friday, January 13, 2012 5:29 PM
Meryl MPicard
Thank you for your enquiry

Dear Meryl,

Thank you for registering with FACIT! If you've registered for a translation of a FACIT
scale, we will contact you with the questionnaire via email. If you've registered to use an
English version but require a letter of permission, please send an email to
information@facit.org and we will respond. If you don't hear from us within five days, please
send an email to information@facit.org. Below is a summary of your information:

Summary of web form submission:
Your Name
Meryl Picard
Email Address
meryl.Qicard@shu.edu
Case Number
3288022
Company
Seton Hall University
Username
Your record has an existing username. This will be emailed to you. [meryl.picard@shu.edu] 
has been ignored.
Password
Your record has an existing password. This will be emailed to you. [nextgenot2910] - has been
ignored.
Work Address
480 South Orange Avenue South Orange, NJ 87974 United States Cell Phone Number
973-275-2910
Terms of Use
I Accept the Terms of Use
Department within Company
Occupational Therapy
Study Type
Cancer-Related Fatigue
Study Title
CANCER-RELATED FATIGUE AND UPPER EXTREMITY FUNCTION IN BREAST CANCER SURVIVORS Funding Source
None Total expected or actual number of study participants
138

Questionnaire(s)
FACIT-F, DASH
Countries or Language(s)
United States
Do you require a letter of permission?
1
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Meryl M Picard

From:
Sent:
To:

Subject:

Jason Bredle Ubredle@facit.org]
Wednesday, September 02, 2009 1:54 PM
Meryl M Picard
RE: copyright and permission question

Hi Meryl..
That's totally fine. In fact .. we've used survey monkey in the past to carry out some
linguistic validation.
Thanks..
Jason
Jason Bredle
FACIT.org
+1. 773.807.9094
From: Meryl M Picard [Meryl.Picard@shu.edu]
Sent: Wednesday.. September 02.. 2009 12:32 PM
To: 'information@facit.org'
Subject: copyright and permission question
Dear FACIT.org:
I wrote to you one year ago and received permission to use the FACIT-fatigue for a
dissertation study on cancer-related fatigue and breast cancer survivors. Unfortunately.. the
original RCT is now in the process of revision due to poor recruitment response for the
clinical trial after the U.S. economy collapsed.
Before I complete the new user profile request.. I wanted to ask if your organization would
permit the use of the FACT-fatigue as part of on-line survey research. I will use Survey
Monkey (surveymonkey.com) as the platform to host the dissertation study. The FACT-fatigue
would only be available to study volunteers who respond to a participation invitation.. and
are then directed to a designated URL link established for my research. In other words .. the
FACT-fatigue would not be placed on a publically available website that anyone could access.
Survey Monkey will also permit me to design the research survey to permit copyright credit of
the FACT-fatigue on the actual survey site.
Please advise as to whether this is possible.
Sincerely..
Meryl Marger Picard.. MSW.. OTR
Assistant Professor
Department of Occupational Therapy
School of Health and Medical Sciences
Seton Hall University
400 South Orange Avenue
South Orange.. New Jersey 07079
(973) 275-2910
meryl.picard@shu.edu
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Appendix G

Demographic Survey Questions

* 1. What is your age?
I

I

* 2. What state do you live in?

State:

* 3. How do you identify yourself?
o

o
o
o
o

Black/African American

Hispanicllatino
Native Hawaiian/Pacific Islander
Asian
White/Caucasian

Other (please specify)

*4. What is your marital status?
o
o
Never married

o
o
o
o
o

Single

Married
living with a significant other
Widowed
Divorced
Separated

* 5. What is your highest level of education?

o
o
o
o
o

Some high school
High school degree
Associate's degree or some college
College degree
Graduate degree or higher

Breast Cancer Survivors Fatigue and Arm Function Survey
*6. Which term BEST describes your current work situation?

o

o
o
o
o
o
o
o
o
*
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Unemployed
Full-time employed (35 or more hours per week)
Part-time employed «35 hours per week)
Leave of absence
On disability
FUll-time student
Part-time student
Full-time homemaker
Retired

7. Has your work situation changed as a result of problems from your breast cancer?

ONO

o

Yes

8. Has your work situation changed as a result of the economy?

ONO

o

Yes

9. Which hand do you use to write?

o
o

Right hand
Left hand

*

1O. What year were you diagnosed?

Four digit year

11. Which side was your breast tumor located?

o
o
o

Right side
Left side
Both sides

*12. Have you had more than one episode (recurrence) of breast cancer?

ONO

o
o

Same side as first episode
Opposite side of firsl episode

Breast Cancer Survivors Fatigue and Arm Function Survey
*13. What was the tumor stage when you were diagnosed?

0
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0

01
011

Om

o

Do not know

* 14. What type of surgery did you have (Check all that apply)?
D
None

D
D

D

Lumpectomy
Mastectomy
Breast reconstruction

*15. What type of node dissection did you have to determine the cancer diagnosis?

o
o
o
o
o

None
Axillary node dissection
Sentinel node dissection
Both
Do not know

If you had node dissection, how many nodes were removed?

*16. What type of cancer treatment did you receive after your surgery? (Select all that
apply.)

D
D
D
D

D

None
Chemotherapy
Radiation
Immunotherapy
Hormone therapy

*17. Have you ever been diagnosed with lymphedema?
ONO

o

Yes

Breast Cancer Survivors Fatigue and Arm Function Survey

* 18. Are you currently receiving treatment for your arm from an occupational or physical
therapist?

206

ONO

Oves

* 19. Do you wear a compression sleeve?
Ves
Never
While exercising
While doing heavy
household work (laundry,

No

0
0
0

o
o
o

0
0

o
o

vacuuming, raking)
When I fly on a plane
Always

* 20. Do you perform compression wrapping with lymphedema bandages?
ONO

Oves

* 21. Do you have fatigue (a tired feeling) at least twice a week that keeps you from
completing any or all of these daily activities?
Ves
Self-care
Care of others
Household tasks such as
cooking, cleaning or yard

No

0
0
0

0
0
0

0
0
0
0

0
0
0
0

wor1<
Shopping or errands
Doing your job at work
leisure or relaxation
Socializing with friends and
family

22. List the ages of children living in your house that depend on you to help them to
complete daily life activities, including self-care, chores, school activities or play:
Age of child 1
Age of child 2
Age of child 3
Age of child 4
Age of child 5

